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Introduction: Adherence to treatment is an important factor for effective therapy and 
limiting the emergence of drug resistant tuberculosis.  However, the prevalence of TB 
continues to soar despite the available comprehensive treatment. The study 
investigated determinants of adherence to TB treatment and the strategies to enhance 
adherence to TB treatment were designed. 
Method: A quantitative descriptive design was used. Data were collected from TB 
clients in two (2) government hospitals in Eswatini. There were 123 participants in the 
study. Data were collected through individual interviews using an investigator-
designed structured questionnaire. The data were entered into the Statistical Package 
of the Social Sciences (SPSS, version 20.0), analysed using descriptive and inferential 
statistics. 
Results: The results revealed an association between educational level and 
adherence to TB treatment (r = 0.184, p = 0.042). Sixty seven percent (67.5%, n=83) 
preferred western treatment, and 32.5% (n=40) of the participants reported that they 
used other types of treatment for ailments. The data also revealed that illness grants 
were not distributed to all TB clients. A 76.4%, (n=94) of the participants did not get 
illness grants while on TB treatment, whereas, 23.6%, (n=29) received illness grants 
for being on TB treatment. The absence of illness grants is likely to impede adherence 
to TB treatment. Receiving health education before initiation on treatment enhanced 
adherence; where 88.6% (n=109) of the participants reported that they received 
counselling on adherence prior to initiation to TB treatment, and 11.4% (n=14) did not 
get any counselling on adherence. An 80.5% (n=99) participants reported that they 
iv 
 
experienced side effects while on TB medication. There was a relationship between 
barriers and adherence to TB treatment (r = -0.416, p = 0.001).  
Conclusion: The data showed that TB clients had challenges with adherence to 
treatment. Key strategies were developed to enhance adherence to TB treatment; 
empower clients on effects and side effects of each TB drug; periodical evaluation of 
clients for side-effects; strengthening of incentive policy for TB clients; and introduction 
of a one stop centre for all TB clients. 
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ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION  
 
Despite the availability of effective regime, tuberculosis (TB) remains a major global 
health problem; and it contributes to morbidity and mortality among millions of people 
each year (Balaky, Mawlood & Shabila 2019:865). TB is a chronic infectious disease that 
involves a complex treatment regimen with potentially severe side effects. Moreover, it is 
frequently associated with non-adherence to treatment, which may result in drug 
resistance (Meda, Lin, Sombie, Mare, Morisky & Chen 2012:223). Adherence to TB drug 
treatment prevents drug resistance (Kliner, Canaan, Ndwandwe, Busulwa, Welfare, 
Richardson, Walley & Wright 2015:1). Globally, TB is ranked the second cause of death 
among the infectious diseases after Acquired Immune Deficiency Syndrome (AIDS), with 
an estimated 1.4 million TB deaths reported among Human Immunodeficiency Virus (HIV) 
positive TB patients in 2014 (Tola, Tol, Shojaeizadeh & Garmaroudi 2015:1). 
 
Tuberculosis is a curable disease if treatment is received early and taken appropriately. 
Tesfahuneygn, Medhin and Legesse (2015:1) indicate that TB can be cured with anti TB 
treatment if taken over a period of at least six months for new patients and eight months 
for TB recurring patients. This include a standard treatment initial drug combination 
comprising of four drugs; Rifampicin, Isoniazid, Pyrazinamide and Ethambutol which are 
taken daily for 2 months. Thereafter, two drugs (Rifampicin and Isoniazid) are taken for 4 
months in the continuation phase (Elden, Lawes, Kudsk-Iversen, Vandelanotte, 
Nkawanyana, Welfare, Walley & Wright 2011:2; National Tuberculosis Control 











1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM 
 
A major challenge to TB cure is poor adherence to the treatment (Balaky, Mawlood & 
Shabila 2019:865). Gebreweld, Kifle, Gebremicheal, Simel, Gezae, Ghebreyesus, 
Mengsteab and Wahd (2018:2) reveal that poor adherence increases risks of treatment 
failure and relapse. Moreover, it is considered to be the most important cause of multiple 
drug resistant (MDR) and extremely drug resistant (XDR) TB. Adherence to medication 
regimen is generally the extent to which a client’s behaviour coincides with the prescribed 
health care regimen (Kulkarni, Akarte, Mankeshwar, Bhawalkar, Banerjee, & Kulkarni 
2013:67). Therefore, it is important to measure adherence to treatment. This is ensured 
by evaluating the treatment success rate which must be above 85% (Swaziland 
Integrated HIV Management Guidelines 2015:88). 
 
 Suwankeeree and Picheansathian (2014:4) suggest that complete treatment is usually 
an independent choice of patients. Thereby, successful TB control is heavily dependent 
on effective treatment of patients, requiring adherence throughout the full course of 
treatment. Adverse outcomes of non-adherence include treatment failure, relapse and 
increased risk of TB spread. Furthermore, drug resistance, increase mobility and 
mortality, and increase TB control programmes are also effects of non-adherence to TB 
treatment (Fang, Shen, Hu, Xu, Jun, Zhang, Kan, Ma & Wu 2019:1929; Gebreweld, Kifle, 
Gebremicheal, Simel, Gezae, Ghebreyesus, Mengstead & Wahd 2018:2). 
 
Failure of TB patients to adhere to medication raises awareness on the issues of drug 
resistance. Adherence to drug treatment and appointments for TB is critical to prevent 
drug resistance (Kliner et al 2015:1). In view of this, attempts to control the TB epidemic 
depend on the client’s adherence to anti TB treatment. Globally, up to half of patients on 
anti-tuberculosis regime do not complete treatment (Silvina, MariaBelen, Adriana & 
Silvina 2012:66). This behaviour can negatively affect treatment success. It is more than 
20 years now after the World Health Organization (WHO) had declared Tuberculosis a 
global public health emergency (Gao, Lu, Bai, Wang, Xu, Catanzaro et al 2015:310). Even 






largest country with TB epidemic, accounting for 12% of the total number of cases (Tang, 
Zhao, Wang, Gong, Yin, Zhao et al 2015:1). Factors such as limited education, knowledge 
deficit about TB treatment and longer travelling time to health centres were reported as 
barriers to TB treatment completion (Tang et al 2015:2). 
 
In South Africa, factors such as health care provider system, treatment relapse, 
effectiveness of treatment, emergence of MDR-TB were reported to be closely related to 
poor TB treatment adherence (Kastien-Hilka, Abulfathi, Rosenkranz, Bennett, 
Schwenkglenks & Sinanovic 2016:2; Dladla 2013:1). Moreover, social, economic and 
client-related factors were also reported to contribute to poor TB treatment adherence. 
 
1.2.1 Tuberculosis in Eswatini 
 
Eswatini is a landlocked country situated in Southern Africa, bordering Mozambique and 
South Africa (Kliner et al 2015:2). The country has a land surface area of about 17,364 
square kilometres, and divided into four administrative regions namely, Hhohho, Manzini, 
Shiselweni and Lubombo (WHO Country Cooperation Strategy 2014:3). Furthermore, the 
country has an estimated population of 1,119.975 in 2015 and classified as a low-middle 
country with an income per capita of USD3, 550 in 2014 (Tuberculosis Control Program 
(TCP) Annual Report 2016:1). Generally, TB services are distributed across the four 
regions. According to the National Control Tuberculosis Program (NCTP) (2015:1) 
Eswatini has about 287 health facilities, and of these 109 (38%) are TB basic 
management units, with the rest being ordinary units. The ordinary units provide TB 
services such as screening, sputum collection, preventive therapy and referrals of 
patients. 
 
All primary health care services are free to patients in all government health facilities in 
Eswatini. Services such as antiretroviral treatment, tuberculosis treatment and others are 
included. The TB treatment guideline used in these facilities is the same as those 







The current anti-TB therapies are weighed down with setbacks, predominately because 
of the long-term treatment and/or poor adherence to the treatment. Regardless of 
emphasis on treatment completion to eliminate TB and improve adherence in Eswatini, 
about 7.7% new TB cases emerged, 33.4% retreatment cases developed drug-resistant 
TB and 13% failure rate reported (WHO, 2012:1). Generally, TB suspected patients in all 
health facilities in Eswatini are diagnosed with TB on sputum smear and culture (Kliner et 
al 2015:2). After initiation on TB treatment, if patients do not improve and sputum fails to 
convert to smear negative, the patient is then referred to the national TB hospital. This 
hospital is a national TB Control Center and was established in 2009 in response to the 
emerging threat of MDR-TB and XDR-TB (Ministry of Health Monitoring & Evaluation 
Report 2011:23). 
 
The magnitude of TB disease in Eswatini is measured in terms of incidence, prevalence 
and mortality in a given year (Haumba, Dlamini, Calnan, Ghazaryan, Smith-Arthur, Preko 
& Ehrenkranz 2015:103). Kliner et al (2015:2) report that Eswatini has the highest 
estimated incidence of TB in the world with at least 565 cases per 100 000 population 
including HIV positive people. Of note was the increased TB rate by 5-fold over the past 
10 years since 2005.This incidence places the country to be amongst the highest burden 
countries in the world.  
  
As the country made an effort to eliminate the situation it was however, faced with 
challenges which fuelled the TB incidence. These included issues of poverty and 
escalating HIV infection. According to the WHO Country Cooperation Strategy (2014:6-
7) Eswatini has an estimated 69% of the population living below poverty line, and about 
80% of TB patients co-infected with HIV. This instigated TB to be a big health problem to 
the government and the people of Eswatini as it constituted an estimated 20% of 
institutional deaths (NTCP 2012:14). Moreover, the mortality rates for TB in 2014 were 
worse among patients who were co-infected with HIV with an estimated 1.7 per 1000 








TB and HIV co-infection is noted in the country as the HIV infection rate increases the risk 
of TB infection on exposure. This accelerates progression from latent TB infection to 
highly active TB, risk of death if not treated timely and risk of recurrence even if 
successfully treated (NTCP 2015:14). The country therefore, engaged itself into the 
TB/HIV integration model. This model specified that all TB patients to be offered HIV 
testing and all HIV patients to be screened for TB (Mchunu, van Griensven, Hinderaker, 
Sikhondze, Manzi, Dlamini & Harries 2016:106). As the country has about 106 health 
facilities that offer the collaborative TB and HIV services, TB and HIV services were co-
localised under the same premises at primary health care level. Although, at higher levels, 
these services were located on the same premises but in different departments (Mchunu 
et al 2016:106). Mchunu et al (2016:106) also assert that all TB and HIV co-infected 
patients are initiated on cotrimoxazole preventive therapy (CPT). In addition, since 2008 
all HIV positive TB patients have been initiated on ART, regardless of their CD4 cell count, 
and within 8 weeks of initiating of anti-tuberculosis treatment. 
 
According to NTCP (2015:14) collaborative TB and HIV services offered in Eswatini 
include action on improved diagnoses, care and prevention services for people living with 
HIV and TB, and HIV testing and counselling (HTC). Of note in the report, is that the HTC 
uptake by TB patients has been increasing over the period with 92% in 2011 to 99% in 
2015. This was attributed to the collaboration of HIV and TB services, which aimed to 
give TB patients proper HIV testing information, counselling, stigma reduction and access 
to ART. Regardless of the country’s effort to reduce TB, the TB and HIV co-infection 
remains high at 80% (United States Agency for International Development (USAID) Assist 
Project 2015:1).  
 
The government of Eswatini through the Ministry of Health established the Global Plan to 
End TB with the vision of “A world free tuberculosis-zero deaths, disease and suffering 
due to tuberculosis” (NTCP, 2015:5). The vision goals and objectives were aimed at 
reducing TB-related morbidity and mortality to such an extent that the disease was no 
longer a public health problem to the Emaswati nation (NTCP Annual Report (2011:23). 






strategy as a framework for TB control with emphasis on the high quality directly observed 
therapy (DOT) expansion and enhancement, TB/HIV integration and MDR-TB. This 
strategy recommended DOT for all TB patients, and provided patient support and 
treatment backing such as incentives (Kliner et al 2015:2). The DOT strategy was one of 
the approaches recommended by the WHO to help cure TB by improving adherence 
(Elden et al 2011:2; Directly Observed Therapy (DOT) Manual for TB Programs 2016:9). 
This strategy was also aimed at involving the nurse or supporter observing the patient 
swallow the TB drug. 
 
The DOT program involved the psychosocial officers, treatment supporters, adherence 
officers, and TB screening officers, all working together to improve treatment success 
(NTCP 2012:15). This program has achieved a coverage of 66.7%, which was 3048 
patients on DOT out of 4567 registered cases (NTCP 2015:24). It is noteworthy that the 
DOT program has improved TB screening which resulted in 240 051 cases screened, of 
these 11641 were presumptive cases and 1139 were diagnosed. Approximately 958 were 
enrolled on treatment and provided with extensive supervision and support (NTCP 
2015:24). The DOT strategy was seen as an achievement in fighting TB in Eswatini. 
However, challenges affecting adherence to treatment were suspected to be watering 
down the effort of total elimination of tuberculosis. TB patients were stopping treatment 
and coming back when they had deteriorated (NTCP 2015:21). 
 
The emphasis of global main concern for development cooperation is guided by national 
priorities in most countries. To improve treatment success rate and consequently achieve 
the international target, a number of interventions were established in Eswatini. The 
country committed itself to ending the TB epidemic by 2030 which was in line with 
Sustainable Development Goal (SDG) 3; of “good health and well-being” (Kumar et al 
2016:2). Despite the SDG intervention, TB treatment success remained at 72%, 
considerably lower than the international target of 85% (Kliner et al 2015:2). In view of the 
escalating TB disease, Eswatini also put into practice the new TB Strategic Plan 2015-
2019 (NCTP 2015:3). The goal of this plan was to achieve a 35% reduction of TB 






The country’s current interventions and strategies were seen as positive progresses in 
fighting against TB non-adherence. However, they did not meet the implemented WHO 
recommendation of 85% minimum for treatment success as they were surrounded by 
many unknown controversies related to its effect compared to self-supervision (Swaziland 
Ministry of Health Final Report 2011:23- 30). Hence, these strategies were not sufficient 
to prevent TB treatment non-adherence. Additionally, NTCP (2015:19) assert that 
Eswatini’s cases of MDR-TB were increasing at 7.7% among new TB cases and 33.9% 
among previously treated cases. This called for the government of Eswatini to strengthen 
diagnostic and treatment pathways including adherence programs (NTCP, 2015:19). 
 
1.3 RESEARCH PROBLEM 
 
Eswatini has recorded an increase of TB cases over the last decade and is among the 
highest in the world. This has been attributed to the co-infection of TB and HIV which has 
risen to an estimated 82% of TB cases who live with the HIV and are on antiretroviral 
therapy (ART) (Elden et al 2011:2). In 2010 the country recorded an increase of TB case 
notification rate of 915 per 100,000 populations, new TB cases at about 600 per 100,000 
and relapse at 900 per 100, 000 cases. Poor adherence to TB treatment is considered as 
one of the obstacles for the TB control due to the consequences that arise from the 
interruption of treatment. This has led to the negative impact on the overall treatment 
success rate (cured and completed) which stands below 70%, far below the WHO target 
of >85 % (Swaziland Ministry of Health Final Report 2011:23-30).  
 
In an effort to ensure treatment adherence, the Eswatini Ministry of Health developed the 
method of DOT and intensified treatment support system as strategies for improving 
adherence to TB treatment. However, these strategies had some challenges in terms of 
treatment adherence. Moreover, an evaluation of the strategies in the Swaziland National 
Tuberculosis Programme Manual (2012:15) and Ministry of Health Final Report (2011:29) 
showed that a 63% of TB clients abandon their treatment before it has been completed 
and this has led to an increase risk of drug resistance, relapse, prolonged infectiousness, 








1.4 RESEARCH PURPOSE 
 
Burns and Grove (2011:146) define a research purpose as a clear, concise statement of 
the specific goal or focus of a study. The purpose of this study was to investigate the 
determinants of adherence to TB treatment in order to design strategies to enhance 
adherence to TB treatment among TB clients in Eswatini. 
 
1.4.1 Research objectives 
 
A research objective is a clear, concise, declarative statement that is expressed to direct 
a study and is focused on identification and description of variables or determination of 
the relationships among variables, or both (Grove, Burns & Gray 2013:708). 
The objectives of this study were to: 
 Describe demographic variables of TB clients on TB treatment in Eswatini.    
 Identify variables that modify adherence to TB treatment among TB clients in 
Eswatini.  
 Explore barriers to adherence to TB treatment among TB clients in Eswatini.   
 Describe factors that facilitate adherence to TB treatment among TB clients in 
Eswatini.   
 Determine an association between factors that facilitate adherence and barriers to 
adherence to TB treatment.  
 Design strategies to enhance adherence to TB treatment among TB clients in 
Eswatini.  
 
1.4.2 Research hypothesis 
 
A hypothesis is a formal statement of the expected relationship or relationships between 
two or more variables in a selected population (Grove et al 2013: 142). Null hypothesis is 
defined as a hypothesis that state no relationship between the variables under study (Polit 






competing with the researcher’s hypothesis, for interpreting the results of a study (Polit & 
Beck 2014:391). The researcher predicted that there was an association between factors 
that facilitated adherence and barriers to adherence to TB treatment.  
 
The null hypothesis of this study stated that: 
There is no association between determinants of adherence (patient-related factors, 
psychological factors, barriers and facilitators) and TB clients’ adherence to treatment. 
 
The rival hypothesis was that:  
There is an association between determinants of adherence (patient-related factors, 
barriers and facilitators) and TB clients’ adherence to treatment. 
 
1.5 SIGNIFICANCE OF THE STUDY 
 
The study could contribute to the existing body of knowledge on adherence to TB 
treatment by providing an insight on the determinants of adherence to TB treatment. The 
study led to the development of strategies in a bid to enhance adherence to TB treatment. 
It could also decrease treatment interruption thus improving the quality of life of clients 
living with tuberculosis. The study could form basis for future research on factors 
influencing adherence to TB treatment. The study could also assist in monitoring and 
evaluating adherence to TB treatment to achieve 90% treatment success for all patients 
diagnosed with TB (NCTP Program Report 2015:16). The result of the study could help 
in developing programs and interventions that could reduce transmission of TB and 
improve adherence to TB treatment. Recommendations of this study could assist in 
improving TB control in Eswatini. 
 
1.6 DEFINITION OF TERMS 
 
A concept is a term that abstractly describes and names an object or phenomenon, thus 
providing it with a separate identity or meaning (Grove, Burns & Gray 2013:689). Since 






The following concepts were used in this study to provide a direction to the clear meanings 
within the study: 
 
1.6.1 Adherence to TB treatment 
 
Adherence is defined by the WHO as “the extent to which a person’s behaviour; taking 
medication, following a diet, and or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider (Gabremariam, Bjune & Frich 2010:1). 
Therefore, adherence to TB treatment is generally a degree to which clients take TB 
medications as advised by the health care provider and is measured by evaluating the 
treatment success rate which must be above 85% (Swaziland Ministry of Health Final 




A recipient of health care, regardless of the person’s state of health and where the service 





A factor that decides whether or how something happens (Hornby 2010:398). In this study 
a determinant meant factor that either increases or decreases adherence to TB treatment. 
 
1.6.4 Tuberculosis (TB) 
 
Is an infectious disease caused by the Mycobacterium tuberculosis which is spread 
primarily by coughing and enters the body through inhalation. It mostly affects the lungs 








1.6.5 TB treatment 
 
Is an anti-TB drug regimen that comprises of three main properties, namely, bactericidal, 
sterilizing activity and the ability to prevent disease resistance. This includes a 
combination of Isoniazid, Rifampicin, Pyrazinamide, Streptomycin and Ethambutol 
(Ministry of Health National Tuberculosis Programme Manual 2012:47). In this study it 
referred to anti-TB drugs that were prescribed as treatment for TB in clients infected with 
TB.  
 
1.7 THEORETICAL FOUNDATION OF THE STUDY 
 
The theoretical foundation for this study was based on Becker’s Health Belief Model 
(HBM)1974. According to Shameen, Badiger and Kumar (2017:1160) the HBM is one of 
the earliest and most effective models in the health promotion to change behaviour. 
Several researchers (Gao, Nau, Rosenbluth, Scott & Woodward 2000:387; Tarkang & 
Zotor 2015:3) had used the HBM to guide studies related to change of behaviour and 
medication compliance. The HBM was first developed in 1950’s to explain what made 
healthy people engaged in preventive behaviour (Tarkang & Zotor 2015:3). This was 
initiated in response to the failure of a free TB health screening programme in the United 
States of America (USA). The Health Belief Model was widely used to study and promote 
uptake of health services and predict health behaviour (Beer, Ali, Eskillson, Jansson, 
Abdul-Kadir et al 2012:2). This model is popular in issues focusing on patient compliance 
and preventive health practices (Beer et al 2012:2). Onoruoiza, Musa, Umar and Kunle 
(2015); Shameen et al (2017) also used this model in the study related to non-compliance 
with hypertension medication. 
The model was relevant for the study because tuberculosis is one of the infectious 
diseases that needs one to adhere to its treatment, to reduce its transmission and to 
prevent drug resistance (Kliner 2015:1). The HBM illustrates that an individual has a 
desire to avoid illness (if ill, he has a desire to get well), and the belief that a specific 
health action will prevent illness or will reduce a threat (Becker 1976 in Beer et al 2012). 






personal understanding of the disease process. Furthermore, it was determined by the 
importance of treatment to attain positive outcomes about a disease and strategies to 
decrease its occurrence. A major feature of this model assumed that a person would take 
a preventative action if that person has a positive expectation that by taking a 
recommended action, the negative health condition would be avoided (Tarkang & Zotor 
2015:3). This model assisted the study in explaining why some TB clients take action to 
adhere to TB treatment while others did not. 
 
The HBM also suggests that an individual’s motivation to act depends on the perceived 
threat to their health and their belief that action will mitigate the threat (Mayer 2007:3). 
Furthermore, the model alludes that whether individuals take action to protect their health 
depends on whether they believe that they are susceptible to an ill health condition; that 
they have a course of action to avoid the condition and benefits of taking the action 
outweigh the costs (Mayer 2007:3). TB patients had choices and were able to make 
suitable decisions regarding their health when they understood the threat of not adhering 
to the TB treatment. This idea of the model was used toward reducing or avoiding a 
disease condition and aimed to explain and predict behaviours. The HBM in this study 
assisted in providing a framework to understand the factors that facilitated adherence and 
those that hindered (barriers) adherence to TB treatment.  
 
According to Tarkang and Zotor (2015:3) the HBM has three broad propositions; namely, 
the individual perceptions about health, the modifying factors which include demographic, 
socio-psychological and structural variables, and the benefits of taking preventive 
measures. The HBM is further composed of six key concepts as follows; perceived 
susceptibility, severity, benefits and barriers, cue for action, and self-efficacy. These 
propositions and concepts assisted the study in searching for literature in the 








Figure 1:1 Health Belief Model (Adapted from Tarkang & Zotor 2015:4)    
 
1.7.1 HBM propositions and their focus  
 
Individual perceptions: are person’s beliefs about one’s own susceptibility to a disease 
and the seriousness with which one views the perceived threat of the illness (Tarkang & 
Zotor 2015:3-4). The HBM in this study assisted in identifying what clients needed in order 
to understand adherence to TB treatment. Once the clients understood about the new 
acquired knowledge, this would bring about minimal risk of the disease and reduce drug 
resistance and complications.  
 
Modifying factors: modifying factors such as demographic, socio-psychological and 
structural variables may affect an individual’s understanding and indirectly influence 






Eswatini, where culture is mostly practiced. This could help in modifying TB clients’ 
decision to adhere to TB treatment. 
 
Likelihood of action: this refers to the individual’s benefits of prevention (Tarkang & 
Zotor 2015:4). In this study, this proposition facilitated in identifying variables that were 
perceived as benefits for adhering to TB treatment and those perceived as barriers to 
taking action to change behaviour. 
 
1.7.2 HBM concepts and their meaning  
 
Perceived susceptibility: refers to the perception of the risk that a condition could 
happen to individuals (Joseph 2018:2). This model predicts that individuals who perceive 
that they are liable to a particular health problem will engage in behaviours to reduce the 
risk of developing the health problem. Whereas, those with low perceived susceptibility 
may deny that they are at risk for contracting a particular disease (Onoruoiza et al 
2015:14). In this study, the HBM assisted in determining if client understood that they had 
TB and would engage in practices that would change behaviour. If followed well, TB 
clients would adhere to their TB treatment to reduce complications such as drug 
resistance. This would help in the development of risk reduction strategies.  
 
Perceived severity: refers to one’s feelings of how severe outcomes could be if the 
condition occurs (Joseph 2018:2). The HBM proposes that individuals who perceive a 
given health problem as serious are more likely to engage in behaviours to prevent health 
problems from occurring or reduce its severity (Tarkang & Zotor 2015:5).Therefore, 
perceived seriousness encompasses beliefs about a disease itself e.g. whether it is life –
threatening or may cause disability or pain (Onoruoiza et al 2015:14). In this study, the 
model assisted in explaining one’s susceptibility to the TB disease. If not explained well, 
it would not motivate the client to change behaviour unless they had serious physical and 
social implications. TB clients must understand TB as a serious infection that has severe 
consequences and implications on their lives, before adhering to TB treatment. This may 






motivation to avert the threat. 
 
Perceived benefits: refer to an individual assessment of the value or efficacy of engaging 
in a health- promoting behaviour to decrease risk of disease (benefit of taking a drug) 
(Onoruoiza et al 2015:14). In this study, this concept of the model helped in identifying 
variables that acted as benefits including incentives, living longer and others. If a TB client 
believes that a particular action would reduce susceptibility to a health problem or 
decrease its seriousness, then the client was likely to adhere to the treatment. It was this 
belief that would give a TB client confidence to take the action because of the expected 
health outcomes. 
 
Perceived barriers: refer to individual’s assessment of the obstacles to behaviour 
change (Onoruoiza et al 2015:14). There could be several barriers that affect peoples’ 
decision to take particular actions such as hindrance in taking medication like cost, 
frequency, side effects, etc (Tarkang & Zotor 2015:5). The model helped in clarifying if 
TB clients understood the threats and barriers that could prevent adherence to TB 
treatment. It also assisted in clarifying certain actions that would reduce the barriers to 
adherence such as reporting side effects. In other words, perceived benefits must 
outweigh perceived barriers in order for behaviour change to occur. It would, only when 
the TB clients would realise that they have the capacity to deal with these barriers, that 
they would be able to take the necessary action.  
 
Cues to action: refers to factors that can initiate an individual to take action like death of 
a close person due to same disease (Onoruoiza et al 2015:14). This can be events or 
experiences, physical symptom of a health condition, interpersonal or environmental 
(media publicity) that motivate a person to take action (Tarkang & Zotor 2015:5). The 
model assisted in identifying factors that facilitated clients to treatment adherence. 
Factors such as incentives, having a treatment supporter, counselling and health 
education were enhancers to TB treatment adherence. This means that TB clients 






have concerns about health matters. Furthermore, they needed to be willing to seek and 
accept health care and to engage in positive health activities. 
 
Self-efficacy: refers to a client’s understanding and confidence in one’s ability to perform 
a behaviour (Joseph 2018:2).  It is the strength of an individual’s belief in one’s own ability 
to respond to difficult situations and to deal with any associated obstacles or setbacks 
(Tarkang & Zotor 2015:5). This model suggests that a client can believe that he can 
successfully complete the behaviour of interest despite considered barriers (Jones, 
Jensen, Scherr, Brown, Christy & Weaver 2015:3). In this study, the HBM helped in 
identifying the confidence in TB clients’ ability to adhere to TB treatment such as 
remembering to take pills every day. A TB client could believe that he could complete or 
adhere to TB treatment without defaulting irrespective of challenges which were barriers 
to TB treatment.  
 
1.8 INTRODUCTION TO RESEARCH DESIGN AND METHODS 
  
The study was conducted in two phases in line with the objectives of the study, which 
entailed the following: 
● Phase 1: Phase 1 involved the research methodology that was applied when eliciting 
data from TB clients and TB experts. This was to identify and describe demographic 
variables of TB clients on TB treatment; identify variables that modify adherence to 
TB treatment among TB clients; explore barriers and facilitators to adherence to TB 
treatment; and to describe the association between factors that facilitate adherence 
and barriers to adherence to TB treatment. This phase also comprised of data 
collection for step 1 and step 2. 
● Phase 2: Phase 2 was to design strategies to enhance adherence to TB treatment 
among TB clients in Eswatini. 
 
 
A quantitative approach was followed; which was an investigation of phenomenon that 






controlled design (Polit & Beck 2014:389). The study utilised this approach as the 
researcher viewed a TB client as integrated with the environment, which shaped the 
behaviour (adherence to TB treatment). This approach generated an account of the 
client’s reality in adherence to the TB treatment and descriptive determinants of 
adherence were measured. 
 
A descriptive non-experimental design was used in this study. Polit and Beck (2014:386) 
define a non-experimental research as a design in which an investigator collects data 
without introducing an intervention. There was no manipulation of the variables of interest 
in this study because they were naturally existing attributes. The primary focus was to 
investigate determinants of adherence to TB treatment. In this study, determinants 
associated with adherence to TB treatment were identified and described. More 
information on the methods are described in detail in Chapters 3, 4 and 5. 
 
1.9 STRUCTURE OF THE THESIS 
 
Chapter 1: Orientation to the study 
Chapter 2: Literature review 
Chapter 3: Research design and methods 
Chapter 4: Analysis, presentation and description of the research findings 
Chapter 5: Strategies to enhance adherence to TB treatment among TB clients in 
Eswatini 




This chapter gave an overview of the background of the study and the statement of the 
study problem. The study aim was to investigate determinants of adherence to TB 
treatment in order to design strategies to enhance adherence to TB treatment. The HBM 



















































This chapter reviewed literature related to determinants of adherence to TB treatment. 
The literature review was guided by the Health Belief Model. According to Polit and Beck 
(2014:384) a literature review is a critical summary of research on a topic of interest, often 
prepared to put a research problem in context. The purpose of the literature review in this 
study was to identify and explore factors that determine adherence to TB treatment in 
Eswatini. Related research studies, articles from professional journals and books were 
reviewed in order to establish other researcher’s findings and views about determinants 
of adherence to TB treatment. The search engines used to obtain information include 
EBSCO host, HINARI, Google Scholar and Open Access for Africa (OAA) – PubMed. The 
words used to search for literature were factors, determinants, adherence, causes, poor 
adherence, non-adherence, TB, determinants, medication, TB treatment.  
 
Several sources on adherence to TB treatment were consulted (Gabremariam, Gunnar, 
Bjune & Frich 2010:1; Kastien-Hilka, Abulfathi, Rosenkranz, Bennett, Schwenkglenks & 
Sinnovic 2016; Dladla 2013:27; Asati, Nayak & Indukar 2017:2759; Deshmukh, Dhande, 
Sachdeva, Sreenivas, Kumar, Satyanarayana, Parmar, Moonan & Lo 2015:1). The 
findings on these studies identified health belief systems, side effects, incentives and 
directly observed therapy (DOT). Furthermore, lack of knowledge, gender, pill burden, 
feeling better and health worker attitude were also identified as determinants of 
adherence to TB treatment. These determinants were grouped according to the HBM 
concepts.  
 
Based on the information above, relevant literature was reviewed confirming some of the 
cited modifiers, barriers and facilitators of adherence to TB treatment. The literature 








2.2 ADHERENCE TO TUBERCULOSIS TREATMENT 
 
Treatment adherence is a complex phenomenon comprising patient behaviour with 
regard to the prescribed interval, dose and dosing regimen and appropriateness of how 
treatment is taken (Kastien-Hilka, Abulfathi, Rosenkranz, Bennett, Schwenkglenks & 
Sinanovic 2016:42). With complete adherence, TB is curable with a six-month anti-TB 
treatment. The association between adherence and therapeutic success has been 
demonstrated across a variety of anti-tuberculosis therapy (Elden, Lawes, Kudsk-Iversen, 
Vandelanotte, Nkawanyana, Welfare, Walley, & Wright, 2011:2; Swaziland National 
Tuberculosis Programme Manual (SNTPM) 2012:49).  
 
Adherence is measured by evaluating the treatment success rate of 85% at 12 months 
for all new culture positive TB cases and 90% for all new smear positive TB cases 
(Holden, Lillebaek, Seersholm, Andersen, Wejse & Johansen 2019;12995). Treatment 
adherence is the key factor for treatment success and improves patients’ quality of life. 
Contrary, poor adherence leads to adverse outcomes, resulting in disability, drug 
resistance, relapse and risk of death (Suwankeeree & Picheansathian 2014:4). 
Furthermore, other factors such as increased health cost, increased transmission rates 
of tubercle bacilli, prolonged infectiousness, treatment failure, relapse and drug 
resistance were reported to be causes of poor adherence. 
  
2.3. MODIFYING FACTORS THAT DETERMINE ADHERENCE TO TUBERCULOSIS 
TREATMENT 
 
Modifying factors such as demographic, psychological and structural variables can affect 
an individual’s understanding and thus indirectly influence health related behaviours 
(Tarkang & Zotor 2015:4). These variables can create a positive or negative influence 
towards adherence to TB treatment. In this study, the modifying variables that were 








2.3.1 Demographic factors and adherence to TB treatment  
 
Demographic factors could determine adherence to TB treatment. Factors discussed in 
this category included age, gender and marital status. 
 
2.3.1.1 Age and adherence to treatment 
 
Patients on TB treatment are of difference age categories. Non-adherence to medication 
is a common problem among the elderly as they are prone to multiple comorbidities and 
at risk of polypharmacy (Yap, Thirumoorthy & Kwan 2016:64). A study by Gellad, Grenard 
and Marcum (2011:11) revealed that cognitive function were among potential barriers to 
adherence in the elderly patients. Similarly, a study done in Ethiopia by Tesfahuneygn, 
Medhin and Legesse (2015:503) reported that being older than 55 years was associated 
with unsuccessful TB treatment outcomes. The study concluded that this group required 
utmost assistance when taking medication as they may forget their treatment due to 
aging. Taken together, these studies indicate that age could be a determinant of 
adherence to TB treatment.  
 
2.3.1.2 Gender and adherence to treatment 
 
Treatment use may be affected by gender differences, and the response to the treatment 
can affect patients’ adherence to the prescribed treatment. According to Mlilo-Chaibva 
(2007:23) women in many African societies are accorded an inferior status that enhances 
their powerlessness and vulnerability to health problem leading to inadequate health care 
seeking behaviours. Daly (2001:45) asserted that women were more controlled by the 
socioeconomic and cultural factors into seeking medical care. Therefore, sex differences 









A study by Manteuffel, Williams, Chen, Verbrugge, Pittman and Steinkellner (2014:112) 
evaluated the differences between women and men in medication use, medication 
adherence and prescribing alignment with clinical guidelines. The study revealed that 
women were less likely than men to be adherent in their use of chronic medication. 
Similarly, Garcio-Basteiro, Respeito, Augusto, Lopez-Varela, Sacoor, Sequera et al 
(2016:214) in a retrospective observational study on TB patients in Mozambique, 
revealed a high proportion of female patients considered to have treatment failure.   Issac 
(2018:12) found that women were faced with greater barriers financially, physically, and 
longer delays in seeking treatment than men in as far as accessing TB services from 
symptom onset to initiation. This indicates that gender could be viewed as a strong 
determinant of adherence to TB treatment.  
 
2.3.1.3 Marital status and adherence to treatment 
 
Marital status can be a determinant factor of TB treatment adherence. According to Mlilo-
Chaibva (2007:23) both unmarried and married women are less likely to seek health 
services due to lack of economic and social support, from parents, guardians or spouses. 
This had an influence in their health seeking behaviour. In line with this, Wu, Lennie, 
Chung, Frazier, Dekker et al (2012:107) revealed that unmarried patients were more likely 
to be non-adherent to their treatment. This indicates that marital status is a contributor to 
non-adherence to treatment.  
 
On another note, a single parent or divorced could be a risk factor for adherence to TB 
treatment. Zhou, Chu, Liu, Tobe, Gen, et al (2012:5) reported that patients who had 
divorced or bereft of spouse were more likely not to adhere to TB treatment due to more 
economic and social burdens after suffering from TB.  
 
In the context of Eswatini, a wife has to get permission from the husband to seek health 
care services. There are a number of factors influencing the way in which Swazi women 
were treated in this society including culture, tradition, political, legal and economic values 






decision-making over family, traditional and societal issues. As a result, the autonomy of 
married women around treatment taking is undermined through societal position which 
could compromise the ability to adhere to treatment. 
 
2.3.2. Psychological factors and adherence to TB treatment 
 
The psychological factors discussed in this study included the use of traditional health 
system, spirituality and religion, stigma and discrimination, and social support.  
 
2.3.2.1Traditional health system and adherence to TB treatment 
 
Eswatini like other African countries relies on the use of traditional healing systems to 
address minor infections and spiritual cleansing. This is evident as more than 85% of the 
population of Eswatini were reported that they used a mixture of Western and Traditional 
medicine to cure ailments (Sibandze 2009:1). This practice could affect TB clients’ 
understanding of the illness resulting to treatment default. Moreover, traditional healing is 
linked to the cultural beliefs of the Swazi people as well as their belief about the cause of 
illness to satisfy the spiritual, mental and physical needs (Sibandze 2009:1). This situation 
has led to a search for possible alternative and /or complementary treatment options 
(Sibandze 2009:1). According to Nyasulu, Kambale, Chirwa, Umanah, Singini, Sikwese 
et al (2016:122) Botswana reported 34% of TB patients seeking care from traditional or 
faith healers before initiation of TB treatment at a health care facility. Whereas, in Malawi 
32% visited a traditional healer before the diagnosis of TB.  
 
Parsons, Cruise, Davenport and Jones (2006:97) in their exploratory study in Southern 
United States reported that certain religious beliefs were negatively related to treatment 
adherence. Likewise, Boru, Shimels and Bilal (2017:3) revealed that a belief in traditional 
healing for curing TB was associated with non-adherence to TB treatment. This was 
observed when TB patients reported the use of traditional healing system before starting 







On the contrary, a study by Piltzer, Friend-du-Preez, Ramlagan, Fomundam, Anderson 
and Chanetsa (2011:337) indicated that patients used traditional medicines prior to 
initiating of ART. This indicates that patients who are on chronic illness are more likely to 
discontinue traditional herbs during the course of their treatment. Further consideration 
of traditional herbs during treatment of chronic disease needs to be considered during 
adherence management. Similarly, Dehkordi (2013:95); Diefenbach-Elstob, Plummer, 
Dowi, Wamagi, Gula, Siwaeya, Pelowa, Siba & Warner 2017:1) revealed that clients with 
high beliefs in traditional medicine and a positive influence of religious beliefs, their 
adherence to medication were increased. The results show that certain traditional 
practices are positively associated with adherence to treatment. This indicates that 
effective integration of alternative therapies is required during counselling to maximize 
health and increase adherence to TB treatment. 
 
Poor adherence by tuberculosis patients to treatment contributes not only to the 
worsening of the TB situation but also paves a way for incidence of drug resistance, 
relapse, deaths and prolong infectiousness (Gabremariam, Bjune & Frich 2010:1). On the 
other hand, a phenomenological study by Boru et al (2017:3) revealed that patients used 
traditional healing systems before starting anti-TB medications. The logic was that it was 
easily accessible than western medicine. This implies that traditional healing system has 
an influence in adhering to TB treatment. This finding indicates that there is a need for 
policy makers and health care system to collaborate with traditional health care workers 
in an attempt to find ways of combining the two health systems in the management of 
tuberculosis.  
 
2.3.2.2 Spirituality and religion in treatment adherence 
 
Both spirituality and religion could have an influence on client’s behaviour to health care 
services especially when coping with life stress and illness (Miller & Thoresen 2003:24). 
Therefore, spirituality beliefs could be linked with the treatment decision-making and 
treatment adherence in people with tuberculosis. A study by Kremer, Ironson and Porr 






belief was a central guiding force in their lives as prayer could influence recovery from 
their illness and influence their medical decisions should they became gravely ill. 
 
Furthermore, the study revealed that patients believing in God to control their health were 
likely to refuse use of treatment for their chronic illnesses.  On the other hand, Osamor, 
Bernard and Owumi (2011:619) indicated that beliefs about the cause of chronic illness 
were not associated with adherence to treatment. This indicates that spirituality could 
have a relationship with adherence to treatment.  
 
2.3.2.3 Stigma and discrimination as determinants of adherence to TB treatment 
 
Despite the fact that TB is curable; it is still a stigmatized disease. TB patients not only 
suffer from TB clinical manifestation, but also the societal prejudice, embarrassing 
situations and even self-discrimination. The co-existing socio-cultural barriers and taboos 
associated with chronic illness are associated with adherence to TB treatment (Tadesse 
2016:2). This behaviour could cause significant challenges to the public health. According 
to the Annual National TB Control Program (ANTCP) (2015:14) Eswatini has about 72% 
of TB patients who are co-infected with HIV. Thus, stigma remains the major obstacle in 
controlling the TB disease because of its association with HIV.   
 
Due to perceived presence of stigma and discrimination in the community, patients hide 
their disease to their friends, families or community members (Boru et al 2017:5). For that 
reason, stigma often contributes to psychological problems and emotional suffering which 
could hinder treatment adherence. Tadesse (2016:2) revealed that the stigmatized 
individual often internalized the sense of devalue and adopted a set of self-regarding 
attitudes about the trait including shame, disgust and guilt. Similarly, Dias, Falcao de 
Oliveria, Turato and Maralez de Figueiredo (2013:595) stated that patients with TB were 
isolated from friends and colleagues in fear of contagion and/or prejudice. This behaviour 
could affect TB clients emotionally. As a result, counselling on problem solving, emotional 







Stigma is known as a hidden killer in patients with chronic illnesses. TB related stigma 
occurs when TB in an individual is devalued and its consequences have a considerable 
impact on TB patients. A study by Chowdhury, Rahman, Mondal, Sayem and Billah 
(2015:461) showed revealed that TB patients did not take part in social programs due to 
stigma. The study concluded that stigma was one of the most important barriers to TB 
treatment adherence in India. Likewise, Kipp, Pungrassami, Stewart, Chongsuvivatwong, 
Strauss and Rie et al (2011:1) revealed that there was an association between stigma 
and missed doses.  
 
On the contrary, Cremers, Manon de Laat, Kapata, Gerrets, Klipstein-Grobusch and 
Grobusch (2015:1) in a mixed methods study with TB patients in Zambia revealed that 
stigma was provoked by TB conceptions associated with HIV infection. This resulted to 
increased immoral behaviour, perceived incurability and traditional myths about TB 
aetiology. This study indicates that a strong collaboration between the healthcare worker 
and the patients is essential to increase adherence to TB treatment.  
 
TB dimensions have indicated that besides its physical impact, it has a strong emotional 
impact on patient’s lives. Makanjuola, Taddese and Booth (2014:5) asserted that HIV 
positive patients posed a risk towards adherence to Isoniazid prophylaxis treatment as 
they were discouraged to take two regimens at the same time. In addition, denial, fear of 
rejection and stigmatization, preventing people from disclosing or coming out for 
treatment were common concerns in patients taking anti-TB treatment.  
 
In support, Paz-Soldan Alban, Jones and   Oberhelman (2013:6) reported that despite 
the fact that drug-susceptible TB patients have to take 6 weeks or more to be virtually 
non-contagious, there was a strong stigma attached to being treated for TB. A study by 
Craig and Zumla (2015:107) revealed that immigrants failed to disclose their TB disease 
in fear of eviction and rejection by the community, which could result in loss of material 
and social support. The study concluded that during counselling session healthcare 
workers needed to talk about stigma and discrimination as these could be barriers to 






2.3.2.4 Social support and adherence to treatment 
 
Good relationships between family, friends or community and patients could determine 
whether patients would feel comfortable about taking treatment or not. Paz-Soldan, 
Alban, Jones and Oberhelman (2013:2) asserted that social support denoted social 
interactions that led the subject to believe that he/she was cared for and loved. This then 
influenced health-seeking behaviour, treatment adherence and health outcomes. A study 
by Ong’ang’o, Mwachari, Kipruto and Karanja (2014:1) revealed that patients utilized 
community health care workers for their TB treatment support. The study concluded that 
utilization of community health care worker as a treatment supporter enhanced TB 
treatment adherence.  
 
A study conducted by Craig and Zumla (2015:107) revealed that patients received 
support from close friends and family for their medication. Similar finding by Makanjuola, 
Taddese and Booth (2014:1) also revealed that patients received support from family and 
other networks and thus they were able to take their medication in time. Therefore, the 
value of emotional support provided by families, mainly in a form of encouragement give 
patients a reason to live, as means to finish their medication Paz-Soldan, Alban, Jones 
and Oberhelman (2013:4). These findings indicate that social support contributes to TB 
treatment adherence.   
 
2.3.3 Structural factors that could determine adherence to TB treatment 
 
Structural factors could affect an individual’s understanding and thus indirectly influenced 
health related behaviours (Tarkang & Zotor 2015:4). The structural variables discussed 
in this section included attitude of patients towards health care workers and adherence, 










2.3.3.1 Attitude of patients towards health care workers and adherence 
 
The reception received by patients when attending health services can influence patient’s 
adherence to treatment. A study by Boru et al (2016:3) revealed that non-adherent 
patients had experienced poor communication with the healthcare workers. Likewise, 
across sectional study by Ibrahim, Hadjia, Nguku, Wazir, Akhimien, et al (2015:8) showed 
that poor interpersonal relationship and communication with patients had negative effects 
on patients’ adherence to the long duration of TB treatment. This indicates that a friendly 
relationship between a healthcare worker and patients is an important contributor for good 
treatment adherence.  
 
On a different note, Widjanarko, Gompelman, Dijkers and van de Werf (2009:236) found 
that patients were positive about the health care staff. As a result, they developed 
confidence in them. However, a marginal one third of these patients (non-adherent) 
mentioned to have experienced problems in communication with the hospital staff. They 
cited unfriendliness as the major contributor to their non-adherence to TB medication. 
This was comparable to the study by Paz-Soldan, Alban, Jones and Oberhelman 2013:5) 
that supportive interactions with the health care providers result to frequent utilization of 
the healthcare services. 
 
2.3.3.2 Knowledge of TB illness and adherence to treatment 
 
Understanding a patient behaviour before and during TB treatment is a foundation for 
adherence to the treatment. According to Tola et al (2016:3) patients require to have 
some minimal level of the TB disease knowledge and motivation towards staying free of 
TB to influence adherence to TB treatment. Similarly, Woimo, Yimer and Gesesew 
(2017:269) revealed that TB patients had poor knowledge towards TB disease and its 
treatment. This was because most patients interrupted their TB medication since they 







Comparably, Horter, Stringer, Greig, Amangeldiev, Tillashaikhov, Parpieva, Tigay, and 
Phillip du Cros (2016:5) found that limited TB knowledge and understanding, and not 
being aware of the disease prior to diagnosis, were relevant determinants of adherence 
to TB medication. These findings indicate that attaining good knowledge about TB could 
be a motivation for adherence to TB treatment. Hence patients need to know about the 
importance of finishing and adhering to the prescribed treatment course.  
 
2.4 FACILITATING FACTORS TO TUBERCULOSIS TREATMENT ADHERENCE 
  
Facilitating factors could be a determinant to TB treatment adherence. In this section, 
facilitating variables discussed included perceived susceptibility and perceived benefits.   
 
2.4.1 Perceived susceptibility and adherence to treatment 
 
Perceived susceptibility defines an individual’s beliefs about the chances of contracting a 
health condition (Tarkang & Zotor 2015:5). This concept predicts that individuals who 
perceive that they are liable to a particular health problem can  engage in behaviours to 
reduce the risk of developing the health problem., Whereas, those with low perceived 
susceptibility can deny that they are at risk for contracting a particular disease (Onoruoiza, 
Musa, Umar & Kunle 2015:14). Therefore, clients with TB disease and who understand 
that they have the TB could engage in practices that could change their behaviour. This 
could help in the development of risk reduction strategies.  
 
Findings by Zhou et al (2012:5) revealed that subjects experienced non-adherence to TB 
treatment because they lacked knowledge about TB and they had not received TB related 
health education. This indicates that TB patients perceived themselves as non-
susceptible to developing resistance. A comparative study by Widjanarko, Gompelman, 
Dijkers and van de Werf (2009:236) reported that in Zambia, adherence behaviour was 
largely influenced by the knowledge of the patients about their disease and treatment. 
Woimo, Yimer, Bati and Gesesew (2017:1) found that poor knowledge towards TB and 






These studies confirm the importance of providing patients with adequate information 
about the TB disease to ensure adherence.  
 
Contrary, a study by Khan, Hutchison and Coker (2017:1) found that patients had some 
knowledge about how TB was transmitted and were aware of some negative 
consequences of missing treatment. This study indicated that patients did not perceive 
themselves as susceptible to TB, hence they lacked knowledge about the disease. 
Therefore, disease knowledge could determine adherence to TB treatment. 
 
 2.4.2 Perceived benefits 
 
Perceived benefits refer to an individual assessment of the value or efficacy of engaging 
in a health- promoting behaviour to decrease risk of disease (benefit of taking a drug) 
(Onoruoiza et al 2015:14). According to Tarkang and Zotor (2015:5) a person (patient) 
needs to believe that by taking a certain action, it might help one to avoid or prevent a 
problem from occurring. It is this belief that gives a person confidence to take action 
because of the expected outcomes (Tarkang & Zotor 2015:5). This means that if a TB 
client believes that a particular action could reduce susceptibility to a health problem or 
decrease its seriousness, then the client is likely to adhere to the treatment. 
Gabremariam, Bjune and Frich (2010:1) also revealed that beliefs in curability of TB 
positively influenced adherence to TB treatment despite the presence of concomitant HIV 
infection. 
 
2.5 CUES TO ACTION 
 
The presence of an internal or external stimulus, refers as cue to action could trigger 
health behaviour of patients in taking TB medication (Onoruoiza et al 2015:14). An 
individual could be initiated to take action to adhere after seeing death of a close person 
due to same disease (Onoruoiza et al 2015:14). Cues for action could be events or 
experiences, personal (physical symptom of a health condition), interpersonal or 






2015:5). According to Tulsky, White, Young, Meakin & Moss (1999:531) early recognition 
of TB through screening and effective treatment through compliance with therapy depend 
on health actions by persons at risk. These health actions are based on the knowledge 
about TB and cues to actions such as education actions. This signifies that a TB client 
needs motivation to have the desire to adhere with the prescribed TB treatment. 
Moreover, to have concerns about health matters, to be willing to seek and accept health 
care and to engage in positive health activities could be stimulus to adherence to TB 
treatment.  
 
2.5.1. Reminders to promote adherence to treatment 
 
Electronic reminders could be used to promote adherence to TB treatment. According to 
Liu, Lewis, Zhang, Lu, Zhang, Zheng et al (2015:2) electronic reminders were devices 
used to remind patients to take medication on time, monitor time of drug intake, and alert 
health care workers to patients who have missed doses. Furthermore, these mobile text 
messaging reminders had been revealed to improve adherence to ART but not yet 
evaluated in TB patients (Liu et al 2015:3). Pop-Eleches, Thirumurthy, Habyarimana, 
Zivin, Goldstein, Walque et al (2011:825) also revealed that short messaging services 
(SMS) reminders were important tools to achieve optimal treatment response. These 
assisted clients with comorbidity to facilitate adherence in resource limited settings. This 
means that the use of mobile health technology could help improve adherence to TB 
treatment.  
 
According to Molton, Pang, Wang, Qui, Wu, Rahman-Shepherd, Ooi and Paton (2016:2) 
smart phone subscriptions in Africa are predicted to increase by more than 200% by 2022. 
These phones are capable of recording and transmitting high-quality video to distant 
healthcare facilities, with potential benefits for public health (Lester, Ritvo, Mills, Kariri, 
Karanja, Chung, Jack et al 2010:1). A study by Molton et al (2016:1) also revealed that 
there was a good relationship in participants’ adherences in those using smart phones for 






have a potential to replace DOT for TB and could be used as a positive measurement for 
adherence.  
 
Furthermore, Kliner, Knight, Mamvura, Wright and Walley (2013:2) revealed that Mobile 
phone had gained popularity in low-and middle-income countries including Eswatini. 
Eswatini has over 70% of patients owning a mobile phone (Kliner et al 2013:4). 
Consequently, many health facilities in Eswatini use phone calls to follow-up and re-
engage with TB patients who has missed appointments. Nglazi, Bekker, Wood, Hussey 
and Wiysonge (2013:2) also stated that Mobile phone text messaging (SMS) was 
frequently used as a tool to improve medication adherence.  
 
TB patients who take medication for at least 6 months or more could not adhere to the 
treatment as prescribed due to forgetfulness. Mobile phone messages have therefore, a 
potential to remind patients to take their treatment in order to promote TB treatment 
adherence (Nglazi et al 2013:2). In argument, Kliner et al (2013:1) conducted an 
operational study to investigate the use of a no-cost alternative mobile phone technology 
using missed calls (buzzing) to act as a patient reminder to HIV positive patients in rural 
Eswatini. The study revealed that in all patients there was no difference in attendance to 
follow-up at the clinic before and after the technology was implemented. This indicates 
that the mobile phone technology (buzzing) do not improve adherence to appointments 
and medication as part of an enhancer package to improve adherence.  
 
2.5.2 Patient incentives and treatment support for treatment adherence  
 
Incentives for provision of treatment support, such as food and travel cost for refills could 
be imperative to support patients on treatment. A study by Kliner, Canaan, Ndwandwe, 
Busulwa, Welfare et al (2015:29) reported that incentives provided to TB treatment 
supporters improved TB treatment outcomes to TB patients. On the other hand, Lutge, 
Wiysonge, Knight, Sinclair and Volmink (2015:2) revealed that the incentives given to TB 
patients as a daily hot meal was not well received by the patients due to the inconvenience 






the vouchers chose to ration their distribution among eligible patients. Furthermore, the 
study showed that even if incentives were available for TB patients, other factors such as 
travelling cost and availability acted as barriers to adherence (Lutge et al 2015:2). 
 
According to NTPM (2012:11) Eswatini has about 66% of the population who lived below 
the poverty line with high rural-urban disparities in access to basic services. In this 
country, most of the TB patients reside in the rural areas where there are no jobs and are 
far away from the nearest health care facility. Therefore, incentives are the one way of 
motivating them to comply with the treatment (NTPM 2012:11). However, only those with 
resistant TB and those with ordinary TB with malnourishment are offered incentives in a 
form of ration food and money for travelling to nearest health care facility. These 
incentives are given to patients on a monthly basis. Those with ordinary TB and not 
malnourished are not given incentives. In view of these, those who do not get incentives 
could default their treatment. In support, a study by Zhou, Chu, Liu, Tobe, Gen, Wang, 
Zheng and Xu (2012:1) revealed that weak incentives for treatment adherence were 
contributing factors for treatment default. This means that incentives given to TB patients 
could be a motivating factor and an obstacle to TB treatment adherence  
 
A patient cannot take drugs on an empty stomach. Intake of inadequate food is related to 
more side effects and difficulty to tolerate the drugs. This behaviour could result to poor 
adherence to treatment if not attended to. This is true, as a study conducted by 
Gabremariam et al (2010:4) revealed that lack of food was a factor adversely affecting 
treatment adherence in patients with insufficient income. This finding was in support of a 
qualitative study by Boru et al (2016:3) that nine of their participants reported to had 
experienced food shortage during treatment and that food played a pivotal role in 
complimenting TB treatment. Furthermore, with food shortage, patients, failed to comply 
with medications. This indicates that food ration could be a contributing factor to TB 
treatment adherence. Therefore, it is important to examine food availability when initiating 








2.6 PERCEIVED BARRIERS 
 
Perceived barriers refer to individual’s assessment of the obstacles to behaviour change 
(Onoruoiza et al 2015:14). Several barriers could affect peoples’ decision to take 
particular actions. These include hindrance in taking medication in terms of frequency, 
and treatment related effects (Tarkang & Zotor 2015:5). A TB client could understand that 
the TB disease is threatening and believe a particular action could reduce the threat. In 
that way, some barriers could prevent engagement in adherence to TB treatment (health 
promotion behaviour). Tarkang and Zotor (2015:5) further mentioned that in perceived 
barriers to health actions, there were possible blocks or hindrances to engage in 
preventive behaviours. These comprised of travelling cost, duration, unpleasantness, 
phobic reaction, physical barriers and complexities. In addition, pill burden, feeling better, 
side effects and directly observed treatment could be barriers to adherence to TB 
treatment.  
 
2.6.1 Travelling and costs burden to adherence 
 
Access to TB treatment could be a determinant for effective TB control services. Woimo, 
Yimer, Bati and Gesesew (2017:5) reported that distance and cost of transport were 
barriers for adherence to treatment. Moreover, in most cases TB was prevalent in 
resource constraint countries where patients had to pay their travel cost to the clinic to 
access the service (Woimo et al 2017:2). Similar study by Widjanarko, Gompelman, 
Dijkers and van der Werf (2009:231) revealed that non-adherent patients mentioned costs 
as an important role in determining adherence to their treatment. In support, Zhang, Ehiri, 
Yang, Tang and Li (2016:1) reported that patients continued to interrupt their treatment 
due to long distance of DOTs centres from individual home. These findings indicate that 










2.6.2 Pill burden and adherence to TB treatment 
 
According to the Annual National Tuberculosis Control Program (ANTCP) (2015:14) TB 
incidence continue to rise in Eswatini where most patients (72%) are also affected by HIV 
epidemic. Swaminathan and Narendran (2008:527) asserted that HIV was the most 
known risk factor that promoted progression to active TB in people with Mycobacterium 
tuberculosis infection. Therefore, co-infected patients on concomitant treatment could be 
at risk for decreased adherence. This could result to pill burden, drug toxicities, drug to 
drug interaction and paradoxical reactions (Swaminathan & Narendran (2008:527). 
 
A study by Gabremariam et al (2010:651) revealed that there was an association between 
poor adherence and the pill burden due to a regimen complexity and the extent to which 
a regimen impacts on the patient’s daily life. In the context of Eswatini, patients who are 
co-infected with HIV/AIDS are required to be initiated on anti- TB therapy first, then 
followed by ART within 8 weeks to prevent complications (SNTPM 2012:52). However, 
some TB patients have comorbidities such as diabetes, hypertension, cancer, hepatitis, 
and renal insufficiency amongst others which need to be treated together with TB 
(Schnippel, Berhanu, Black, Firnhaber, Maitisa, Evans & Sinanovic 2016:4). Likewise, a 
study by Nachega, Parienti, Uthman, Gross, Dowdy, Sax, Gallant et al (2014:1297) 
revealed that higher pill burden was associated with lower TB treatment adherence rates. 
This indicates that pill burden is associated with adherence to TB treatment.  
 
2.6.3 Feeling better and adherence to treatment 
 
The therapeutic regimen given to TB patients needs to be completed to eradicate the TB 
bacteria. However, a study by Kaona, Tuba, Siziya and Sikaona (2004:5) revealed that 
patients stopped their TB treatment when they started to be feeling well with a belief that 
they had been cured. Similarly, Mathew, Kurian, Mathew, Senan, Kumar and Sivakumar 
(2015:986) in their quantitative study revealed that the common reason for default were 
feeling better and eventually stopped treatment. This means that factors that could cause 






to a health centre. Likewise, Widjanarko, Gompelman, Dijkers and van de Werf 
(2009:234) also revealed that the main reason why TB patients quitted and stopped their 
medication was feeling better. Furthermore, a belief that the medication would then make 
them feel worse if they continue with medication was another reason for quitting.  
 
2.6.4 Side effects and adherence to TB treatment 
 
Side effects could be a barrier to treatment adherence. In support of this statement, 
Schnippel et al (2016:593) revealed that patients with at least one adverse effect 
experienced, HIV positive patients, and those newly initiating on ART were more likely to 
experience severe unpleasant effects. This indicates that patients with co-infecting could 
have the highest hazard from severe side effects which could result to risk of death and 
loss of treatment. Similarly, a study by Mathew et al (2015:986) revealed that the common 
reason for TB patients to default their treatment was side effects following medications 
and fear of adverse reaction. This indicates that side effects of TB treatment could be a 
barrier to TB treatment adherence. Therefore, patients on anti-TB treatment need to be 
monitored for side effects as they could be lost during the treatment due to severe side 
effects (Mathew et al 2015:986). 
 
In a study by Boru et al (2016:5) side effects were revealed as major causes for 
discontinuing TB treatment, mainly at the beginning of TB treatment or upon initiation of 
concomitant treatment. This is compared to a study by Horter, Stringer, Greg, 
Amangeldiev, Tillashaikhov, Parpieva, Tigay and Phillipp du Cros (2016:8) that patients 
viewed side effects as being worse at the beginning of treatment, becoming more 
tolerable after 2 to 3 months when the body has adjusted to the drugs. However, side 
effects are considered to become worse over time, as the body starts refusing the drugs 
(Horter et al 2016:8). This means that side effects could occur anytime during the 
treatment period and could be a strong determinant of adherence as patients could stop 








2.6.5 Directly Observed Therapy (DOT) 
 
To address issues of poor adherence for TB, the World Health Organization adopted 
Direct Observed Therapy (DOT) as a means to help cure tuberculosis (DOT Manual 
2011:9).Therefore, DOT is the short course strategy which is used by health care 
providers as a primary approach to ensure TB treatment adherence (NTPM 2012:56). 
DOT aims to improve adherence to TB treatment by observing patient while swallowing 
each dose of anti-TB medication (DOT Manual 2011:9). 
 
In Eswatini, the DOT program has achieved a coverage of 66.7% which was 3048 patients 
on DOT out of 4567 registered cases, (NTCP 2015:24). DOT could be beneficial for 
prevention, diagnosis, support and care with its primary aim being an improvement in 
medication adherence (Zhang, Ehiri, Yang, Tang & Li 2016:2). This initiative primarily 
involves direct observation of adherence. This usually requires a patient to travel to a 
clinic daily where the health care worker directly observes the patient taking or swallowing 
the tablets (Molton, Pang, Wang, Qiu, Wu, Rahman-Shepherd, Ooi & Paton 2016:1).  
Furthermore, the DOT strategy is seen as an achievement in fighting TB in Eswatini. 
However, patients are stopping treatment and coming back when they had already 
deteriorated (NTCP 2015:21).  
 
A study by Yin, Yuan, Hu and Wei (2016:1) revealed a significantly higher treatment 
success rates to patients on full DOT and to those with self-administration therapy. This 
indicates that DOT provided to all TB patients during their full course of treatment can 
improve treatment success rate thus improving adherence to TB treatment. On contrary, 
Karumbi and Garner (2015:2) in their randomized control trial found that DOT did not 
provide any solution to poor adherence in TB treatment citing financial and logistics as 










2.7 PERCEIVED SEVERITY  
 
Perceived severity refers to one’s belief of how serious a condition and its consequences 
are (Tarkang & Zotor 2015:5). This concept states that individuals who perceive a given 
health problem as serious are more likely to engage in behaviours to prevent health 
problems from occurring or reduce its severity (Jones, Jansen, Scherr, Brown, Chrisy & 
Weaver 2016:3). Furthermore, perceived severity includes beliefs about a disease itself; 
for example, whether it is life-threatening, or may cause disability or pain (Onoruoiza et 
al 2015:14). When a TB patient recognized one’s susceptibility to the TB disease, it could 
not motivate him to change behaviour unless he realizes that getting TB could have 
serious physical and social implications. For that reason, patients need to first perceive 
TB as a serious infection that could have severe consequences on their health and social 
lives. Thereafter, they could be commenced on treatment in order to adhere.  
 
A study by Gabremariam et al (2010:651) reported that beliefs in the curability and 
severity of TB could positively influence adherence to TB treatment. Contrary, 
Makanjuola, Taddese and Booth (2014:5) asserted that individual personal beliefs such 
as fear of Isoniazid (INH) side effects, understanding of ITP and its importance, and belief 
in INH safety were core factors that negatively affect adherence. However, Naidoo, 
Peltzer, Louw, Matseke, Mchunu and Tutshana (2013:2) asserted that adherence to anti-
TB treatment was positively influenced by beliefs in the curability of TB and beliefs in the 




In this chapter literature review was presented. Specific determinants of adherence to TB 
treatment were identified as guided by the HBM. This chapter also attempted to explain 
some of the factors that influenced adherence and those that acted as barriers to 
adherence to TB treatment from related literature sources. The determinants discussed 







● Demographic variables including gender, age and marital status. 
● Modifying variables such as psychological and structural factors.  
● Facilitating factors included perceived susceptibility about tuberculosis, perceived 
benefits, and cues to action. 
● Barriers to adherence such as perceived severity and perceived barriers  




































This chapter presents the research design and methods employed for this study. The 
study was done in two phases. Phase 1 described the research methodology that was 
applied when eliciting data from the participants. This was done in line with the objectives 
of the study as summarised in table 3.1. Phase 2 was to design strategies to enhance 
adherence to TB treatment among TB clients in Eswatini, as reflected in the table 3.1. 
 




Compilation of evidence in preparation for 
the development of strategies to improve 
TB treatment adherence 
 
Design of strategies to enhance 
adherence to TB treatment 
Objectives of phase 1 
 
 Describe demographic variables of TB 
clients on TB treatment in Eswatini 
 Identify variables that modify 
adherence to TB treatment among TB 
clients in Eswatini  
 Explore barriers to adherence to TB 
treatment among TB clients in Eswatini 
 Describe factors that facilitate 
adherence to TB treatment among TB 
clients in Eswatini  
 Determine an association between 
factors that facilitate adherence and 
barriers to adherence to TB treatment  
 
Objective of phase 2 
 
 Design strategies to enhance 
adherence to TB treatment among 







3.2 RESEARCH APPROACH AND DESIGN  
 
A research design is an overall plan for addressing the question, including strategies for 






conducting a study and maximizes control over factors that could interfere with the validity 
of the findings (Grove, Burns & Gray 2013:195). In this study, a quantitative, exploratory 
and descriptive non-experimental design was used. 
 
3.2.1 Quantitative approach 
 
A quantitative research is the process of testing relationships, differences, and cause and 
effect interactions among and between variables (LoBiondo-Wood & Haber 2010:584). 
Grove et al (2013:706) define quantitative research as a formal, objective, systematic 
study process to describe and test relationships and to examine cause and effect 
interactions among variables. The study utilized this approach as the researcher viewed 
a client as integrated with the environment, which shaped the behaviour of adherence. 
Therefore, the only reliable source of information was the client. This method generated 
an in-depth account that presented a lively picture of the client’s reality in adherence to 
the TB treatment, and descriptive determinants of adherence was measured. 
 
3.2.2 Exploratory design 
 
Exploratory research is designed to increase the knowledge of a field of study and not 
intended for generalization to large populations (Grove et al 2013:694). Polit and Beck 
(2012:727) define exploratory design as a research that explores the dimensions of a 
phenomenon or that develops or refines hypotheses about relationships between 
phenomena. The study explored the full nature of the phenomenon of adherence to TB 
treatment as well as related factors that could influence or impede adherence. The 
researcher chose this approach to gain a better understanding on what could make clients 
adhere and not adhere to their treatment. Items such as ‘identification of factors that act 











3.2.3 Descriptive design 
 
A descriptive research design was used in which the primary focus was to identify and 
describe determinants of adherence to TB treatment. According to Grove et al (2013:692) 
a descriptive design is used to identify a phenomenon of interest, identify variables within 
the phenomenon, develop conceptual and operational definitions of variables, and 
describe variables in a study situation. In this study, determinants associated with 
adherence to TB treatment were identified and described. The researcher did not 
manipulate the variables of interest because they were naturally existing attributes. The 
descriptive design was appropriate in the sense that the findings of the study were 
expected to provide detailed information about the variables under study. 
 
3.2.4 Non-experimental research  
 
Non-experimental research is a study in which the researcher collects data without 
introducing an intervention; also called observational research (Polit & Beck 2014:735). 
LoBiondo-Wood and Haber (2010:582) also defines a non-experimental research design 
as a design in which an investigator observes a phenomenon without manipulating the 
independent variable(s). Non-experimental research design was used to investigate 
determinants of adherence to TB treatment on TB clients to understand barriers and 
facilitators of TB treatment adherence.  
 
3.3 ORGANISATION OF THE STUDY IN TWO PHASES 
 
The study was conducted into two phases. Phase 1 was the research methods used for 
collection of evidence in relation to the objectives of the study. Furthermore, Phase 1 
comprised of steps 1 and 2 due to different populations for the study. The evidence was 









3.4 RESEARCH METHODS PHASE 1 STEP 1: TB CLIENTS 
 
Research methods refer to the techniques used to structure a study and to gather and 
analyse information in a systematic fashion (Polit & Beck 2012:741). The study followed 
a series of steps according to the plan of action and gathered evidence from clients by 
using a questionnaire. The findings of the study were then measured and analysed 
statistically to provide detailed information about the variables under study.  
 
According to Grove et al (2013:700) methodological designs are used to develop the 
validity and reliability of instruments in order to measure research concepts and variables. 
The study methods were used to describe the data collection process from the TB clients 
in two government hospitals in Eswatini. Opinions of the clients about determinants of 
adherence to TB treatment assisted in validating findings from the TB experts. Findings 
of the study from the TB experts could help provide detailed information about the 
variables under study. 
 
3.4.1 Purpose of step 1 
 
The purpose of the phase 1 was to investigate the determinants of adherence to TB 
treatment in order to compile evidence to design strategies to enhance adherence to TB 
treatment among TB clients in Eswatini.  
 
3.4.2 Objectives of step 1 
 
The objectives were to; identify and describe demographic variables of TB clients on TB 
treatment in Eswatini, identify variables that modify adherence to TB treatment, to explore 
barriers to adherence to TB treatment, and describe factors that facilitate adherence to 
TB treatment in TB clients in Eswatini. In addition, to determine an association between 
factors that facilitate adherence and barriers to adherence to TB treatment and to design 
strategies to enhance adherence to TB treatment among TB clients in Eswatini were other 






3.4.3 Setting for the study 
 
A setting in a study is defined by Grove et al (2013:709) as a location for conducting 
research; it may be natural, partially controlled, or highly controlled. The research was 
conducted in two major government hospitals in Eswatini; Mbabane and Hlatikulu 
hospitals. Eswatini has four main administrative regions. Each region has one referral 
hospital. Government owns the two regional referral hospitals and the others are owned 
by the missionaries. 
 
Mbabane government hospital is situated in the capital city of Mbabane which has a 
population of about 61.940 (City Baseline Report 2015:1). This hospital is the country’s 
main referral and also a regional hospital (Hhohho region). This region has a population 
of 282,734 (Swaziland Population Projection 2007-2030:8). The Mbabane government 
hospital was chosen because it has a TB Clinic where most TB patients residing within 
the city and surrounding places were treated.  
 
On the other hand, Hlatikulu government hospital is situated in the southern part of 
Eswatini in the Shiselweni region. This region has a population of about 208.454 in 2010 
(Swaziland Population Projection 2007-2030:8). The reason for choosing this hospital 
was because it is the main regional hospital and has a TB clinic where a lot of TB patients 
from the region were referred to and treated. 
 
In addition, each of these hospitals has a TB clinic with TB nurses, doctors and other TB 
officers, who in this study were referred to as TB experts. These experts found in the TB 
clinics assisted with knowledge of the determinants to adherence in TB treatment.  
 
3.4.4 Population  
 
Population is the entire set of individuals or objects having some common characteristics 
(Polit & Beck 2012:738). Grove et al (2013:703) also define population as all elements 






population. The population for the study in step 1 were all clients with TB and attended to 
TB clinics in the two major government hospitals. TB clients who came for refill of 
treatment, those who defaulted, or reinitiated made the population of the study provided 
they satisfied the inclusion criteria. TB clients who accessed treatment in both hospitals 
were those residing in close proximity to the hospitals or were referrals from other health 
care facilities for either reinitiating to TB treatment or defaulted treatment. 
 
The researcher visited the two hospitals on separate days in a week between mid-June 
to mid-July 2018; 3 days in Mbabane government hospital and 2 days in Hlatikulu 
government hospital. Mbabane government hospital was the most visited because it had 
a large flow of TB patients and very busy than the other hospital. 
 
The average daily attendance of TB clients who came for refill of TB treatment in Mbabane 
government hospital as reflected in the TB register book was12 clients, making a weekly 
total of 36 clients for 3 days, with an estimated monthly population of (36 x 4) = 144 TB 
clients. On the other hand, Hlatikulu government hospital’s register book reflected an 
average daily attendance of about 7 TB clients, making a weekly total of about 13 TB 
clients for 2 days, with an estimated monthly population of (26 x 4) = 104 TB clients. 
Therefore, the estimated population in both institutions in a period of 4 weeks (a month) 
was 62 x 4 = 248 TB clients. 
 
3.4.5 Sample and sampling method 
 
Sample is defined as the subset of the population that is selected for a study (Grove et al 
2013:708). The sample comprised of TB clients that came for treatment or refill in the TB 
clinics during the data collection process provided they met the selection criteria. The 
inclusion criteria were clients:  
 
● on TB treatment for at least 3 months 







● who defaulted TB treatment and were on retreatment course  
 
Sample size is defined by Polit and Beck (2012:742) as the number of people who 
participate in a study; an important factor in the power analysis and in statistical 
conclusion validity. A procedure called power analysis can be used to estimate a sample 
size (Polit & Beck 2012:283). In this study, the researcher used the parameters by Lipsey 
(1990: 92); study power of 0.88, effect of 0.35 and significance level of 0.05, the sample 
size was 123 participants. 
 
Sampling method is the process of selecting a group of people, event, behaviour or other 
elements that are representative of the population being studied (Burns & Grove 
2011:548).  Probability sampling was used with strength based on the inclusion criteria to 
select available TB clients. Probability sampling involves the selection of sampling units 
from a population using random procedures (Polit & Beck 2014:388).  
 
The researcher randomly selected TB clients using a systematic sampling method. 
Systematic random sampling was used because it ensured that every TB client had a 
chance to be selected from the sample. Sampling interval was considered when selecting 
TB clients. This method includes the standard distance between sampled elements and 
involves selecting every kth person from the list (Polit & Beck 2012:282-3). In this study 
kth was the sampling interval width which was established by dividing the population size 
(N) which was 248 by desired sample size (n) which was 123. The following formula 
adopted in Polit and Beck (2012:283) was used for sampling interval:  
    kth = population size (N) ÷ desired sample size (n) 
    kth = 248 ÷ 123 
    kth= 2 
 
The researcher then selected every second (2th) TB client, provided they met the 
inclusion criteria until a total of 123 was achieved. The monthly register was reviewed to 






records as sampling frame. However, due to protection of the client’s health information, 
a register book was then utilised.  
 
3.4.6 Recruitment method 
 
Recruiting prospective participants involved identifying eligible participants (Polit & Beck 
2012:286). The researcher developed an eligibility criterion for TB clients as reflected in 
Section 3.4.5. A prospective participant was identified by the researcher while waiting to 
be seen by TB nurses. The researcher introduced herself and requested the client to be 
interviewed after consultation. The client was explained that participation was voluntary. 
The intention and benefits of the study were also stated (see ANNEXURE F). Thereafter, 
if agreed to participate, the researcher showed the client the original letter of permission 
from the hospital to conduct the study (see ANNEXURE D & E). The client was also 
assured that he/she was free to withdraw anytime from the study without incurring any 
penalties. 
 
The client was also promised that the information he/she would share would be kept 
confidential. Then the researcher read the consent form (see ANNEXURE F) and the 
client signed it, if agreeable. The signed consent form was then kept into a folder. This 
folder was different from that of questionnaires in order to disassociate it with a particular 
questionnaire. The client was then invited to be interviewed in a private corner where it 
was quieter. Those who gave a hesitant answer to participate, the researcher requested 
them to come after consultation with either the nurse or doctor.  
 
3.4.7 Data collection method 
 
Data collection method is the precise, systemic gathering of information relevant to the 
research purpose or specific objectives, questions or hypothesis of a study (Burns & 
Grove 2011:52). Data from the TB clients were collected between June to July 2018 in 
both settings. Data were collected on weekly basis in the two government hospitals until 






clients were booked between 8am -13:00pm. The interview continued until the researcher 
reached a sample size for the specific site.  
 
3.4.7.1 Data collection tool 
 
A self-designed structured questionnaire was used to collect data from TB clients in both 
hospitals (see ANNEXURE H). A structured questionnaire was a form of instrument that 
allowed participants to respond to the questions to provide data for this study. The 
researcher designed the questions based on the literature review in Chapter 2 (HBM’s 
major tenets) and the study objectives. This was done to identify and describe 
determinants of adherence to TB treatment among TB clients in Eswatini. The study 
sought to measure adherence to TB treatment among TB clients. According to 
Gabremariam et al (2010:2) adherence to medication is a concept that allows for a 
comprehensive assessment of factors related to medication intake. This included 
characteristics of the regimen, attitudes of providers, socio-economic, cultural and 
environmental factors. The tool was designed in English and translated to Siswati to 
accommodate both languages. 
 
Table 3.2 Items in the tool: TB clients 






To describe demographic 
variables of clients who are on 
TB treatment in Eswatini 
(section 1.4.1.1) 
Structural factors to 
adherence  
Psychosocial factors and 
adherence 
 
Modifying factors that 
determine adherence to TB 
treatment (sections 2.4) 
To identify variables that 
modify adherence to TB 
treatment among TB clients in 
Eswatini (section 1.4.1.2) 
Facilitators of adherence 
to TB treatment 
Perceived susceptibility 
(section 2.5.1) 
Perceived benefits (section 
2.5.2) 
Cues to action (section 2.6) 
To describe factors that 
facilitate adherence to TB 
treatment among TB clients in 







Barriers of adherence to 
TB treatment 
Perceived barriers (section 
2.7) 
Perceived severity (section 
2.8) 
To explore barriers to 
adherence to TB treatment 
clients among TB in Eswatini 
(section 1.4.1.4) 
 
3.4.8 Data collection process 
 
The researcher administered questionnaires in both English and Siswati; and the 
researcher used the participant’s choice of language for the interview and completion of 
the questionnaire. Items in both English and Siswati tools were the same as participants 
differed in their reading levels, and in their ability to communicate in writing. The 
researcher asked the questions orally in a face-to-face interview, by reading the questions 
and ticking the responses on behalf of the participants. The researcher and the language 
expert checked both versions of the questionnaire to ensure language adequacy, 
correctness, clarity and lack of confusion. The language expert agreed that the meaning 
of each question was the same in both languages. 
 
The questionnaires had both close-ended and open-ended questions in order to 
accommodate some ideas that might be missed in both types of questions. Polit and Beck 
(2012:721) define closed-ended questions as questions that offer participants a set of 
specific response options. Additionally, open-ended questions are questions in a 
questionnaire that do not restrict participants’ answers to pre-established alternatives 
(Polit & Beck 2012:736). Each participant responded to closed-ended and open-ended 
questions. 
 
The closed-ended questions had dichotomous data (yes or no) responses where factual 
data was required and answers were selected by the researcher. Other closed-ended 
questions required the participants to select answers from multiple-choice questions. The 
multiple-choice questions enabled the researcher to measure the intensity and direction 
of determinants of adherence to TB treatment among the participants (Polit & Beck 
2012:298). There was only one open-ended question in the tool. The open-ended 






ended questions. The researcher being the one administrating the questionnaire by 
ticking the responses, had to write the responses for the open-ended question verbatim.  
 
 Advantages/strengths of the questionnaire 
 
Questionnaires used in the study enabled the researcher to encode instead of writing 
names of the participants. This made participants to be comfortable and willing to give 
information, which resulted in higher response rate. 
 
The researcher was able to develop and gather information in a standardized manner, as 
the questions were the same in the questionnaires. This helped the researcher to ask the 
same questions to all the participants without introducing new questions. 
 
The collection of data using the structured questionnaire was faster, and asking questions 
was done within a limited period. This made participants to participate freely as 
questioning was done within a specified time. 
 
 Disadvantages/weaknesses of the questionnaire 
 
The questionnaire limited participants to explain about some other determinants to TB 
adherence, which were not in the item.  
The participants did not respond to the last question which was open-ended. 
 
3.5 VALIDITY AND RELIABILITY OF THE DATA COLLECTION INSTRUMENT 
 
Validity and reliability of a research study are forms of evaluating the quality of data 










3.5.1 Validity  
 
Validity is defined by Polit and Beck (2014:394) as a quality criterion to the degree to 
which inferences made in a study are accurate. To enhance validity of this study, the 
following were done: 
 
● Content validity, which is the degree to which the items in an instrument adequately 
represent the content for the concept being measured (Polit & Beck 2012:723). To 
enhance validity of this study,  
- the questionnaire was designed in relation to the study objectives as illustrated 
in Table 3.1. 
- a TB expert and TB hospital manager were consulted to examine the 
appropriateness of the tool. 
- Self-designed questions were based on the objectives of the study and the 
literature review, see Chapters 1 and 2. 
 
 Construct validity, examines the fit between conceptual and operational definitions 
of variables and determines whether the instrument actually measures the theoretical 
construct that it purports to measure (Grove, Burns & Gray 2013:690).   
- The researcher developed a hypothesis regarding the determinants of 
adherence to TB treatment (see Chapter 1). 
- Literature was examined to identify variables to be delineated (see Chapter 2: 
(Gabremariam, Gunnar, Bjune & Frich 2010:1; Kastien-Hilka, Abulfathi, 
Rosenkranz, Bennett, Schwenkglenks & Sinnovic 2016; Dladla 2013:27; Asati, 
Nayak & Indukar 2017:2759).  
- Questions used for data collection were in line with the theoretical framework 
(HBM) of the study (see Chapter 1) 
-  Data were collected to test the hypothesis and to make inferences based on 







 Face validity, verifies that the instrument looks as though it is measuring what it 
purports to measure (Polit & Beck 2014:380).  
- A statistician (see ANNEXURE J) was consulted with the design of the 
questions in the tool to ensure that data analysis was congruent with the 
method of analysis. 
- The structured questionnaire was pretested on four TB clients who were not 




Reliability relates to the degree to which a measurement is free from measurement error 
–its consistency and accuracy (Polit & Beck, 2014; 390). Reliability is a pre-requisite for 
tool validity. 
  
Reliability of instrument was enhanced through pre-testing it on four TB clients who 
were not part of the main study. 
● Items in the questionnaires were the same to all participants and measured the 
determinants of adherence to TB treatment. 
● In this study, English or Siswati was the language of instruction depending on the 
participant’s choice. This enabled the participants to express themselves better in 
the language that they understood. 
● The researcher was the only one who collected data from participants. This made it 
possible for the researcher to make a follow-up on the responses and maintained 
consistency in the data collection process,  
 
3.6 PRE-TESTING THE DATA COLLECTION INSTRUMENT 
 
A pre-test is defined by Polit and Beck (2012:738) as a collection of data prior to the trial 






the approval (see ANNEXURE A & C) of the research proposal the researcher with the 
help of Clinic Managers in the TB clinics identified prospective participants to form part of 
the sample provided they met the inclusion criteria. The pretesting was done on 4 TB 
clients with similar characteristics to those who were in the actual study sample in order 
to test if the tool measured the study variables. 
The questionnaire used in the pre-test were the same as those in the main study. The 
results of the pre-test assisted the researcher in refining the tool and familiarization with 
the interview technique for data collection.  
In the TB client questionnaire (see ANNEXURE H), changes that were made were as 
follows: 
In section 1.0: in question 1.1, age categories were replaced with an open-ended 
question, and in 1.2 “bisexual” was removed as it was a sensitive, yet insignificant variable 
to include. 
In section 2.0: in 2.0 “related” factors was replaced with “structural” factors, in 2.1 “6-8 
months” was replaced with 7-8 months, “above 8 months” was replaced with “above 9 
months…”, “more than one” was added in relevant questions , in 2.2 the question was cut 
short to read “what is your HIV status? In 2.3 “treatment” was replaced with “ART”, in 2.5: 
“illicit/illegal drugs” was replaced with “alcohol”, in 2.6 the question was replaced with “do 
you have a family member with TB?”  
Section 3.0: in 3.0 “psychosocial” was replaced with “psychological, “more than one” was 
added in relevant questions, questions 3.3 and, 3.4 were deleted, in 3.5 “don’t know”, low 
immunity”, “related to HIV” and “smoking” were added 
Section 4.0: “More than one” was added to relevant questions, in 4.7 “counselling on 
adherence” was added 
Section 5.0: ‘more than one” was added to relevant questions, in 5.11 responses were 
reshuffled to look like; 1. “Lack of food”, 2. “Sick continuously”, 3. “Living alone” and “4. 
Lack of social support”, in 5.10 the question was modified and began with “are there any 






with “forget”, in 5.15 “stop treatment” was added, in 5.17 in the question “stopping” was 
replaced with “forgetting” ,“don’t know” and “more than one” response were also added,  
in 5.19(3) “mellitus” was added and “more than one response” was added, in 5.23 the 
responses were changed to 1. “Poor”, 2. “Good”, and 3. “Excellent”, in question 5.24 “not 
good” was replaced with “poor” 
Section 6.0: the question was deleted and replaced with "any additional barrier to TB 
treatment adherence”? 
In TB experts, pretesting was done on 2 experts with similar characteristics to those who 
were in the actual study sample in order to test if the tool measured the study variables. 
Changes made included: 
In section 2.0 “related” factors was replaced with “structural factors”, in 2.3 “more than 
one “was added, in 2.9 (4) “daily” was replaced with “monthly”, in 2.11(3) “good” was 
deleted, in 2.12 “more than one” was added. 
Section 3.0: in 3.4 additions included “more than one method, don’t know, low immunity, 
related to HIV and smoking”  
Section 4.0: in 4.1 in the question “treatment” was added, in the responses, all were 
deleted and replaced with; 1. “No” and 2. “Yes”, in 4.5 the responses were reshuffled to 
look like; 1. “Switch to another regimen if side effects are severe”, 2. “Give medication to 
treat side effects”, 3. “Report to the TB clinic manager”, 4. “Advise to stop taking tablets”, 
5. “More than one” was added, in 4.7 “on adherence” was added in the question. In 4.9 
in the table; line no. 5 “lacking” was deleted, in line 6 “time’ was deleted, in line 7 
“occurrence of” was deleted, in line 8 “un” was deleted, in line 9 “deficit” was deleted. 
Section 5.0: the whole question was deleted and replaced with “any additional hindrance 










3.7 ETHICAL CONSIDERATIONS 
 
The researcher ensured that ethical considerations were followed, and participants’ rights 
were protected. To collect data from the participants, the researcher first sought and 
obtained ethical approval from Health Studies Research Ethics Committee, University of 
South Africa (see ANNEXURE A) and permission was granted by the Swaziland National 
Health Research and Ethics Council (see ANNEXURE C). After the approval, the 
researcher sought permission to conduct the study from the hospital managers of the two 
proposed government hospitals (see ANNEXURES D & E). Written and informed 
consents (see ANNEXURE F)) were sought from the TB clients attending the TB clinics 
before interview. 
  
The researcher followed the three following fundamental ethical principles which were 
applied:  
 
● Respect for persons (Burns & Grove 2011:547) is a principle that indicates that 
each person has the right to self-determination and the freedom to participate or 
not participate in research. In this study, participants voluntarily participated 
without incurring any negative consequences whatsoever. Participants were 
assured that they had the right to ask questions, to refuse to give information and 
to withdraw from the study at any time if they so wished. Full disclosure of 
information was maintained. The risks and benefits of the study were explained 
before the interview began (see ANNEXURES F & G). It was explained to the 
participants that the possible risks in participating were fatigue and some 
inconvenience. There were no immediate benefits in participating in the study. 
However, future TB patients may benefit from the implementation of the adherence 
strategy based on the findings. Confidentiality was maintained in all the phases of 
data collection. To maintain anonymity, the questionnaires were coded with 
numbers, and no participant’s name was written on the tool. Those who agreed to 
participate were requested to sign a consent form which was then clipped to a 






● Beneficence is defined by Polit and Beck (2012:720) as “a principle that seeks to 
maximize benefits for study participants and prevent harm”. Since the study was 
non-intervention, there were indirect benefits. The participants were explained to 
that their participation in the study was very important to generate and refine 
nursing knowledge for practice as their responses would help others with similar 
condition in future. They were also ensured that participating in this research would 
help in developing strategies to enhance adherence to TB treatment.  
● Justice is a principle stating that human subjects should be treated fairly (Burns & 
Grove 2011:540). The selection of the population, and the risks and benefits of this 
study were fairly disseminated based on the participants’ needs and rights. The 
researcher treated the participants who declined to participate and/or those who 
withdrew during the interview process in a non-prejudicial manner. Participants 
were selected for reasons that they were directly related to the problem being 
studied and not for their easy availability. The researcher also honoured all 
agreements made with participants; the researcher terminated the data collection 
process at the agreed-on time. Data collected was kept in a private place, where 
only the researcher and the supervisor had access. 
 
3.8 DATA ANALYSIS 
 
Data analysis is the systematic organization and synthesis of research data and, in 
quantitative studies the testing of hypothesis using those data (Polit & Beck 2012:725). 
Data gathered through closed-ended questions from TB clients were first coded then 
entered into the computer for analysis. Quantitative data were analysed by descriptive 
statistics using the Statistical Package for the Social Sciences (SPSS) version 20.0. 
Association between variables were examined using inferential statistics and the help of 
a statistician was sought throughout the data process. Data solicited from open-ended 
questions were analysed using simple descriptive analyses. The statistician was sought 







3.9 RESEARCH METHODS PHASE 1 STEP 2: TB EXPERTS 
 
Step 2 in this study, followed a stage according to the plan of action and gathered 
evidence from TB experts by using a self-administered questionnaire. The findings of the 
study were measured and analysed statistically to provide detailed information about the 
variables under study. The study methods were used to describe the data collection 
process from TB experts in two government hospitals in Eswatini. Opinions of the TB 
experts about determinants of adherence to TB treatment among TB clients assisted in 
validating findings from the TB clients. The findings of the study also helped in providing 
detailed information about the variables under study. 
 
3.9.1 Purpose of step 2 
 
The purpose of the step 2 was to investigate the determinants of adherence to TB 
treatment in order to compile evidence to design strategies to enhance adherence to TB 
treatment among TB clients in Eswatini.  
 
3.9.2 Population for step 2 
 
The population comprised of all TB experts working in different TB clinics sections in the 
two major government hospitals. TB experts included doctors, nurses and TB experts in 
DOTS or/and TB development of strategy, provided they satisfied the inclusion criteria. 
In these TB clinics, TB experts worked from 8am-5pm on weekdays only, and no night 
shift duty. Therefore, the target population was the TB experts on duty on the day the 
researcher collected data provided they satisfied the inclusion criteria. In Mbabane 
Hospital TB clinic, the duty roster reflected approximately 11 TB experts, while Hlatikulu 
had 8 TB experts during June to July 2018. Therefore, an estimated population was 11+ 









3.9.3 Sample and sampling  
 
In this study, the researcher used the parameters by Lipsey (1990:92) to calculate the 
sample size from the two hospitals. The study power of 0.86, effect of 1.00 and 
significance level of 0.05 resulted in a sample size of 12 participants. The sample size 
comprised of TB experts who were found in the TB clinics during the time of data 
collection and they had to satisfy the selection criteria. The inclusion criteria in this 
category were those TB experts who had worked in the TB clinics for more than 2 months, 
as they would understand adherence to TB treatment.  
 
Purposive sampling was employed because the researcher had to use own judgement to 
select TB experts that met the inclusion criterion. 
 
3.9.4 Recruitment method 
 
The researcher developed the eligibility criterion for TB experts as reflected in Section 
3.9.3. Prospective participants were identified in the duty station using a duty roster. The 
researcher approached the prospective participant and stated the intention of the study. 
The researcher also showed the participant the original letter of permission from the 
hospital to conduct the study (see ANNEXURES D & E). When agreed to participate, the 
purpose and benefits of the study was then explained, and a consent form was signed 
(see ANNEXURE F). The form was then clipped to a folder that was different from that of 
the questionnaire. The self-administered questionnaire (see ANNEXURE I) was then 
given to the TB expert to fill at his/her appropriate time. When the TB expert gave a 
hesitant answer to participate, the researcher requested another time when would be 
ready to sign the consent. Each TB expert set a suitable date for the submission of the 










3.9.5 Data collection method 
 
Data collection method is the precise, systemic gathering of information relevant to the 
research purpose or specific objectives, questions or hypothesis of a study (Burns & 
Grove 2011:52). Quantitative approach of data collection was followed in this step, using 
a self-administered questionnaire. 
 
3.9.6 Data collection tool 
 
Self-administered questionnaire (SAQ) was used to collect data from TB experts (see 
ANNEXURE I). Polit and Beck (2012:740) define a self-administered questionnaire as a 
document used to gather self-report data via self-administration of questions. The self-
administered questionnaire was written in English as TB experts were literate and were 
able to read the questions on the form and responded to the questions independently. 
The questionnaires were hand delivered by the researcher. The researcher designed the 
questions in the questionnaire based on the literature review in Chapter 2 (HBM’s major 
tenets) and the study objectives. This was done to identify and describe determinants of 



















Table 3.3 Items in the tool: TB experts 
Aspects in the Tool  Literature Review Objectives 
 
Demographic details Demographic 
variables(section 2.3) 
To describe demographic 
variables of TB clients and 
experts working in TB clinics 
in Eswatini (section 1.4.1.1) 
 
Structural factors to 
adherence  
 
Modifying factors that 
determine adherence to TB 
treatment (sections 2.4) 
To identify variables that 
modify adherence to TB 
treatment among TB clients in 
Eswatini (section 1.4.1.2) 
Determinants enhancing  







Perceived benefits (section 
2.5.2) 
Cues to action (section 2.6) 
To describe factors that 
facilitate adherence to TB 
treatment among TB clients in 
Eswatini (section 1.4.1.3) 
 
Barriers of adherence to 
TB treatment 
 
Perceived barriers (section 
2.7) 
Perceived severity (section 
2.8) 
To explore barriers to 
adherence to TB treatment 
among TB clients in Eswatini 
(section 1.4.1.4) 
 
3.9.7 Data collection process 
 
Self-administered questionnaires (SAQs) designed in English were hand delivered by the 
researcher to collect data. Items in the tools were the same. Questions were written in 
English which was checked by a language expert. The participants read the questions in 
the tool and gave their answers in writing. Questions were completed anonymously and 
independently minimising chances of the researcher bias. 
 
The self-administered questionnaires were coded and no participant’s names were 
written on them. The questionnaires had both close-ended and open-ended questions. 
This was done to accommodate some ideas that might be missed in both types of 
questions. Polit and Beck (2012:721-736) define closed-ended questions as questions 
that offer participants a set of specific response option, and open- ended questions as 







Each participant replied to closed-ended questions and an open-ended question. There 
was only one open-ended question in the tool. The closed-ended questions had 
dichotomous data (yes or no) responses where factual data was required and answers 
were selected by the participant. Other closed-ended questions required the participants 
to select answers from the multiple choice which enabled the researcher to measure the 
intensity and direction of phenomenon under study (Polit & Beck 2012:298). A Likert 
Scale was also used to measure TB expert’s hindrances to TB treatment adherence. Polit 
and Beck (2014:384) define a Likert scale as a composite measure of attribute involving 
the summation of scores on a set of items that participant’s rate for their degree of 
agreement or disagreement. Data collection was done simultaneously on weekly basis in 
the two government hospitals until the required samples size was met.  
 
 Advantages/strengths of the self-administered questionnaire 
 
Self-administered questionnaires used in the study enabled participants to independently 
fill the questionnaire at their own pace and time. This helped in the increase of the 
response rate.   
 
The researcher was able to develop and gather information in a standardized manner as 
the questions were the same in the questionnaires. This helped the researcher to ask 
same questions to all respondent without introducing a new question, thus increased 
validity and reliability of the study. 
 
The collection of data using the self-administered questionnaire reduced researcher bias 
as the presence of the researcher might had forced the participant to tick untruthful 











 Disadvantages/weaknesses of the questionnaire 
 
Closed-ended questions limited participants to give a clear picture of the determinants of 
adherence to TB treatment. Some of the participants did not answer the open-ended 
question, which requested them to add any other hindrance of TB client’s adherence. 
 
3.10 SUMMARY  
  
Chapter 3 described the research approach, design, sampling and sample size, data 
collection tools and their psychometric properties. In addition, the data collection process, 






































In this chapter, analysis, presentation and description of the research findings for Phase 
1 were presented. The chapter begins with the presentation of research findings from TB 
clients, and followed by findings from TB experts respectively. For each category, data 
were presented according to research objectives. Each objective was analysed using 
descriptive and inferential statistics, including Pearson’s Correlation and Chi-square. 
Finally, the researcher’s hypothesis was tested.  
 
The study’s objectives were to: 
 Describe demographic variables of TB clients on TB treatment in Eswatini   
 Identify variables that modify adherence to TB treatment among TB clients in 
Eswatini 
 Explore barriers to adherence to TB treatment among TB clients in Eswatini 
 Describe factors that facilitate adherence to TB treatment among TB clients in 
Eswatini   
 Determine an association between factors that facilitate adherence and barriers to 
adherence to TB treatment  
 
4.2. DATA MANAGEMENT, ANALYSIS AND PRESENTATION OF PHASE 1 STEP 1: 
TB CLIENTS 
 
In total 125 questionnaires were administered by the researcher. However, 2 participants 
withdrew from the study. The study remained with 123 questionnaires, which were 
entered into SPSS for analysis. During data entry there were no challenges (e.g. outliers, 






123 participants. In presenting and analysing the data N depicts the whole sample and n 
reflects a subset of the whole sample.  
 
4.2.1 Demographic variables of clients on TB treatment  
 
For the demographic variables the statistical analysis of this data fell into two main 
categories, namely, descriptive statistics for continuous variables and the calculation of 
frequencies and or percentages for the categorical variables. A categorical variable is 
made up of categories and is one that names distinct entities. It names just two types of 
things for example male or female and this is known as binary variable. 
 






























































Never- attended school 
Primary level 
Secondary level 




















































Age is a continuous variable and the composition of age revealed different generational 
groups of patients. Accordingly, there are more patients of middle age who are affected 
by TB. 
 
Gender is a categorical variable. The results indicate that there is a fair representation of 
the population, as males have been over-represented in the study. The distribution of 
males over females is significant as in the table 4.1. 
 
Marital status is another categorical variable. The marital status of the participants 
characterised the possible marital categories. The possible marital status categories were 
represented in the study. However, the participants who were single or not married were 
significantly higher compared to the other marital status categories, as reflected in table 
4.1. 
 
 The participant’s place of residence was a categorical variable. A considerable proportion 
of participants resided in the rural area and very few were from the urban setting. 
Evidence (WHO Country Cooperation Strategy Swaziland 2015:3) supports that the 77% 
of the populace in Eswatini reside in rural areas. 
 
The educational level of participants was also a categorical variable. The data denotes 
that participants of different educational level were included in the study. The distribution 
of participants who had attained secondary education was significant compared to the 
other educational level categories, as shown in table 4.1. 
 
Employment status is a categorical variable. A considerable proportion of the clients are 
not employed as indicated in table 4.1. 
 
Religion is a categorical variable. A significant proportion of the participants were 









4.2.1.1.1 Association between demographic variables and adherence to TB treatment 
 
Table 4.2 Association between demographic variables and adherence (N=123) 
Variables Pearson’s 
Correlation (r) 
Significance level (p) 
 




















Table 4.2 reveals that there was a significant association between gender and 
employment status (r = -0.303, p = 0.001), indicating that males were less likely to be 
employed. There was an association between marital status and employment (r=0.212, 
p = 0.018), reflecting that those that were single were more likely to be employed. 
Furthermore, the table reveals an association between age and employment (r = -0.207, 
p = 0.022) meaning that with advancing age the participants were less likely to be 
employed.  
 
The table also shows an association between marital status and age (r =0.435, p = 0.001), 
indicating that those that were single were older. There was also a significant association 
between educational level and adherence to TB treatment (r = 0.184, p = 0.042). This 













4.2.2 Variables that modify adherence to TB treatment among TB clients 
 
The following were the variables identified. 
 
4.2.2.1 Participant’s structural factors and adherence to TB treatment  
 
The information representing modifying factors was organized into structural and 
psychological categories. Each category is discussed separately.   
 
4.2.2.1.1 Structural variables and adherence to TB treatment  
  
Most participants had been on TB treatment for 3 – 4 months. With reference to Figure 
4.1 forty-three percent (43%, n=53) of the participants reported to be on TB treatment for 
about 3-4 months, 18% (n=22) 5-6 months, and 16% (n=20) had been on treatment for 
7-8 months. In addition, 10% (n=12) of the participants reported to have been on TB 
treatment for 9 months and above but were still on retreatment, 8.9% (n=11) finished 
treatment course, but reinitiated, and lastly 4.1% (n=5) defaulted treatment, and re-
initiated. The participants had been on treatment for a mean period of 2.4 months with a 









Figure 4.1: Period of taking TB treatment (N=123) 
 
With reference to Figure 4.2, 74%, (n=91) of participants reported that they were HIV 
positive, 24% (n=29) HIV were negative, and 2.4%, (n=3) reported that they did not know 
their HIV status. The HIV status of the participants is likely to influence adherence to TB 
treatment. This indicates that taking both ART and TB treatment could increase the pill-
burden. However, in the current study the data did not support an association between 
HIV status and adherence to TB treatment (F = 1.649, p = 0.201). This reflected that HIV 
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Figure 4.2: Participant’s HIV status (N=123) 
  
Out of the 74.8% (n= 92) of the participants who reported that they were HIV positive, 
70.7% (n=87) were on antiretroviral therapy (ART), while 4.1% (n=5) were not on ART. 
  
Seventy-seven percent (77.2%, n=95) of the participants reported that they did not 
smoke, and 22.8% (n=28) were smoking.  
On the other hand, when participants were asked if they took alcohol, 79.7% (n=98) 
reported that they did not take alcohol, and 20.3% (n=25) took alcohol. 
 
A majority (73.2%, n=90) of the participants reported that they did not have any family 
member with TB, and 26.8% (n=33) had a family member who had TB. Moreover, out of 
the 26.8% (n=33) participants who reported to have a family member with TB, 12.2% 
(n=15) reported that the family member was a sibling, 4.9% (n=6) parent, 4.1% (n=5) 
reported more than one relationship which included sibling, uncle and parent, 2.4% (n=3) 







4.2.2.1.2 Associations between patient structural factors to adherence and other 
variables. 
The associations between patient structural factors on adherence to TB treatment and 
other variables were examined, findings are presented below.  
  
The data revealed a relationship between current HIV status and antiretroviral therapy (r 
= 0.437, p =0.001), meaning that, those that were HIV positive were more likely to be on 
antiretroviral therapy. Noteworthy is that taking TB treatment and ART is likely to increase 
the pill burden which could adversely affect adherence to medication. 
 
There was an association between smoking and alcohol (X2 = 66.920, p = 0.001). The 25 
out of 123 participants who smoked provide enough evidence that there is an association 
between smoking and taking alcohol at p ≤ 0.05. This relationship can affect adherence 
to TB treatment. 
 
Data showed an association between smoking and antiretroviral therapy (X2= 4.549, p = 
0.033), reflecting that the 87 out of 123 participants who were on ART provide enough 
evidence to conclude that there is an association between smoking and being on ART, at 
p ≤ 0.05. 
 
The data supported a relationship between being HIV-positive and taking ART (F = 
21.277, p = 0.001). This reflects that the HIV-positive is a good predictor of being on ART, 
at p ≤ 0.05.  
 
The findings revealed an association between patient –related factors and barriers to 
adherence to TB treatment (F = 9.019, p = 0.003). This reflected that patient-related 










4.2.2.2 Psychological factors related to adherence to TB treatment 
 
The data representing psychological factors were organized into treatment modality, 
understanding the meaning of TB, beliefs about TB, causes of TB and its transmission. 
Each of these factors was analysed using descriptive statistics.  
 
Most participants preferred western treatment for any disease. Sixty seven percent 
(67.5%), (n=83) of the participants reported that they preferred western treatment, and 
26% (n=32) reported that they liked better a combination of traditional and western 
treatment. In addition, 3.3% (n=4) preferred traditional treatment, 2.4% (n=3) favoured 
mixing western, traditional, and spiritual treatment. Lastly, only 0.8% (n= 1) reported to 
favour merely the spiritual modality. The preference of other treatment modalities by a 
minority of the participants may have negative effects on adherence to TB treatment. 
 
Forty one percent (41.5%), n=51) of the participants reported that adherence meant 
taking tablets as instructed, 30.1% (n=37) taking tables every day, 25.2% (n=31) taking 
tables until recovery. Moreover, 3.3% (n=4) reported that adherence meant a combination 
of taking tables as instructed and until recovery. 
 
A majority of the participants were informed about TB. Ninety-five percent (95.9%, n=118) 
of the participants believed that TB was curable, 2.4% (n=3) was both a killer and curable 
disease, lastly 1.6% (n=2) believed that TB was only a killer disease. The findings reflect 














Table 4.3 Causes of TB (N=123) 







































Table 4.3 shows that forty-four percent (44.7%, n=55) of participants reported that TB 
was caused by a micro-organism, 31.7% (n=39) occurred naturally, 8.1% (n=10) did not 
know, and another 8.1% (n=10) reported that TB was caused by many factors including 
micro-organism, smoking, and natural factors. Two percent 2.4% (n=3) reported smoking 
as a cause for TB. In addition, 1.6% (n=2) reported that TB was caused by low immunity, 
1.6% (n=2) related to HIV, another 1.6% (n=2) of participants reported that TB was related 
to witchcraft. This indicates that the participants need to be empowered on the causes 
and risk factors of TB. 
 
The participants reported various modes for TB transmission. Eighty-two percent (82.1%, 
n=101) of participants reported that TB was transmitted through coughing only, and 
15.4% (n=19) reported a combination of transmission modes which included coughing 
and exposure to tobacco smoke. An equivalent amount of 0.8% (n=1) reported that TB 
was transmitted through sharing linen, and exposure to tobacco smoke respectively. Only 
0.8% (n=1) of the participants did not know what transmitted TB from one person to 
another. The participants need to be empowered on the modes of TB transmission to 






4.2.2.2.1 Associations between psychological variables related to adherence to TB 
 
Associations found between the variables are presented in this section. 
There was an association between beliefs on TB and adherence to TB treatment (r=-280, 
p =0.002), reflecting that those who believed that TB was a killer were less likely to take 
their treatment every day. 
 
The data supported a relationship between beliefs on TB and knowledge on transmission 
of TB (r = 0.278, p = 0.002). This means that those who believed that TB was a killer 
thought that TB was transmitted from one person to another through sharing of utensils. 
 
There was a significant association between TB clients’ psychological variables and 
adherence (r = 1.000, p = 0.01). With increasing psychological variables, there was an 
increase in adherence to TB treatment. 
 
There was a significant association between age and treatment modality (r = 0.196, p = 
0.030). This indicates that with increasing age, clients preferred spiritual treatment for any 
disease. Such preference may have a negative impact on adherence to TB treatment. 
 
4.2.3 Variables that facilitate adherence to TB treatment among TB clients  
 
Factors that enhanced adherence to TB treatment among participants were analysed 
using descriptive statistics. 
 
Most of the participants did not receive illness grants while on TB treatment. Seventy six 
percent (76.4%, n=94) of the participants reported that they did not receive illness grants 
while on TB treatment, 23.6%, (n=29) received incentives for being on TB treatment. The 
absence of illness grants is likely to impede adherence to TB treatment.  
 
Participants reported various forms of illness grants, including food rations or food 






received, 19.5% (n=24) reported that they received food rations/food vouchers as grants, 
while 4.1%, (n=5) reported that they received both food rations and monetary illness 
grants. The illness grants may need to be expanded to include all TB patients. 
 
The wish to have a longer life expectancy motivated most participants to take TB 
treatment. A majority (91.9%, n=113) of the participants reported that the desire to live 
longer motivated them to take the treatment, 3.3% (n=4) were motivated by support from 
families, 2.4% (n=3) wished to return to work, and another 2.4% (n=3) reported that they 
wanted to see their children finishing school. Living each day for various reasons 
motivated the participants to take treatment. It’s a stand-alone question still under 
facilitators (what motivates you to take your TB treatment?)  
 
Table 4.4 Treatment supporter (N=123) 
Treatment supporter Frequency (f) Percent (%) 
 
Had no treatment supporter 
 
7 5.7 







With reference to table 4.4, 94.3% (n=116) of the participants reported that they had a 
treatment supporter, and 5.7% (n=7) reported that they did not have a treatment 
supporter. Evidence (Gebreweld, Kifle, Gebremicheal, Simel, Gezae, Ghebreyesus, 
Mengstead & Wahd 2018:7) has revealed that the absence of a treatment supporter has 
adverse effects on adherence to TB. 
 
Family members were found to be key treatment supports. Out of the 94.3% (n=116) of 
the participants who reported that they had a treatment supporter, 83.7% (n=103) 
reported that the treatment supporter was a family member, 2.4% (n=3) neighbours, 2.4% 






members. One percent (1.6%, n=2) reported that the treatment supporter was a rural 
health motivator, and another 1.6% (n=2) a health care provider. The presence of a 
treatment support is vital to adherence to TB treatment. 
 























No 14 11.4 Health 
education 
on TB 
No 18 14.6 
Yes 109 88.6 Yes 105 85.4 
Total  123  100  123 100 
 
With reference to table 4.5, 88.6% (n=109) of the participants reported that they received 
counselling on adherence prior to initiation to TB treatment, 11.4% (n=14) did not get any 
counselling on adherence. Lack of counselling before initiation to treatment may hinder 
adherence. On the other hand, a majority (85.4%, n=105) of the participants reported that 
they received health education on TB before initiation on treatment, 14.6% (n-18) did not 
receive any health education before initiation to TB treatment. Knowledge empowers 
participant which in turn facilitates adherence to TB treatment. 
 
Various sources of counselling on adherence were reported by the participants. A majority 
(85.4%, n=105) of the participants reported that counselling on adherence was offered by 
the health care provider, 2.4% (n=3) by family members, lastly 0.8% (n=1) reported that 
counselling on adherence was provided by TB expert clients.  
 
Health care providers play an active role in health education on TB. When participants 
were asked on who gave health education on TB, 83.7% (n=103) reported the health care 
provider, and 1.6% (n=2) reported that a client expert offered health education. Health 








Table 4.6 How health education helped participant (n =105) 
 
How health education helped Frequency (f) Percentage (%) 
 
 




Helped me recognize the dangers of 








Empowered me with knowledge about 














With reference to table 4.6, most (26.8%, n=33) participants reported that health 
education helped them to recognize the dangers of non-adherence to TB treatment. The 
participants reported various benefits from receiving health education. These benefits 
may promote adherence to treatment. 
 
4.2.3.1 Associations between facilitating factors 
 
These are indicated in Table 4.7. 
 
Table 4.7:  Association between facilitating factors and adherence to TB treatment 
Variables R P 
 
Incentives and community support -0.414 0.026 
Community support and health education benefits 0.200 0.011 
Health education on TB and adherence counselling 0.721 0.001 
Person offering health education and counselling 0.948 0.001 




Table 4.7 reveals a relationship between incentives and community support (r = -0.414, 






community. There was a relationship between community support and health education 
(r = 0.200, p = 0.011). Participants who received community support were motivated to 
take TB treatment through health education on TB, hence they were more likely to adhere 
to treatment. 
 
Furthermore, the table also reveals an association between person offering health 
education on TB and counselling on adherence (r=0.948, p=0.001). Health care providers 
offered both counselling on adherence and health education on TB in an effort to promote 
adherence to treatment. The table also showed an association between health education 
on TB and counselling on adherence (X2= 63.893, p = 0.001). The 105 out of 123 
participants who received health education on TB provide enough evidence to conclude 
that there is an association between health education on TB and counselling on 
adherence at p ≤ 0.05. 
  
4.2.4 Barriers to adherence to TB treatment among TB clients  
 
Variables on barriers to TB treatment adherence were analysed using descriptive 
statistics. Figure 4.3 reveals that a majority (36.6% ,n=45) of the participants reported that 
they travelled about 5 km to the health care facility to receive TB treatment, 28.5%, (n=35) 
more than 10 km, 22.8% (n=28) about 6-8 km, and lastly 12.2%, (n=15) travelled about 
9-10 km to the health care facility to receive treatment. The longer distance travelled by 
participants to the health care facility to receive treatment could be a barrier to adherence, 







Figure 4.3 Participants distance to health care facility (N=123) 
 
Figure 4.4 reveals that a majority (87%, n=107) of the participants reported that they 
honoured treatment refill appointment dates, and only 13% (n=16) did not honour dates. 



































Figure 4.4 Honouring treatment refill appointment dates (N=123) 
 
The participants reported various reasons for not honouring refill appointment dates. Out 
of 13.0% (n=16) of participants who reported that they did not honour the refill 
appointment dates, 5.7% (n=7) reported that they were usually sick, 2.4% (n=3) lacked 
money for transport, and 1.6% (n=2) reported that the unavailability of transport hindered 
them from honouring refill appointment dates. Furthermore, 3.3% (n=4) of the participants 
reported a combination factors including being usually sick, lack of money for transport, 
and unavailability of transport in their communities as barriers to honouring refill 
appointment dates. Regardless of the reason for not honouring the refill appointment 
date, these are indicative of poor adherence to treatment. 
 
Most health facilities met their obligation, that is, provision of medication to TB clients. 
Ninety four percent (94.3%, n=116) of the participants reported that medication was 
always available, and only 4.9% (n=6) reported that medication was not always available 
at the health care facility. On the other hand, 0.8%, (n=1) reported that they were not sure 
if TB medication was always available in the TB clinic. The sporadic availability of TB 






Most participants took medication as required. Fifty five percent (55.3%, n=68) of the 
participants reported that they took their pills as advised in the health care facility, 36.6% 
(n=45) as written on the pill container, while a minority of 8.1%, (n=10) took tablets as 
both advised and written on the pill container. However, collecting data from verbal 
reports by participants is a subjective measure of adherence, an objective measure of 
adherence is ideal. 
 
Figure 4.5 shows that most participants reported that they experienced side effects from 
the medication. Eighty percent (80.5%, n=99) participants reported that they experienced 
side effects, and 19.5% (n=24) reported that they experienced no side effects while on 
TB medication. This is in reference to figure 4.5. The experience of side effects is a 
possible barrier to adherence. 
 
 













Table 4.8 Type of side effects experienced by the participants (n =99) 
 





































Table 4.8 reveals that the participants reported various side effects related to the 
medication.  Forty-nine percent (49.6%, n=61) of participants experienced a combination 
of more than one side effects, which included tingling, burning or numbness of hands and 
feet, nausea and vomiting, 9.8% (n=12) reported tingling, burning or numbness of hands 
and feet only. Moreover, 8.9% (n=11) reported that nausea and vomiting were 
experienced, 5.7% (n=7) reported skin disorders, 3.3% (n=4) reported fatigue, and an 
equivalent amount of 1.6% (n=2) participants reported fever and ringing in their ears 
respectively. Despite of the type of effect, side effects are a threat to adherence to 
treatment. 
 
Participants reported that they took varied steps after experiencing side effects from the 
medication. Out of 80.5% (n=99) participants who reported to experience side effects 
from TB medication, 52.4% (n=65) reported that they continued with the medication and 
14.5% (n=18) notified the health care provider of the side effects. However, 8.9% (n=11) 
reported that they stopped taking the medication for a while and then resumed when side 
effects subsided. Lastly 4.0% (n=5) reported that they took more than one steps as they 






care provider and stopping to take the medication temporarily. Most participants reported 
social barriers to adherence. Sixty-two percent (61.8%, n=76) of participants reported that 
they had social barriers that disrupted adherence to TB treatment, while 38.2%, (n=47) 
reported that they did not have any social barriers to adherence. 
 
Key barrier to adherence was lack of food. Twenty two percent (22.8%, n=28) of the 
participants reported and lack of food, 17.9% (n =22) lack of social support, and 11.4% 
(n = 14) reported more than one (1) social barrier, including, being sick continuously, lack 
of food and social support.  In addition, 9.8%, (n=12) reported being sick continuously as 
a social barrier to adherence.  
 
Table 4.9 Feeling better since started TB treatment (N=123) 
Variable  Frequency (f) Percent (%) 
 
Not sure if treatment had any effect  
 
9 7.3 
Not feeling better since started treatment 
 
14 11.4 







With reference to table 4.9, a majority (81.3%, n=100) of the participants reported that 
since they started taking medication on TB they felt better, 11.4%, (n=14) did not feel any 
better, and 7.3%, (n=9) reported that they were not sure because the illness was 
intermittent. Improved wellbeing could promote adherence. However, not feeling better 
could be a deterrent to adherence.  
 
Out of 18.7% (n=23) participants who reported that they did not feel any better since 
initiated on TB treatment; 11.4%, (n=14) reported that they had other comorbidities 
besides TB, and lacked food, and 7.3%, (n=9) reported that they frequently fell sick 
despite being on TB treatment. Suffering from comorbidities could be related to drug-drug 







Table 4.10 Forgetting taking medication (N=123) 
Variable  Frequency (f) Percent (%) 
 
Not forgetting to take medication 
 
75 61 







Table 4.10 reveals that a majority (61%, n=75) of participants reported that they did not 
forget taking their medication, while 39% (n=48) sometimes forgot to take medication. 
Forgetting to take medication is a risk for drug resistance resulting to MDR. 
 
The participants revealed that they took different measures after forgetting to take 
medication. Out of the 39% (n=48) participants who reported that they sometimes forgot 
to take TB medication; 28.4% (n=35) took the medication immediately they remembered, 
8.1%, (n= 10) waited for the next dose period, 1.6%, (n=2) stopped taking medication 
completely, and 0.8% (n=1) took a double dosage. The different strategies used by 
participants, are cause for concern because they were all risks for developing resistance 
to treatment. 
 
Table 4.11 Participants consequences of forgetting to take medication (n=46) 
 
Consequences of stopping TB medication 
 
Frequency (f) Percentage (%) 

















Noteworthy is that the participants were aware of the consequences of forgetting to take 






to forgot to take medication on time, 29.3% (n=36) reported that they knew that forgetting 
to take medication would not cure TB, 4.9% (n=6) would acquire other diseases, while 
3.3% (n=4) reported that by forgetting to take medication they would develop drug 
resistance. It seems there is need for health care providers to emphasize on strategies 
that serve as reminders for taking medication. 
 
A majority of the participants took medication as prescribed. Out of 61% (n=75) 
participants who reported that they always remembered to take medication, 31.7% (n=39) 
reported that they set time as a reminder, 13.8% (n=17) had a natural feeling, and 12.2% 
(n=15) had a family member who reminded them to take medication. Likewise, 2.4% (n=3) 
reported that they had a combination of reminders, which included setting the time, family 
members and natural feelings, and lastly 0.8%, (n=1) reported that friends reminded them 
to take treatment. The various sources that serve as reminders could promote adherence 
to treatment. 
 
With reference to Figure 4.6, a majority (83.7%, n=103) of the participants reported that 
they were also treated for other diseases besides TB, while 16.3% (n=20) were not on 
treatment for any other disease except TB. Being on treatment for comorbidities could be 
a barrier to adherence since the pill burden is increased. 
 
 




































Table 4.12 Type of disease treated for besides TB (N=123) 
Type of Diseases Frequency (f) Percent (%) 
 
No disease 20 
 
16.3 
Gastrointestinal Problem 1 
 
0.8 
















TB is an opportunistic infection. With reference to Table 4.12, sixty-nine percent (69.1%, 
n=85) of the participants reported that they were also on treatment for HIV and AIDS 
related disorders, and 6.5%, (n=8) were being treated for more than one condition 
including HIV, diabetes mellitus and hypertension. Moreover, 4.1%, (n=5) were also on 
antihypertensive therapy, 3.3%, (n=4) were taking hypoglycaemic medication, and 0.8%, 
(n=1) were on gastrointestinal disorders medication in addition to the TB treatment. 
Taking treatment for comorbidities in addition to that for TB could be a barrier to 
adherence. A one shop strategy is mandatory to increase adherence. 
 
Table 4.13 Number of pills taken per day (N=123) 
Number of pills per day Frequency (f) Percent (%) 
 
More than 5 pills 94 
 
76.4 
5 pills 15 
 
12.2 
4 pills 6 
 
4.9 
3 pills 4 
 
3.3 













Most participants were taking more than three (3) tablets per day. This is revealed in 
Table 4.13.Seventy-six percent (76.4%, n=94) of participants reported that they took more 
than five (5) pills per day, 12.2% (n=15) took five (5) pills per day, 4.9% (n=6) consumed 
four (4) pills per day, 3.3% (n=4) reported that they took three (3) pills, and another 3.3% 
(n=4) took less than three (3) pills per day. Taking more than three (3) tablets per day 
could be a risk for poor adherence. 
 
A majority of the participants took tablets as prescribed. Eighty three percent (83.7%, 
n=103) of participants reported that they were able, while only 16.3% (n=20) reported that 
they were not able to take the tablets as prescribed. The minority participants who were 
not able to take tablets as prescribed were at high risk for developing drug resistance.  
 
The study sought from the participant’s reasons for not taking the tablets as prescribed. 
Out of the 16.2% (n=20) participants who reported difficulty in taking their prescribed 
tablets, 7.3% (n=9) had more than one reason for not taking the tablets as prescribed, 
which included side effects, pill burden and long period of TB treatment. Moreover, 6.5% 
(n=8) reported pill burden only, and 2.4%, (n=3) were bothered by side effects only from 
medication as rationale for the inability to take tablets as prescribed. This subgroup may 
benefit from daily visits by expert clients, reducing the likelihood of developing drug 
resistance.  
 
Table 4.14 Relationship between participant and health care provider (N=123) 















With reference to Table 4.14, a majority (81.53%, n=100) of the participants reported that 






relationship, 2.4% (n=3) poor relationship with health care providers. The rapport between 
participants and the health care provider is likely to increase adherence to TB treatment. 
 
There was one open-ended question which was asked from participants if there was 
anything to add on what they had already reported on barriers to adherence. A majority 
(84.5%, n=104) reported that there had no additional information to share and 15.4% (n 
=19) emphasized on a combination of barriers to adherence, such as lack of food, side 
effects and lack of money. There seems to be a need for policy to address poverty among 
TB patients who are on treatment.  
 
Table 4.15 Association between perceived barriers and adherence 
Variables R P 
 
Taking pills as prescribed and feeling better  -0.447 0.001 
 
Reason for not taking treatment as prescribed and feeling better -0.627 0.003 
 
Reason for not taking treatment as prescribed and cause of not feeling better  0.883 0.004 
 
Relationship with care provider and side effects 
 
-0.215 0.017 
Relationship with care provider and adherence 
 
0.191 0.035 
Stop taking pills and other barriers  
 
0.252 0.005 
Feeling better since commenced treatment and honour appointment  
 
0.325 0.001 
Feeling better since commenced treatment and other illnesses  
 
0.552 0.027 
Not feeling better since commenced treatment and side effects 
 
0.432 0.40 
Stop treatment and honour refill appointment 
 
-0.335 0.001 
Consequences of stopping treatment and side effects 
 
0.344 0.046 




With reference to table 4.15, there was an association between taking pills as prescribed 
and feeling better (r = -0.447, p = 0.001), reflecting that participants who felt better were 
less likely to take treatment as prescribed. The data support a relationship between 






This means that those who were not taking treatment as prescribed were less likely to 
feel better. 
 
Furthermore, the table reveals that there was also a significant correlation between 
stopping to take pills and other barriers (r= 252, p= 0.005). This means that participants 
who stopped taking pills had other barriers to adherence. The data support a relationship 
between rapport with health care provider and adherence (r=0.191, p=0.035). Participants 
who had good rapport with the health care provider adhered to treatment. A majority of 
the participants took medication as prescribed. 
 
4.2.4.1 Hypothesis testing 
  
Null hypothesis: There is no association between determinants of adherence (patient-
related factors, psychological factors, barriers and facilitators) and TB clients’ adherence 
to treatment. 
 
4.2.4.1.1 Patient-related factors and adherence to TB treatment: 
  
The data did not support a relationship between patient-related factors and adherence to 
TB treatment (r = -0.035, p = 0.701). We therefore accept the null hypothesis. 
Null hypothesis 2: There was no association between psychological factors and 
adherence to TB treatment. 
 
4.2.4.1.2 Psychological factors and adherence to TB treatment:  
 
The data did not support a relationship between psychological factors and adherence to 










4.2.4.1.3 Barriers and adherence to TB treatment: 
 
There is a relationship between barriers and adherence to TB treatment (r = -0.416, p = 
0.001), reflecting that clients who encountered barriers did not adhere to TB treatment. 
We therefore reject the null hypothesis for the alternative hypothesis which states that 
there is a relationship between barriers and adherence to TB treatment p ≤ 0.05. Health 
care providers therefore need to assess clients for potential barriers (e.g. side effects and 
comorbidities) to treatment adherence and attend to these instantly to reduce the risk of 
drug resistance. 
 
4.2.4.1.4 Facilitators and adherence to TB treatment: 
 
The data supported a relationship between facilitators and adherence to TB treatment (r 
= 0.176, p = 0.050). This indicated that facilitators of adherence enhanced TB clients’ 
adherence to treatment. Health care providers will need to strengthen incentives, 
availability of treatment supporter, counselling on TB treatment and health education on 
the disease which were factors that facilitate client adherence to TB treatment.  
 
4.3 SUMMARY OF RESULTS OBTAINED FROM PHASE 1 STEP 1: TB CLIENTS  
 
Data analysis in this phase 1 step 1 described the results of data gathered from TB clients. 
The findings reflected that the age of the participants ranged between 18 and 64 years, 
with a mean of 37.2 years and a standard deviation of 10.5 years. Most participants were 
unemployed. A majority of the study participants were HIV positive and were on ART. 
Patient related factors (HIV status, smoking, alcohol, length of treatment) were to 
adherence. A majority of the participants were informed about TB, increasing the 
likelihood of adherence to treatment. However, the participants need to be empowered 
on the causes and modes of TB transmission to reduce the risk of TB-recurrence. 
 
A large number of the participants did not receive any incentive while on TB treatment. 






Family members were found to be key treatment supporters. Health care providers played 
an active role in health education clients on TB. A minority of the participants did not 
honour treatment refill appointment dates and were at risk of developing MDR. Most 
health facilities met their obligation to provide medication to TB clients. A minority of the 
participants did not take medication as required increasing the risk of developing 
resistance. The reported key barrier to TB medication adherence was lack of food. Most 
participants reported that they experienced side effects from the medication and were 
taking more than three (3) tablets daily. 
 
4.4 DATA MANAGEMENT, ANALYSIS AND PRESENTATION PHASE 1: STEP 2 TB 
EXPERTS 
 
In Mbabane government hospital, 8 questionnaires were distributed to TB experts, but 
only 6 were returned, while 7 questionnaires were distributed to TB experts in Hlatikulu 
government hospital and only 6 were returned. This made a total of 12 TB experts who 
participated in the study.  
 
In total 13 self-administered questionnaires (SAQ) were completed by the respondents, 
however, one (1) respondent did not return the questionnaire. The study remained with 
12 completed SAQ which were entered into SPSS for analysis. The sample therefore 
comprised of N = 12 participants. During data entry there were no challenges (e.g. 
outliers, incomplete questionnaires) noted in the data. In presenting and analysing the 
data N depicts the whole sample and n reflects a subset of the whole sample. The study 
investigated determinants of adherence to TB treatment among TB clients. It also sought 
to come up with effective strategies that would enhance adherence to TB treatment 











4.4.1 Demographic variables of TB experts working in TB facilities in Eswatini 
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4.4.1.1 Associations between demographic variables of TB experts 
 
There was an association between educational level and employment position (r=-0.632, 







4.4.2 TB expert’s perspective on patient-related factors and adherence to TB 
treatment 
 
With reference to Figure 4.7, Thirty-three percent (33.3%, n=4) of the respondents 
indicated that they had worked in the TB facility for 1-2 years, 33.3% (n=4) had worked 
3-4 years and another 33.3% (n=4) reported that they had worked for 5 years and above 
in the TB facility. The study findings suggest that the TB experts had worked for more 




Figure 4.7 Duration of working in TB facility (N=12) 
 
 
The participants were using TB standard treatment guidelines. All (100%, n=12) the 
respondents indicated that they were using a TB guideline in the facility. The use of TB 
standard treatment guidelines promotes consistency in the management of TB. Such a 














The participants were using TB standard treatment guidelines from two (2) entities. Fifty-
eight percent (58.3%, n=7) of respondents indicated that they used guidelines from the 
Eswatini Ministry of Health, while 41.7% (n=5) used guidelines from the World Health 
Organization (WHO). Notable, the use of guidelines from different bodies may bring 
inconsistencies in prescription of similar drugs. 
 
The findings on availability of TB drugs in the facility were comparable with those of 
clients. Ninety four percent (94.3%, n=116) of the clients reported that TB drugs were 
always available at the facility. Likewise, ninety-one percent (91.7%, n=11) of TB experts 
indicated that TB drugs were always available, and 8.3% (n=1) reported that TB drugs 
were not always available at the health facility. The availability of TB drugs is a potential 
promoter of adherence to treatment.  
 
Table 4.17 Procedures used when initiating clients on TB drugs (N=12) 
Procedure Frequency (f) Percent (%) 
 
 





Advise client on honouring 
















With reference to Table 4.17, a majority (66.7%, n=8) of the participants indicated that 
they followed more than one procedure when initiation TB clients on TB treatment, 
including advising the clients to honour TB treatment refill appointment dates, referring 
clients to Adherence Officer and adherence to therapy. In addition, 16.7% (n=2) of the 
participants revealed that they referred clients to an Adherence Officer when they were 
initiated on TB treatment, 8.3% (n=1) advised clients on adherence to therapy only, and 
another 8.3% (n=1) advised clients to honouring TB treatment refill appointment dates. 






The different procedures reported in initiating clients may have a negative impact on 
adherence. 
Assessment of client level of adherence to treatment is important because it may assist 
in early isolating treatment defaulters and need to re-assessment. All (100%, n=12) the 
participants indicated that they performed TB treatment adherence assessment on TB 
clients. The performance of client TB treatment adherence assessment may motivate 
clients to adhere.  
 
Table 4.18 Types of TB treatment adherence assessment (N=12)  











Check daily treatment record 
 
1 8.3 
Trace clients who missed appointments 
 
0 0 







Table 4.18 indicates that 58.3% (n=7) of the participants revealed that they conducted 
more than one TB adherence assessment on TB clients which included pill count, self-
reporting, daily treatment record and tracing clients who missed appointments. Moreover, 
25% (n=3) of the participants used pill count only, 8.3 % (n=1) utilized DOT, and another 
(8.3%, n=1) reported that they used the daily treatment record as a tool for TB treatment 
assessment. The use of TB treatment adherence assessment on clients may promote 
client adherence to therapy.   
 
The TB experts ‘responses on client adherence were not consistent with those from the 
clients. Sixteen percent (16.3%, n=20) of clients reported that they were not able to 






clients were performing well on adherence to TB treatment. There is need for physiologic 
measures for TB clients’ adherence to treatment.  
 
Consistent with responses from clients (97.4%, n = 120), most TB experts revealed that 
rapport contributed to adherence. With reference to Figure 4.8, a majority (58.3%, n=7) 
of participants indicated that rapport with clients contributed to adherence, 16.7% (n=2) 
reported incentives, and another 16.7% (n=2) reported that social support contributed to 
adherence. In addition, eight percent (8.3%, n=1) of the participants indicated that there 
were more than one factors that contributed to adherence including client-health care 
provider rapport and incentives.  
 
 
Figure 4.8 Factors contributing to TB treatment adherence (N=12) 
 
4.4.2.1 Associations between patient-related factors and adherence to TB 
treatment 
 
The data supported association between treatment adherence tool and procedure 















those who used treatment adherence tools were more likely to follow a certain procedure 
when initiating the TB client on treatment, a practice which is likely to increase client 
adherence. 
 
There was an association between adherence and duration of work (r = -0.592, p = 0.043), 
reflecting that clients cared for by TB experts who had worked for a longer duration in the 
facility were less likely to adhere to treatment. There is need for continuous workshops 
on adherence, even for TB experts that have worked for a longer period. 
 
The relationship between adherence and causes of adherence was significant (r = -0.614, 
p = 0.034). This meant that clients who received incentives were less likely to adhere to 
treatment. Because of poverty, the incentives may motivate the client to be on treatment 
for an extended duration, making them to be entitled to incentives for a longer period.  
 
4.4.2.2 Associations between structural variables  
 
Data revealed that there was a relationship between factors contributing to adherence 
and duration of working in TB facility (r = -0.592, p = 0.043). This means that participants 
with less duration of working in TB facility were less likely know that incentives contributed 
to adherence. There could be need for on-going capacity building education particularly 
for new TB experts. 
 
There was a relationship between procedure followed when initiating TB clients and type 
of adherence assessment (r = 0.703, p = 0.011), reflecting that participants were more 
likely to use DOT procedure when initiating a TB client on treatment. 
 
4.4.3 Factors that facilitate adherence to TB treatment among TB clients in Eswatini 
 
Incentives facilitate adherence to TB treatment. Most participants (66.7%, n=8) indicated 






any incentives. There is a need for a policy for even distribution of incentives to TB clients 
who are on treatment. 
 
On the other hand, out of the 66.7% (n=8) of the participants who indicated that TB clients 
received incentives, 33.3% (n=4) reported that the incentives received by TB clients were 
food rations or vouchers. Additionally, 25% (n=3) revealed a combination of money and 
food rations/voucher as incentives received by TB clients.  Eight percent (8.3%, n=1) of 
the participants reported that TB clients received money only as an incentive. There are 
inconsistencies in the incentives received by clients, there is need for research to 
determine the impact on each of these incentives on adherence to TB treatment. 
 
Most participants had reminders on treatment adherence. Eighty-three percent (83.3%, 
n=10) of the participants reported that they reminded TB clients to take TB medication, 
and 16.7% (n=2) did not remind TB client about taking medication. The minority that did 
not remind their clients to take TB treatment might contribute towards poor client 
adherence. 
 
Table 4.19 Method used to remind TB clients to take medication (n=10) 





DOT officer visitation 
 
1 8.3 
Contact family member 
 
2 16.7 
More than one (1) response 
 
3 25.0 
Total 10 83.3 
 
 
Table 4.19, reveals that a majority (33.3%, n=4) of the participants indicated that they 
used phone calls to remind TB client to take medications, 25% (n=3) used a combination 
of methods including phone call, DOT visitation and contacting a family member. Sixteen 
percent 16.7% (n=2) of the participants indicated that they contacted a family member to 






of reminding TB clients to take medication. The various methods used as reminders for 
TB clients could positively contribute towards TB client adherence. 
 
4.4.3.1 Associations between variables that enhanced adherence 
 
There was an association between receiving incentives and being reminded to take 
medication (r = 0.632, p = 0.027), indicating that TB clients who were reminded to take 
medications also received incentives. This practice may need to be encouraged to 
promote adherence.  
 
4.4.4 Barriers to adherence to TB treatment among TB clients in Eswatini 
 
 
Consistent with responses from clients, where a majority (87%, n=107) reported that they 
honoured the TB medication refill appointment dates, 66.7% (n=8) of TB experts revealed 
that TB clients honoured medication refill appointment dates. However, 33.3% (n=4) of 
TB experts reported that TB clients did not honour TB medication refill appointment dates. 
The client inability to honour TB medication refill appointment dates may be a precursor 
for poor adherence to treatment. 
 
Monetary constraints were reported as barriers to client honouring TB medication refill 
dates. The thirty-three percent (33.3%, n=4) of the participants who reported that TB 
clients were not keeping the medication refill appointment dates indicated that transport 
costs contributed to client’s failure to honouring medication refill appointment dates. The 
response from TB experts was contrary to that of clients. TB clients reported various 
reasons for not honouring refill appointment dates, including lack of transport money, 
unavailability of transport, usually sick and forgetfulness.  
 
Consistent with responses from TB clients where 80.5% (n = 99) reported that they 
experienced side effects from the medication. All (100%, n=12) the TB experts indicated 
that TB clients reported side effects while on TB treatment. The experience of side effects 







Much like the TB clients, 100% (n=12) of the TB experts indicated that clients reported 
various side effect which included ringing ears, nausea and vomiting, poor appetite, skin 
disorders, fatigue and tingling, burning or numbness of hands and feet, abdominal 
disorders, and polyuria. The health care provider needs to be sensitive and address each 
of the side effects reported by clients in order to promote adherence.  
 
Table 4.20 Steps taken for reported side effects (N=12) 
Steps taken for reported side effects Frequency (f) Percent (%) 
 
Advise to stop treatment 
 
0 0.0 
Report to TB clinic manager 
 
2 16.7 
Switch to another regimen 
 
1 8.3 
Give medication to treat side effects 
 
6 50 







Only half of the TB experts addressed side-effects reported by TB patients. Table 4.20, 
reveals that 50% (n =6) of respondents indicated that they alleviated side effects reported 
by clients, 25% (n=3) reported a combination of steps they took which included switching 
TB clients to another regimen, alleviating side effects, and reporting TB client to Clinic 
Manager. Moreover, 16.7% (n=2) of participants indicated that they only referred TB 
clients with side effects to the Clinic Manager, and 8.3% (n=1) indicated that TB clients 
who reported side effects were only switched to another treatment regimen. The health 
care provider needs to consider asking the TB client for the presence of any side effect 
during each follow-up visit, and not wait for the client to report these side effects. Some 
clients may not be educated about some side effects; hence they may not report these to 








Contrary to the responses from TB clients were only 85.4% (n=105) who reported that 
they received health education on TB, 100% (n=12) of the TB experts reported that TB 
clients were educated on the importance of adherence to TB treatment. Health education 
on TB empowers the client to make informed decision on adherence, which may in turn 
promote adherence. 
 
Health education on TB yielded positive feedback from the clients. All 100% (n=12) the 
participants reported that following health education on TB, clients promised to adhere to 
treatment so as to reduce the risk of developing drug resistance. However, the verbal 
promise may require objective or physiological measure to determine that adherence is 
observed by the client.  
 
Contrary to responses from TB clients where only 88.7% (n =109) reported that they 
experienced various social barriers to adherence, all (100%, n=12) TB experts reported 
that there were diverse social barriers which TB clients reported. Social barriers reported 
by TB experts included lack of incentives, co-morbidities, absconding without trace, and 
alcohol abuse. The social barriers encountered by clients could impede adherence to 
treatment. 
  
4.4.4.1. Other barriers to adherence to TB treatment 
 
In addition to social barriers, TB experts reported extra barriers which they observed.  
These included gender, educational level, monetary, distance to heath care facility, 
treatment supporter, length of treatment, treatment supporter, food, knowledge and 
beliefs. 
 
TB client’s gender was reported as a barrier to treatment adherence. Fifty percent (50.0%, 
n=6) of the participants revealed that gender of TB clients did hinder TB treatment 
adherence, yet 50.0% (n=6) reported that gender did not hinder adherence to TB 
treatment. However, data from clients did not support an association between gender and 






The client’s educational level was reported to be barrier to adherence. Most (91.6%, 
n=11) TB experts reported that clients’ educational level hindered adherence to TB 
treatment, whilst 8.3% (n=1) reported that educational level of TB clients did not hinder 
adherence to TB treatment. This finding was consistent with data from clients, which 
revealed an association between educational level and adherence (r = 0.184, p = 0.042). 
This means that males were more likely to adhere to TB treatment.  
 
The higher the client costs associated with receiving treatment could be a barrier to 
adherence. All (100%, n=12) TB experts reported that transport costs hindered TB client 
adherence to TB treatment. However, clients were not assessed on cost implications on 
adherence. 
 
The longer distance travelled by client to the health care facility to receive treatment could 
be a barrier to adherence. Seventy-five percent (75.0%, n=9) of the participants indicated 
that the distance to the healthcare facility hindered client adherence to TB treatment.  
However, twenty-five percent 25% (n=3) reported that the distance to the health care 
facility could not hinder TB client’s adherence to TB treatment. Conversely, data did not 
support a relationship between adherence and distance (r = -0.051, p = 0.576). 
 
All (100%, n=12) TB experts reported that lack of a treatment supporter was a barrier to 
client adherence to treatment. Consistent with scientific evidence, data supported an 
association between adherence and treatment supporter (r = 0.275, p = 0.003). This 
means that having a rural health motivator as a treatment supporter promoted client 
adherence to TB treatment.  
 
The longer the length the client was on TB treatment the higher the risk of not adhering 
to treatment. This was evident when most (83.3%, n=10) of TB experts reported that 
client’s length of time on TB treatment was a hindrance to adherence. However, 16.6% 
(n=2) reported that client’s length of time on treatment was not be a hindrance to TB 
treatment adherence. This finding was consistent with data from clients which revealed 






that the longer the client was on TB treatment, the higher the risk of not adhering (r=0.271, 
p = 0.002). 
 
Evidence (Gebreweld et al 2018:6) suggests that the experience of side effects from 
medication was a hindrance to adherence. Most (75.0%, n=9) TB experts reported that 
the occurrence of side effects impeded client adherence to TB treatment. Nevertheless, 
25.0% (n=3) TB experts reported that side effects did not client hinder adherence to TB 
treatment. The data are consistent with findings from TB clients where data showed a 
relationship between side effects and poor adherence (F = 57.625, p = 0.001). This data 
supported that side effects were a good predictor of poor adherence to TB treatment at p 
= 0.05.  
 
Lack food was a barrier to adherence. Moreover, some medication has to be taken with 
or immediately after meals. All (100%, n=12) TB experts reported that the unavailability 
of food hindered TB clients from adhering to treatment. Conversely, data from clients did 
not support a relationship between food and adherence (r = -0.115, p = 0.323).  
 
Knowledge on the condition is a potential facilitator for adherence. Seventy-five percent 
(75.0%, n=9) of the TB experts revealed that knowledge deficit on TB was a barrier to 
client’s treatment adherence. Nonetheless, 25.0% (n=3) of The TB experts reported that 
knowledge deficit on TB was not a barrier to TB treatment adherence. This finding was in 
harmony with findings from clients, which revealed an association between knowledge 
and adherence (r = 0.650, p = 0.001). This means that clients who were empowered on 
TB through health education were more likely to adhere to treatment.  
 
Client’s beliefs about the condition and its treatment are potential facilitators or barriers 
to adherence. Seventy-five percent (75.0%, n=9) of the TB experts reported that the 
client’s belief system was a hindrance to TB treatment adherence. Yet, 25% (n=3) of TB 
experts revealed that the client’s belief system was not an impediment to treatment 
adherence. However, data from clients did not support an association between beliefs 






There was one open-ended question in which the TB experts were asked if there was 
anything they wanted to add on what had already stated. Fifty percent (50%, n=6) of the 
TB experts revealed that food was a barrier to TB treatment adherence among the TB 
clients, and 50% (n=6) revealed that there was nothing to add. This finding has an 
implication on policy on food distribution to TB clients who are receiving treatment. 
 
4.4.4.2 Associations between variables that are barriers to adherence 
 
The data revealed an association between side effects and steps taken (r = 0.777, p = 
0.003). This means that TB clients reported side effects were switched to another regimen 
by the health care provider. Switching the client to another regimen is a potential facilitator 
for adherence. 
 
The data showed an association between side effects and length of treatment (r = 0.761, 
p = 0.004). This means that TB clients who were on treatment for a longer time developed 
side effects. The experience of side effects could deter clients from adhering to treatment. 
 
4.4.4.3 Hypothesis testing: 
 
Null hypothesis: There is no association between determinants of adherence (patient-
related factors, facilitators and barriers) and TB clients’ adherence to treatment. 
 
4.4.4.3.1 Patient-related factors and adherence to TB treatment: 
  
The data did not support a relationship between patient-related factors and adherence 
to TB treatment (r=-0.319, p = 0.312). The null hypothesis is thus accepted.  
 
4.4.4.3.2 Facilitators and adherence to TB treatment: 
 
The data did not support a relationship between facilitators and adherence to TB 






4.4.4.3.3 Barriers and adherence to TB treatment: 
 
The data did not support a relationship between barriers and adherence to TB treatment 
(r=-0.062, p = 0.848). I therefore fail to reject the null hypothesis 
 
4.5 SUMMARY OF THE RESULTS IN PHASE 1 STEP 2: TB EXPERTS 
  
The findings suggested that a majority (41.7%, n=5) of respondents were ranging 
between 40-49 years old. About 66.7% (n=8) had indicated that the employment status 
they held was that of an adherence officer. All (91.7%, n=11) the respondents had 
indicated that TB drugs were always available in the health care facilities. Also, a majority 
(58.3%, n=7) indicated that they conducted more than one TB treatment adherence 
assessment to TB clients which included pill count, self-reporting, daily treatment record 




In this chapter, analysis, presentation and description of the research findings were 
presented. The study findings were presented and guided by the HBM conceptual 
framework. The chapter began with the presentation of research findings from TB clients 
and TB experts respectively. Data was analysed through SPSS for both TB clients and 
TB experts in the two government hospitals. Descriptive analysis was done for open 






















This chapter presents the strategies designed to enhance adherence of TB treatment 
among TB clients receiving treatment from two government hospitals in Eswatini. The 
strategies were designed based on the findings of the study.   
 
5.2 THE PURPOSE OF THE STRATEGIES 
 
The purpose of designing the strategies was to address some challenges that were 
highlighted by the participants in the study as determinants of adherence to TB treatment, 
as indicated in chapter 4. 
 
5.3 THEORETICAL FRAMEWORK 
 
In chapter 1 of the study, the Becker’s Health Belief Model (HBM) 1974 by Tarkang and 
Zotor (2015) was introduced with the aim of having a framework to guide the study. The 
significance of this theory in designing of the strategies was acknowledged in this section. 
 
Change of behaviour was the main focus of the theory. The theory described that change 
of behaviour was important in health studies to guide health promotion. This theory is 
used to explain behaviours that individuals use as disease prevention measures. This 
therefore, had assisted the study to effectively describe the determinants of adherence to 
TB treatment among TB clients. TB is a transmittable disease and is curable. Individuals 
need to adhere to its treatment to reduce its transmission and also to be cured. Therefore, 
the HBM theory was relevant for this study. 
 
 Based on the purpose of the study, and the need to develop strategies, the HBM theory 
was also used to assist the study in explaining why some TB clients took action to adhere 






The appropriateness of the theory for this study was founded on the premise that 
individuals’ motivation to act depends on the perceived threat to their health and also to 
their belief that action will mitigate the threat. The theory further alludes that individuals 
have a course of action to avoid a condition. The idea of the theory was used to reduce 
disease condition to predict behaviours. The theory explains three broad propositions that 
are used to change behaviour, namely; modifying factors, benefits of taking preventive 
measures and individual perception.  
 
Tarkang and Zotor (2015:3) explain that modifying factors are those factors that alter 
behaviour such as demographic, socio-psychological and structural variables, as 
illustrated in chapters 1, 2 and 4 of the study. The identification of barriers for taking the 
preventive measures was one of the strengths of this theory. The theory explains that 
individuals take action to protect their health only if they believe that they are susceptible 
to an ill health condition.  
 
Adherence to treatment is one of the main elements of the theory. In order for individuals 
to adhere, the theory proposes six key concepts, namely; perceived susceptibility, 
severity, benefits, barriers, cue for action, and self-efficacy. These concepts provided the 
basis for designing strategies to enhance adherence to TB treatment among TB clients. 
 
According to Joseph (2018:2) to reduce developing a health condition, an individual need 
to perceive the risk of developing a condition and engage in positive health behaviours. 
Contrary, individuals with low perceived risk may deny that they are at risk of contracting 
a particular disease (Onoruoiza et al 2015:14). By understanding the risk of the disease, 
the theory explains that individuals would adhere to their treatment. Tuberculosis is a life-
threatening disease, and individuals suffering from it need to be enlightened about 
importance of changing behaviour. The theory further explains that individuals need to 
understand the seriousness of the disease before adhering to the treatment. This may 







The theory identifies obstacles to behaviour change. Tarkang and Zotor (2015:5) concur 
with the assertion of the theory by identifying cost, frequency and side effects as burdens 
to adherence to treatment. The suggestion of the burdens set the stage for contemplating 
about strategies for enhancing motivation to avert the threat. The theory assisted in 
clarifying certain actions that reduced barriers to TB treatment. When individuals realize 
that they have the capacity to deal with barriers, they take necessary action. 
 
The theory identifies factors that act as enhancers to treatment adherence. These include 
remembering to take pills, incentives, having a treatment supporter, counselling and 
health education. Jones et al (2015:3) also concurs that remembering to take pills every 
day motivates individuals to complete the behaviour of interest despite considered 
barriers. The theory postulates that in order for the individual to adhere to treatment, 
motivation is a good factor in engaging in positive health activities. 
  
5.4 METHODOLOGY FOR DESIGNING OF STRATEGIES 
 
Strategies to enhance adherence were formulated in relation to the findings from the 
interviews as evidence from Chapter 4 Phase I. Findings were supported with literature 
and the results from TB experts. Clients revealed the following challenges of adherence 
to TB treatment that need to be enhanced: 
 
5.4.1 Experiencing side effects while on TB treatment 
 
Clients experienced side effects (80.5%, n=99) from the TB treatment. This can impede 
adherence. This finding is consistent with findings from TB experts (75.0%, n=9) that 
clients experienced side effects while taking treatment. Similar sentiment by Schnippel et 
al (2016:593) that clients on longer period of treatment are more likely to experience 
severe side effects such as nausea, vomiting and body itching which are challenges 
leading to non-adherence to treatment. The experience of side effects could result to 
clients defaulting treatment which is a deterrent to adherence. The interruption of 






indicates that TB clients are more likely to develop drug resistance if side effects are not 
treated. Clients may not be educated about side effects; hence they may not report the 
side effects. This finding is consistent with Niilonga and Nghitanwa (2017:33) that clients 
who are not well informed about side effects of a treatment find it harder to tolerate side 
effects which leads to non-adherence. Health care providers to consider asking clients 
for the presence of side effects during each client’s follow- up visit and not wait until the 
client reports. 
 
Strategy 1: Education of clients on effects and side effects of each TB drug  
Rationale: TB experts will educate clients on effects and side effects of each drug during 
treatment refill visits. Empowering clients with knowledge will promote adherence to TB 
treatment. When clients are educated about side effects, drug resistant will be minimised.  
Strategy 2: Assessment of clients for side-effects during follow-up visits 
Rationale: TB experts will assess clients for side effects and treat them during clients 
follow up visits. When side effects are treated, clients will adhere to TB treatment. TB 
experts will be sensitive to client’s complaints which will enable the clients to trust the 




A considerable proportion of TB clients were unemployed (43.1%, n=53). According to 
NTPM (2012:11) Eswatini has about 66% of the population living below poverty line. The 
increase demand brought by unemployment causes clients to spend a day without food. 
This has a negative impact in adherence to TB treatment. This finding is consistent with 
Niilonga and Nghitanwa (2017:33) that unemployment could result to treatment default.  
 
 On the other hand, clients could not afford the cost of travelling to the health care facility 
for refill of treatment as they did not have money. Data from all TB experts (100%, n=12) 






TB client’s adherence. However, clients were not assessed on cost implication. 
Furthermore, while the clients were unemployed, they also lacked food. This finding is 
supporting the study by Gabremariam et al (2010:4) that lack of food was a factor 
adversely affecting treatment adherence in patients with insufficient income. Conversely, 
data from TB experts did not support that having sufficient money for food can enhance 
adherence to treatment (r=-0.115, p=0.323). Issues on food policy and unemployment 
among TB clients to be strengthened to promote adherence to treatment. 
 
Strategy 3: Review food policy and establishment of home backyard gardens for 
TB clients  
 
Rationale: Government will review criterion for receiving food rations among clients with 
TB. This will assist clients who are unemployed and who do not get food parcels as 
incentives to put something on the table. Establishment of home backyard gardens will 
help TB clients to plough vegetables which they will eat to boost the immune system. The 
vegetables will also be sold in exchange for money and thus client will have sufficient 
income. 
 
5.4.3 Lack of illness grants for clients on TB treatment 
 
Clients lacked incentives (76.4%, n=94) while on TB treatment. A study by Zhou et al 
2012:1) revealed that unavailability of incentives for treatment adherence are contributing 
factors for treatment default. When clients are no longer motivated to take treatment, they 
are more likely to default treatment. The criteria for receiving incentives in these TB clinics 
are clients with ordinary TB but malnourished, and those with MDR or XDR condition. 
Either monetary vouchers or food rations are used as incentives. Not getting incentives 
results to treatment default as there was no food. As clients are lacking food in their 
households, taking treatments on an empty stomach can result to intolerance of the 
treatments. Evidence from TB experts (100%, n=12) also supports that the unavailability 
of food in clients on TB treatment hindered adherence to treatment. Clients fear taking 






taking treatment without food. Moreover, treatments have to be taken with or immediately 
after foods. This has an implication on incentive policy.  
 
Strategy 4: Strengthening of incentive policy for TB clients  
 Rationale: All TB clients will be entitled to incentives irrespective of body weight and 
other conditions. Issues of poverty and inconsistencies in the distribution of incentives 
received by TB clients will be addressed. Money as incentive will reimburse the expense 
of attending the treatment centre. It will also improve the attractiveness of visiting the 
health facility for check-ups. Availability of incentives to all clients on TB treatment will not 
only improve the client’s health but will also enhance adherence to the treatment. Food 
rations or vouchers will act as a motivation to take treatment in order to adhere to the 
treatment regime as most pills are taken with or after meals.  
 
5.4.4 Living with comorbidities besides TB 
 
Clients had other ailments besides TB (83.7%, n=103). Being treated for comorbidities 
could increase pill burden. Clients can have difficulty in taking treatment as prescribed if 
the number of pills is many, thus may lead to poor adherence to treatment. According to 
ANTCP (2015:14) Eswatini has about 72% of TB patients who are co-infected with 
HIV/AIDS. TB patients not only suffer from TB clinical manifestation, but also the 
HIV/AIDS societal prejudice and embarrassing situations. Therefore, TB clients can be 
stigmatised by the co-infection which could affect the emotional aspect and thus fail to 
adhere to treatment. Suffering from comorbidities can also result to drug-drug interaction, 
which can make clients to be persistently sick. Health care workers need to attend to the 










Strategy 5: A one stop centre for all TB clients who are treated for other illnesses 
to increase adherence to treatment. 
 
 Rationale: A one stop centre will assist in treating TB clients using a holistically approach 
(including HIV/AIDS and counselling) in one place and by the same health care providers. 
This will reduce the time spent by clients seeking health care. 
 
5.4.5 Lack of health education about the TB disease and its transmission 
 
Clients had inadequate information regarding TB disease and its transmission (55.3%, 
n=68) which risk adherence to TB treatment. This is consistent with findings from the TB 
experts (75.0%, n=9) that knowledge deficit on TB disease was a barrier to the client’s 
treatment adherence. According to Tola et al (2016:3) clients require to have some 
minimal level of disease knowledge to influence adherence. Continuous health education 
promotes adherence to treatment. Study findings also revealed an association between 
knowledge and adherence (r = 0.650, p = 0.001) signifying that clients with knowledge 
about the TB are more likely to adhere to the treatment. Strengthening education among 
males residing in rural settings (53.7%, n=66) as revealed in chapter 4 table 4.2 need to 
be done. Evidence supports that the 77% of the populace in Eswatini reside in rural areas 
(WHO Country Cooperation Strategy Swaziland 2015:3). 
 
 On the other hand, findings from TB experts (50%, n=6) revealed that gender was a 
barrier to treatment adherence among TB clients. Although this finding was not specific 
to the type of gender referred to. In the study the mean age of clients was 37.2 years and 
majority (53.7%, n=66) were males. This finding is consistent with a study by Niilonga and 
Nghitanwa (2017:33) that non-adherence to treatment was higher among male patients 
ages 25-34 years. TB experts need to enhance health promotion to places frequently 









Strategy 6: On-going in-service training on adherence for TB experts  
 
Rationale: On-going in-service training on adherence will capacitate TB experts with 
knowledge about the causes, modes and transmission of TB disease. New TB experts 
will undergo in-service training regularly until they master.    
 
Strategy 7: Enhance health promotion through on-going health education 
 
Rationale: Clients will be targeted on places which are frequently visited to impart 
knowledge about TB and its transmission. This will help clients to adhere to TB treatment. 
Provision of information about tuberculosis will change the clients’ behaviour thus adhere 
to the treatment. Health education delivered in different settings will enable clients and 
the community to understand the disease and support those infected. The main focus of 
the education will be males from the rural settings as the data revealed that the majority 
of males in rural setting had tuberculosis.  
 
5.4.6 Mixing western and traditional medicine to cure ailments 
Clients mixed western and traditional medicines when treating ailments (31.7%, n=39). 
This is in consistent with TB experts’ (75%, n=9) findings that clients’ beliefs about the 
condition and its treatment were potential barriers to adherence to TB treatment which 
could result to clients using any modality to treat the condition. According to (Sibandze 
2009:1) Eswatini had more than 85% of the population using both western and traditional 
medicine in curing ailments before and after visiting health care facilities. This could affect 
the understanding of TB disease and result to non-adherence to treatment. When clients 
do not get well soon, they change the western treatment modality to traditional or spiritual. 
This could result to drug overdose, toxicity and drug-to-drug interaction which could be 








Strategy 8: Collaboration of traditional healers and spiritualists in the treatment of 
TB disease 
Rationale: Involvement of traditional healers and spiritualists in treating TB will assist in 
the reduction of drug to drug interaction in clients on TB treatment. This will also help in 
empowering traditional healers and spiritualists with knowledge about TB and its 
treatment. Working in collaboration with traditional healers will call for a scientific research 
on the herbs that traditional healers use to treat tuberculosis.  
5.4.7 Clients length of time on TB treatment 
 
Clients were on treatment for a longer period with a mean of 2.4 months which could be 
a barrier to treatment adherence. This finding was consistent with that from TB experts 
(83.3%, n=10) that client’s length of time on TB treatment was a hindrance to adherence. 
TB is a chronic disease that takes a longer period to be treated. As a result, clients stop 
taking their treatment along the course of treatment resulting to drug resistance. Most 
clients are no longer isolated in the health care facilities. Only those who are considered 
high risks are isolated such as critically ill, or those with a drug resistant condition. 
 
Strategy 9: Isolation of all TB clients during the course of treatment  
 
Rationale: Isolating all TB clients will help TB experts to closely monitor clients on TB 
treatment by strengthening the existing DOT strategy to enhance adherence to TB 
treatment.  
 
5.4.8 Clients taking more tablets per day 
 
Clients took more than 3 tablets per day (96.7, n=119) as treatment for TB and other 
ailments. This result to pill burden which could be a deterrent to adherence to treatment. 
According to NTCP (2012:49) a TB client is initiated to 1 tablet per day which is a standard 
treatment initial drug combination comprising of four drugs. However, TB clients are also 






taken. This could cause risk for decrease adherence and pill burden. Gabremariam et al 
(210:651) revealed that there is an association between poor adherence and pill burden 
due to the extent of the treatment regimen and treatment of comorbidities. 
 
Strategy 10: Reduce pill burden 
 
Rationale: Clients will be initiated with lower a dosage of treatment to prevent pill burden 
and thus enhance adherence to TB treatment. The reduction of tablets taken per day will 





The chapter described the main purpose of designing strategies to enhance adherence 
to TB treatment amongst TB clients. The significance of the HBM theory in designing the 
strategies was acknowledged. Strategies were formulated in relation to findings from TB 
clients and supported by the literature and the results from TB experts. Challenges of 
adherence identified by TB clients include emerging of side effects, unemployment, lack 
of incentives, living with comorbidities, lack of health education about the disease and its 
transmission. In addition, mixing western and traditional medicine to cure ailments, length 
of time on treatment and taking more tablets per day were also reported as challenges.  
 
Strategies were then designed based on the identified problems. These include education 
of clients on effects and side effects of drugs, assessment of clients for side effects, 
establishment of home backyard gardens, strengthening of food policy for TB clients, a 
mandatory one stop centres for TB clients, on-going in-service training on adherence for 
TB experts, and enhancement of health promotion. Collaboration of traditional healers 
and spiritualists in the treatment of TB, a mandatory isolation of all TB clients, and the 
reduction of pill burden were also strategies designed in this chapter.  












The purpose of this chapter was to present the conclusions, recommendations and 
limitations for the future. 
 
6.2 THE PURPOSE OF THE STUDY 
 
The purpose of the study was to investigate the determinants of adherence to TB 
treatment in order to design strategies to enhance adherence to TB treatment among TB 
clients in Eswatini.  
 
6.3 RESEARCH DESIGN AND METHODS 
 
The researcher used a quantitative, exploratory and descriptive non-experimental design 
to investigate determinants to TB treatment. The study utilised this approach as the 
researcher viewed a TB client as integrated with the environment, which shaped the 
behaviour. This approach generated an account of the client’s reality in adherence to the 
TB treatment and descriptive determinants of adherence were measured. The Health 
Belief Model (HBM) assisted in guiding the study research questions and explaining and 
supporting the findings of the study. 
The exploratory design was used to investigate the full nature of the phenomenon. The 
descriptive design was used in identifying variables within the phenomenon and to 
develop operational and conceptual variables. Ethical considerations were met through 
seeking permission from UNISA, National Health Research & Ethics Council of Eswatini 
and Managers of the two government hospitals as well as from TB clients and experts 
who participated in the study. 
 
The study was conducted in Mbabane and Hlatikulu Government Hospitals, following a 
pre-testing in one of the government hospitals which was not part of the main study. A 






twenty-three clients participated in the study. Data was also collected from the 12 TB 
experts using purposive sampling for recruitment. Data from the TB experts helped in 
supporting the findings from the TB clients. Data were analysed using SPSS version 20.0. 
Data revealed the determinants to adherence to TB treatment among TB clients.  
 
6.4 CONCLUSIONS FROM THE STUDY 
 
This section gives the conclusion drawn from the 2 phases of the study; phase 1 and 
phase 2. Phase 1 of the study involved step 1 and step 2. Step 1 was the procedure for 
collecting data from 123 TB clients and step 2 involved data collection from 12 TB experts. 
Phase 2 of the study involved the design of the strategies to enhance adherence to TB 
treatment.  
 
6.4.1 Conclusions phase 1 step 1 
 
Conclusions were drawn from the findings of the interview conducted with TB clients who 
were attending TB services in the two government hospitals at the time of conducting the 
study. Step 1 of the study revealed the following determinants: 
 
Modifying factors such as age, gender, residential area and unemployment negatively 
influenced adherence to TB treatment. This suggests that the middle age group of male 
TB clients who were unemployed and residing in rural areas were unlikely to adhere to 
TB treatment. However, there was an association between educational level and 
adherence (r=0.184, p=0.042) indicating that with the increased educational level, there 
was an increased in adherence to TB treatment.   
 
Structural factors such as length of time on treatment influenced TB client’s decisions on 
adherence to TB treatment. TB client had been on treatment for a mean period of 2.4 
months with a standard deviation of 1.5 months. This means that the longer the clients 
were on treatment, the increased rate of not adhering to treatment. Conversely, in the 






to TB treatment (F=.649, p=0.201), reflecting that HIV status was not a predictor of 
adherence to TB treatment. 
 
Data revealed an association between TB clients’ psychological variables and adherence 
(r=1.00, p=0.01). However, psychological factors such as treatment modalities, lack of 
knowledge about TB disease, causes and transmission were deterrent to adherence to 
TB treatment. This revealed that clients still had misconceptions about TB disease and 
its treatment. Lack of information about the TB and its treatment could be a barrier to 
adherence to TB treatment.   
 
Perceived benefits such as client’s support from family members, motivation to take 
treatment and counselling were facilitators to adherence to TB treatment. However, lack 
of incentives and health education both enhanced the client’s decision to not adhere to 
TB treatment.  
 
Data revealed an association between perceived barriers and adherence to TB treatment 
(r = -0.416, p= 0.001). This reflects that clients who encountered side effects from the TB 
treatment, having comorbidities besides TB, lack of food, and pill burden did not to adhere 
to TB treatment. However, honouring refill appointment dates, presence of reminders, 
availability of treatment in health facilities, taking pills as prescribed, and good relationship 
with health care providers were revealed as strong enhancers to adherence to TB 
treatment.  
 
The study, concludes that those factors can be deterrent of adherence to TB treatment 
call for policy makers and program implementers to design new strategies and/or 











6.4.2 Conclusions phase 1 Step 2 
 
Conclusions in step 2 of the study were drawn from responses of TB experts who were 
working in the two government hospitals TB centres at the time of the data collection. 
Data revealed that TB experts supported the findings in step 1. The findings showed that 
lack of incentives, costs, travelling distance to the health care facility, side effects, lack of 
knowledge about the disease, beliefs, and length of treatment influenced TB client’s 
decision not adhere to TB treatment. However, TB experts revealed that a combination 
of adherence assessment tools, and variety methods of reminders promoted adherence 
to treatment amongst clients.  
 
 6.4.3 Conclusions Phase 2 
  
Phase 2 of the study involved the design of strategies to enhance adherence to TB. 
Conclusions in this phase were drawn based on the strategies that were designed in this 
study. These strategies included an on-going education of clients on TB disease, 
assessment of clients on side effects, review of food policy and strengthening incentive 
policy. A one stop centres for TB clients, on-going in-service for TB experts, collaboration 
of traditional healers and spiritualists in TB treatment, isolation of TB clients and reduction 




The study findings unveiled a number of gaps in the adherence to TB treatment amongst 
TB clients. Recommendations of this study would assist in improving TB control in 
Eswatini. The following recommendations were drawn from the findings in phase 1 step I 
of the study: 
 To enhance outreach programs to reach those TB clients living in the rural settings. 
Data revealed that male clients living in rural areas were poorly performing in terms of 






 To reinforce holistic health assessment programs of TB clients including a one stop 
centres in all TB centres. Data revealed that TB clients were also co-infected with HIV 
and other diseases. 
 
 To strengthen issues of food policy for TB clients such as even distribution of food to 
impoverished families or mandatory incentives to all clients on TB treatment. Data had 
revealed that most clients did not receive incentives as a motivation to adhere to 
treatment. 
 
 To strengthen the health promotion programs in rural areas to increase awareness 
about TB treatment and problems of non-adherence. Data revealed that client’s 
education about the TB disease was insufficient and thus risking adherence to 
treatment. 
 
 To strengthen continuing in-service education programs for TB experts to ensure 
placement of appropriately trained TB experts in the TB centres. 
 
 To collaborate traditional healers and spiritualists in the treatment of TB. Data has 
revealed that clients mix both western and traditional medicine to cure ailments. 
 
6.6 CONTRIBUTIONS OF THE STUDY 
 
The study generated knowledge regarding determinants of adherence to TB treatment. 
The study therefore, has drawn focus towards the need to improve adherence to TB 
treatment. 
 
The study findings will act as a point of reference for researchers who wish to conduct 








The investigations of determinants have resulted in the design of strategies to enhance 
adherence to TB treatment. This will remain a permanent record of reference should there 




The study applied one theoretical framework (HBM) which accommodated the important 
variables likely to influence adherence to TB treatment among TB clients. The use of a 
multi-theory approach might had added richness to the study findings. 
 
The probability method that was used did not afford the study participants opportunities 
to be selected into the sample, meaning that the sample was not representative of the 
study population.  
 
The generalization of the findings was limited as the high proportion of extra pulmonary 
TB were not included. This suggested that the study population might not be the 
representative of the general TB in the two hospitals. 
 
The sample size of this study was relatively small for the two hospitals with a high burden 
of TB as TB services were decentralized to all the peripheral clinics and other non-
governmental organizations. 
 
Considering that the data was captured in the hospital settings where only those clients 
who resided nearer to the hospitals or were referrals came for the check-ups. This 
selection was bias as most clients were ambulatory and potentially more adherent 
compared to those who were admitted at the hospital wards. Therefore, inclusion criteria 








The study targeted only two regional hospitals in Eswatini because of their accessibility 
to the researcher. The other regional hospitals fell off the target because they were non-




The chapter summarizes the design and methods used in the study. The Health Belief 
Model was acknowledged as the theoretical framework guiding the research questions 
and supporting the findings of the study. Conclusion of the study in two phases was done. 
The study has unveiled a number of gaps in terms of adherence to TB treatment hence, 
recommendations were made. The study identified a number of limitations that were 
encountered in the study for current and future use.  
 
6.9 CONCLUSION REMARKS 
 
Behavioural change is a foundation to TB treatment adherence. Adherence could be 
enhanced if effective education on change of behaviour could be emphasized when the 
client is initiated to TB treatment. This requires TB experts to obtain in-depth knowledge 
about TB disease and appropriate actions taken if side effects are reported. It also 
requires that TB clients should know about advantages of adhering to TB treatment. 
Further, it requires that clients should receive motivation such as incentives to adhere to 
treatment. These ideas will become achievable in Eswatini if adherence to TB treatment 
would be a major focus in all health care facilities as most clients have other comorbidities 
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LETTER FOR SEEKING PERMISSION TO CONDUCT THE STUDY IN THE TWO HOSPITALS 
University of South Africa 
P. O. Box 392 
UNISA  
 
National Research and Ethics Council  
Swaziland Ministry of Health 




REQUEST FOR PERMISSION TO CONDUCT A RESEARCH STUDY 
I am a registered student currently pursuing a doctorate programme at the University of South 
Africa. My research is entitled “Determinants of adherence to tuberculosis treatment among 
clients with tuberculosis in Swaziland”, under the supervision of Professor MC Matlakala of 
the Department of Health Studies, UNISA. 
The main purpose of this study is to investigate the determinants of adherence to TB treatment 
among TB clients in Swaziland. The study will lead to the development of TB adherence 
strategies. To complete this study, I need to conduct interviews with respondents. The study 
settings will be the Mbabane Government Hospital and Hlatikulu Government Hospital. The 
duration of the study data collection will be approximately 3-6 months and the time for each 
session will be 30-40 minutes per respondent. Ethical considerations will be ensured in all the 
procedures and with the respondents. Direct benefit of this study to hospital TB centres is that the 
research findings will be made available to these centres. Long term benefit of the study is that 
the research findings will be used to develop strategies to enhance adherence to TB treatment.  
I hope this request will receive your favourable consideration. 
Yours sincerely 
 


















































Researcher: Ms Percis P. Khumalo 
REQUEST FOR CONSENT TO PARTICIPATE IN THE STUDY 
I am a student at the University of South Africa, conducting a study on, “Determinants of 
adherence to tuberculosis treatment among patients with tuberculosis in Swaziland” under 
the supervision of Professor MC Matlakala who is a Lecturer in the Department of Health Sciences 
at UNISA. 
The purpose of the study is to identify and describe factors that may enhance adherence to your 
TB treatment, factors that may hinder your adherence to your therapy, as well as the relationship 
between factors that enhance and those that hinder your adherence to the TB treatment. 
The study and all procedures related to the study have been reviewed and approved by the Research 
& Ethics Committee of the University of South Africa as well as the Research & Ethics Committee 
of the Ministry of Health in Swaziland. You are therefore, kindly requested to participate in the 
study. The study will require you to answer questions about yourself as well as the factors that 
influence your adherence to TB treatment. Participating in the study will take you less than an 
hour. 
Participating in the study is voluntary. You are not coerced into participation in the study. You 
have a right to withdraw at any time, and your relationship with health care workers will not be 
compromised in any way. 
A number will be given to you to use as a participation code, as opposed to your name. Your 
personal information will not be revealed at any point during the course of the study, even when 
the study has been concluded. All information pertaining to the study will be kept in a safe place 
known by only the researcher and her supervisor, who will have access to the information. 
The direct benefit of participating in the study is the satisfaction you will get from providing 
responses that may be of assistance to others in future. Another benefit is that your opinions will 
be used to design strategies to improve adherence to TB treatment. 
You are free to ask any questions pertaining to the study and participation. You can contact the 
researcher at this number, 76758841. 
Declaration by Participant 
I have read and understood the consent form, and I hereby grant my consent to participate in the 
study 
 Signature of Participant: _______________________________ Date: _________________ 
Declaration by Researcher: The participant has been given all the required information 
pertaining to the study and has understood the purpose of the study. 






ANNEXURE F SISWATI VERSION 
LIFOMU LWEMVUMO  
Umcwaningi: Ms Percis P. Khumalo 
SICELO SEMVUMO YEKUNGENELA LUCWANINGO 
Mine ngingumfundzi enyuvesi yaseSikhwahlande, ngenta lucwaningo “ngetinkhomba tekunatsa 
imitsi yesifuba sengati ngekwetsembeka kubantfu labanesifo sesifuba sengati eSwatini” 
ngaphansi kweliso la Professor MC Matlakala lofundzisa etikweni letemphilo enyuvesi 
eSikhwahlande. 
Umgomo walolucwaningo kukhomba nekuchaza tintfo letingagcugcutela kunatsa kahle emaphilisi 
akho esifuba sengati, futsi sicwaninge tivimbeko ekunatseni imitsi yesifuba sengati, nekubuka 
budlelwano emkhatsini wetintfo letikhutsatako naletisivimbeko ekunatseni imitsi yesifuba sengati 
ngendlela. 
Lolucwaningo netinchubo lwato luvunyiwe bantfu labafanele nelibandla lelicwaningako enyuvesi 
yaseSikhwahlande kanye nelibandla lakaNgwane lwelucwaningo etikweni Letemphilo. Ngaloko, 
uyacelwa kutsi ungenele lolucwaningo. Inchubo yalolucwaningo lutawufaka kutsi uphendvule 
imibuto lekuloluhla ngebungawe bakho kanye ngetimbangela tekunatsa imitsi yesifuba sengati 
ngendlela. Kungenela lolucwaningo kutawutsatsa sikhatsi lesingaba ngephansi weli awa. 
Kungenela lolucwaningo kungekutinikela. Awukaphocelelwa kutsi ungenele lolucwaningo. Unalo 
lilungelo lekuhocisa noma kunini futsi budlelwano bakho netisebenti tetemphilo angeke 
kukhinyabeteke. 
Lolucwaningo lutawuniketwa inombolo hhayi libito lakho. Bunguwe bakho angeke buvetwe 
lucwaningo lusachubeka noma seluvetwa ngaphandle. Lonkhe lwati lutawugcogcwa 
ngumcwaningi, lugcinwe endzaweni lephephile futsi kute umuntfu luvumelekile kwati ngaphandle 
kwemcwaningi nemphatsi wakhe kulolucwaningo. 
Inzuzo lecondzile yekungenela lolucwaningo kutsi unetiseke ngetimphenvulo letingaba lusito 
ngemhlomunye kulabanye. Lenye inzuzo kutsi umbono wakho utawusebentiswa ekwakheni 
tindlela letincono kute kutfutfukiswe kunatsa kahle imitsi yesifuba sengati. 
Ukhululekile kubuta noma ngiyiphi imibuto ngalolucwaningo noma ngalokungenela futsi 
ungatsintsa umcwaningi kunansi inombolo yelucingo 76758841 uma unemibuto. 
Kufunga kwalongenele: Ngifundzile ngalemvumo futsi ngiyatinikela kungenela kulolucwaningo 
Sishicilelo Salongenele: ----------------------------------------Lusuku: ------------------------------ 
 







CONFIDENTIALITY BINDING FORM 
 The purpose of this agreement is to help you understand your duty regarding the access, use, 
disclosure, storage and disposal of confidential information. 
Confidentiality Agreement:  
As a participant of this study, I (Name) -----------------------------------------------------------------
understand and agree that I may have the opportunity to participate in this study of determinants 
of adherence to TB treatment. In consideration of being selected to participate in this study, I 
understand and agree as follows: 
1. That the purpose of this study was clearly explained to me “to investigate determinants of 
adherence to TB treatment in order to design strategies for adherence”  
2. That my participation in this study is entirely voluntary and I am free to withdraw from the study 
anytime I wish. My discontinuation in this study will not jeopardize my health care in this facility. 
3. That my right to use confidential information is allowed and the researcher will assure me that 
all information elicited from my participation will remain confidential. Information will not be made 
available to any other person outside the scope of the study. The researcher will assure me that 
she will be the only one collecting data and collected data will be put in a secured place. 
4. That the study is non-experimental and there are no immediate benefits of taking part in this 
study. Potential benefits of participating in this study will be the satisfaction that the information 
given will help others with similar condition. Minimal risk such as fatigue from answering questions 
may be anticipated in my participation in this study. The whole interview process will be explained 
before signing a consent form. 
 5. That there will be no payment or incentives for my participation in this study. 
6. That the researcher will show me letters of permission from UNISA and Swaziland Ministry of 
Health National Research and Ethics Council to conduct the study. 
7. That the researcher will assure me that findings of the study may be used in nursing 
publications or presentation and confidentiality will still be maintained. My name will not appear in 
all the publications of this study.  
I agree to be bound by this confidentiality agreement as a condition of participation in this 
research. I have read this Confidentiality Binding and agree to its terms. 
---------------------------------------------------------------------------------------------------------------------Name 
of Participant  
---------------------------------------------------------------------------------------------------------------------







ANNEXURE G: SISWATI VERSION 
LIFOMU SESIVUMELWANO SEMFIHLO 
Inhloso yalesivumelwano kusita kutsi ucondze tintfo lekufanele utente letihambisana 
nekufinyelela, kusebentisa, kuveta imfihlo, nekugcinwa kwemfihlo yalolucwaningo. 
Njengalomunye loyincenye yelucwaningo, mine (libito) -------------------------------------------------------
------------------------------------ ngiyacondza futsi ngiyavuma kutsi ngingaba nenhlanhla yekungenela 
lolucwaningo lolumayelana netinkhomba tekunatsa ngendlela imitsi yesifo sesifuba sengati, 
ngendlela lengifundziswe ngayo emtfolampilo, ngiyacondza futsi ngiyavuma ngalokulandzelako: 
1. Kutsi inhloso yalolucwaningo ngachazeleka kahle kutsi kucubungula tinkhomba 
letihambelana nekunatsa ngendlela imitsi yesifo sesifuba sengati kute kwakheke indlela 
lencono yekutfutfukiswa kunatfwa kwemaphilisi esifo sesifuba sengati. 
2. Kutsi kubayincenye yalolucwaningo kube ngekutinikela, futsi nginelilungelo lekuyekela 
kuchubeka nalolucwaningo uma ngifuna. Kuyekela kwami angeke kubeke engcopheni 
kwelashwa kwami kulomtfolampilo. 
3. Kutsi lilungelo lami lekusebentisa timfihlo kulolucwaningo luvumelekile futsi nemcwaningi 
ungitsembisile kutsi konkhe kutoba yimfihlo. Lwati ngalolucwaningo angeke luniketwe 
lomunye umuntfu longekho kulolucwaningo.Umcwaningi utangitsembisa kutsi kutobe 
kunguye kuphela lotawugcogca lwati bese uyalugcina endzaweni lephephile. 
4. Kutsi lolucwaningo lulingiselwe, futsi kute inzuzo lemasinyane ngekungenela lona. 
Lokungaba yinzuzo yekubandzanyeka kulolucwaningo kungaba kunetiseka kutsi lolwati 
lengitolunika litosita labanye labanesifuba sengati ngomhlomunye. Ingoti lencane 
njengekudzinwa ekuphendvuleni imibuto ingaba khona. Konkhe lokutawubutwa 
kutochazwa ngaphambi kwekushicilela sivumelwano. 
5. Kutsi kute inzuzo noma imbadalo yekungenela kulolucwaningo.Kutsi umcwaningi 
utongikhombisa tincwadzi temvume yekwenta lolucwaningo letibuya esikolweni sakhe 
(UNISA) nakaHulumende weSwatini etiko Letemphilo. 
6. Kutsi umcwaningi utangetsembisa kutsi lakutfolile kulolucwaningi kungasebentiswa 
ekukhipheni lwati kuletinye tingoni tetemphilo futsi nemfihlo itochubeka igcinwe. Libito lami 
angeke luvetwe kulolucwaningo. 
Ngiyavuma kutibophelela kulesivumelwano semfihlo sekubayincenye yalolucwaningo 
Ngifundzile ngekutibophelela kulemfihlo futsi ngiyavuma kulemicabo yayo. 
 
Libito Lalongenele: ------------------------------------------------------------------------------------------------ 








QUESTIONNAIRE FOR TB CLIENTS 
Questions in this questionnaire have been structured according to the purpose, objectives as well 
as predetermined responses (hypothesis). The researcher will tick the answers in the relevant 
boxes. 
Participant’s code number: _______________ 
1.0 DEMOGRAPHIC DETAILS 
1.1 Age: -------------------------years 
1.2 Gender: 
1. Male (  ) 
2. Female  (  ) 
 
1.3 Marital Status: 
1. Single   (  ) 
2. Married   (  ) 
3. Divorced   (  ) 
4. Separated  (  ) 
5. Widowed    (  ) 
6. Cohabiting (  ) 
 
1.4 Residential place: 
1. Rural  (  ) 
2. Urban  (  ) 
3. Peri-urban (  ) 
 
1.5 Educational Level: 
1. Never attended school (  ) 
2. Primary level  (  ) 
3. Secondary level  (  ) 
4. High school level  (  ) 
5. Tertiary level (  ) 
 
1.6 Employment status: 
1. Unemployed  (  ) 
2. Employed   (  ) 
3. Self-employed  (  ) 
 
1.7 Religion: 
1. None   (  ) 
2. Ancestral   (  ) 
3. Satanism    (  ) 






5. Islam    (  ) 
6. Judaism    (  ) 
 
2.0 STRUCTURAL FACTORS TO ADHERENCE  
 
2.1 How long have you been receiving TB treatment? 
1. 3 - 4 months     (  ) 
2. 5 - 6 months     (  ) 
3. 7 - 8 months      (  ) 
4. Above 9 months but on treatment course (  ) 
5. Finished treatment, but re-initiated           (  ) 
6. Defaulted treatment, and re-initiated  (  ) 
 
2.2 What is your current HIV status? If negative, skip to question 2.4 
1. Unknown  (  ) 
2. Negative  (  ) 
3. Positive (  ) 
 
2.3 If positive, are you on ART? 
1. No  (  ) 
2. Yes  (  ) 
 
2.4 Are you smoking? 
1. No  (  ) 
2. Yes  (  ) 
 
2.5 Are you drinking alcohol? 
1. No  (  ) 
2. Yes  (  ) 
 
2.6 Do you have a family member with TB? If no, skip to question 3.1 
1. No  (  ) 
2. Yes  (  ) 
 
2.7 If yes, how are you related to that family member?  
1. Parent    (  ) 
2. Sibling    (  ) 
3. Aunt/uncle   (  ) 
4. Spouse    (  ) 
5. Friend    (  ) 
6. Grandparent   (  ) 
7. Adopted family member (  ) 








3.0 PSYCHOLOGICAL FACTORS 
3.1 Which treatment modality do you use in the treatment of any disease(s)? 
1. Spiritual     (  ) 
2. Traditional     (  )   
3. Western      (  ) 
4. Mixing both traditional and western  (  ) 
5. More than one response   (  ) 
 
3.2 What do you think adherence to treatment mean to you? 
1. Taking the tablets every day   (  ) 
2. Taking the tablets until death   (  ) 
3. Taking the tablets as instructed   (  ) 
4. Taking the tablets until you recover  (  ) 
5. More than one response   (  ) 
 
3.3 According to you, what causes TB? 
1. Curse    (  )  
2. Bewitchment   (  ) 
3. Just occurs naturally  (  ) 
4. Microorganism             (  ) 
5. More than one response  (  ) 
6. Don’t know   (  ) 
7. Low immunity   (  ) 
8. Related to HIV  (  ) 
9. Smoking    (  ) 
 
3.4 According to you, how is TB transmitted from one person to another? 
1. Sharing utensils     (  ) 
2. Sharing linen     (  ) 
3. Exposure to tobacco smoke  (  ) 
4. Coughing     (  ) 
5. More than one response   (  ) 
6. Don’t know      (  ) 
 
4.0 FACILITATORS OF ADHERENCE TO TB TREATMENT 
4.1 Do you receive any incentive for taking TB treatment? 
1. No  (  ) 
2. Yes  (  ) 
 
4.2 If yes, what kind of incentive do you receive? If no, skip to question 4.3 
1. Cell phone                            (  ) 
2. Food rations/food vouchers (  ) 
3. Money                 (  ) 








4.3 Do you get any form of support from your community as you take your TB treatment? 
1. No   (  ) 
2. Yes (  ) 
 
4.4 If yes, who is your treatment supporter? If no, skip to question 4.5 
1. Rural health motivator  (  ) 
2. Community volunteer (  ) 
3. Health care provider (  ) 
4. Neighbours    (  ) 
5. Family member  (  ) 
6. Adherence officer  (  ) 
7. More than one response (  ) 
 
4.5 What motivates you to take your TB treatment?  
1. Wish to return to work              (  ) 
2. Wish to see my children finishing school  (  ) 
3. Wish to live longer               (  ) 
4. To have family support              (  ) 
 
4.6 Did you receive any adherence counselling prior to being initiated on TB treatment? 
1. No   (  ) 
2. Yes  (  ) 
 
4.7 If yes, who offered you the counselling on adherence? If no, skip to question 4.11 
1. Family member   (  ) 
2. Expert client  (  ) 
3. Health care provider   (  ) 
 
4.8 Do you receive health education on TB at your health facility? 
1. No  (  ) 
2. Yes (  ) 
 
4.9 If yes, who offers the health education to you? If no skip to question 5.1 
1. Client expert  (  ) 
2. Health care provider  (  ) 
 
4.10 If you receive the health education or counselling, how does it assist you?  
1. Makes me feel better that TB is curable                   (  ) 
2. Helps me recognize the dangers of non-adhering to TB treatment (  ) 
3. Helps me to teach others about TB          (  ) 
4. Empowers me with knowledge about TB and its treatment       (  )  










5.0 FACTORS YOU PERCEIVE TO BE BARRIERS TO ADHERING TO YOUR TB TREATMENT 
5.1 How far are you from your health facility? 
1. About 5 km (  ) 
2. About 6 to 8 km  (  ) 
3. About 9 to 10 km  (  ) 
4. More than 10 km  (  ) 
 
5.2 Are you able to honour your treatment refill appointment dates? If yes, skip to question 5.4 
1. No   (  ) 
2. Yes  (  ) 
 
5.3 If no to 5.2, what could be the cause? Responses may be more than one. 
1. Lack of transport money   (  ) 
2. Unavailability of transport  (  ) 
3. I am usually sick    (  ) 
4. I usually forget    (  ) 
5. More than one responses  (  ) 
 
5.4 Is your TB treatment always available at your health facility? If yes, skip to question 5.6 
1. Not sure  (  ) 
2. No           (  ) 
3. Yes          (  ) 
 
5.5 If no, which steps do you usually take? 
1. Buy from pharmacy      (  ) 
2. Ask from other clients  (  ) 
3. Wait until its available  (  ) 
 
 
5.6 How do you take your pills? 
1. Anyhow             (  ) 
2. As written on the pill containers       (  ) 
3. As advised in the health care facility (  ) 
4. More than one response        (  ) 
 
5.7 Do you experience any side effects as you take your pills? If no, skip to question 5.10 
1. No   (  ) 
2. Yes  (  ) 
 
5.8 If yes, what are those side effects? 
1.   Fever        (  ) 
2.   Ringing ears       (  ) 
3.   Nausea and vomiting (  ) 
4.   Poor appetite       (  ) 






6.  Skin disorders       (  ) 
7.  Polyuria        (  ) 
8.  Abdominal discomfort (  ) 
9.  Fatigue    (  ) 
10. Discoloured urine   (  ) 
11. Tingling, burning or numbness of hands and feet (  ) 
12. More than one response      (  ) 
  
5.9 If there are side effects, what steps do you take? 
1. I continue taking the pills            (  ) 
2. I stop taking the pills for a while and then resume (  ) 
3. I report the side effects to the health care facility   (  ) 
4. More than one response       (  ) 
5. Don’t know        (  ) 
 
5.10 Is there any other barrier which disrupts your adherence to treatment? If no, skip to question 
5.12 
1. No   (  ) 
2. Yes  (  ) 
 
5.11 If yes, what could be those barriers?  
 1. Lack of food         (  ) 
 2. Sick continuously            (  ) 
 3. Living alone                     (  )  
 4. Lack of social support     (  ) 
 5. More than one response (  ) 
 
5.12 Are you feeling any better since you started your TB treatment? If yes, skip to question 5.14 
1. Not sure (  ) 
2. No          (  ) 
3. Yes         (  ) 
 
5.13 If no, what do you think could be the cause? 
1. Having other illness besides TB  (  ) 
2. Pills make me feel worse   (  ) 
3. Lack of social support   (  ) 
4. Fall sick again   (  ) 
5. Lack of food    (  ) 
6. More than one response  (  ) 
 
5.14 Do you usually forget taking your pills? If no, skip to question 5.17 
1. No   (  ) 
2. Yes  (  ) 
 
5.15 If yes, which step do you take after realizing? 
 1. Take double dose next time        (  ) 
 2. Take medication immediately as I remember (  ) 






4. Wait for the next dose to take pills      (  ) 
5. More than one response       (  ) 
6. I stop treatment         (  )  
 
5.16 If no to 5.14, what reminds you to take your pills? 
 1. I just feel it that I have to take the pills (  ) 
 2. A friend   (  ) 
 3. A family member  (  ) 
 4. I set the time (  ) 
            5. More than one response (  ) 
 
5.17 If yes to 5.14, what do you think are the consequences of forgetting the treatment?  
1. I will develop resistant to the treatment (  ) 
2. I will acquire other diseases              (  ) 
3. I will not be cured of TB                  (  )   
4. More than one response            (  ) 
5. Don’t know             (  ) 
 
5.18 Are you treated for any other disease, other than the TB? If no, skip to question 5.21 
1. No   (  ) 
2. Yes  (  ) 
 
 5.19 If yes, for what?  
1. Cancer         (  ) 
2. Gastrointestinal problem   (  ) 
3. Diabetes    mellitus              (  ) 
4. Hypertension                (  ) 
5. HIV/AIDS          (  ) 
6. More than one response  (  ) 
 
5.20 How many pills are you taking per day? 
 1. More than 5 pills     (  ) 
 2. 5 pills   (  ) 
 3. 4 pills   (  ) 
 4. 3 pills   (  ) 
 5. Less than 3 pills  (  ) 
 
5.21 Are you able to take them as prescribed? If yes, skip to question 5.23. 
1. Yes   (  ) 
2. No   (  ) 
 
5.22 If no, what could be the reason?  
1. Long period  (  ) 
2. Pill burden   (  ) 
3. Side effects  (  ) 









5.23 How is your relationship with the health care providers? 
1. Poor  (  ) 
2. Good (  ) 
3. Excellent (  ) 
 
5.24 If poor, what could be the reason? 
1. Always busy   (  ) 
2. Short staffed   (  ) 
3. Poor communication  (  ) 
4. Attitude    (  ) 
 
6.0 Any additional barrier to TB treatment adherence?  
...........................................................................................................................................
...............................................................................................................................  









































ANNEXURE H: SISWATI VERSION 
 
LITFULUSI LEKUGCOGCA LWATI ETIGULANENI LETINESIFO SESIFUBA SENGATI 
Imibuto kulolucwaningo yakhiwe ngendlela lehambelana nenhloso, nemigomo nangekucombelela 
imiphumela. Timphendvulo titomakwa kumcwangingi emabhokisini. 
Inombolo yalongenele --------------------------------------------------------- 
1.0 LWATI NGENHLALO YAKHO  
1.1. Iminyaka yakho ------------------------------------------ 
1.2. Bulili: 
1. Ngimdvuna   (  )  
2. Ngimsikati   (  )  
 
1.3. Sigaba sekwendza: 
1. Angikendzi      (  ) 
2. Ngendzile      (  ) 
3. Ngahlukanisa ngekwemtsetfo   (  ) 
4. Angihlali ndzawonye nalengivana naye      (  ) 
5. Ngingumfelokati     (  ) 
6. Ngingumasihlalisane     (  ) 
 
1.4. Kuhlala kwakho: 
1. Emaphandleni     (  ) 
2. Edolobheni      (  ) 
3. Emacentselweni nelidolobha/eskomu   (  ) 
 
1.5. Sigaba semfundvo: 
1. Angikafundzi       (  ) 
2. Nginemfundvo yasesigabeni lesincane    (  ) 
3. Nginemfundvo yasesigabeni lesisemkhatsini           (  ) 
4. Nginemfundvo yasesigabeni lesisetulu              (  ) 
5. Nginemfundvo yasesigabeni sekufundzela    (  ) 
 
1.6. Sigaba sekusebenta: 
1. Angisebenti   (  ) 
2. Ngiyasebenta  (  ) 
3. Ngiyatisebenta (  )  
 
1.7. Inkholo: 
1. Kute    (  ) 
2. Budloti   (  ) 
3. Busathane   (  ) 
4. BuKrestu  (  ) 
5. BuIslam   (  ) 







2.0. LWATI NGALOKUHAMBISANA NESIFUBA SENGATI 
2.1 Sonesikhatsi lesinganani ulashelwa sifuba sengati? 
1. Tinyanga letintsatfu kuya kuletine     (  ) 
2. Tinyanga letisihlanu kuya kuletisitfupha    (  ) 
3. Tiyanga letisikhombisa kuya kuletisiphohlongo   (  ) 
4. Kungetulu kwetinyanga letiyimfica kodvwa angikacedzi (  ) 
5. Ngacedza kunatsa imitsi kodvwa wabuyiselwa emuva  (  ) 
6. Ngayekela emkhatsini kodvwa ngabuyiselwa emuva   (  ) 
 
2.2. Sitsini simo sakho sengati ngeligciwane lembulalave? Uma sihlobile, chubeka uye kumbuto 2.4 
1. Angisati   (  ) 
2. Ngihlobile  (  )  
3. Nginalo   (  ) 
 
2.3. Uma unalo, uyawanatsa yini emaphilisi ekulintsintsibalisa? 
1. Chake    (  ) 
2. Yebo      (  ) 
 
2.4. Uyabhema yini? 
1. Chake (  ) 
2. Yebo              (  ) 
 
2.5. Uyabunatsa yini tjwala? 
1. Chake  (  ) 
2. Yebo  (  ) 
 
2.6. Ukhona yini emndenini wakho losesifo sesifuba sengati? Uma kute, chubeka uye kumbuto 3.1 
1. Kute   (  ) 
2. Ukhona   (  ) 
 
2.7. Uma akhona, uhlobene kanjani naye?  
  1. Ngumtali   (  ) 
 2. Wakitsi   (  ) 
 3. Malume/anti   (  ) 
 4. Sitsandzani   (  ) 
 5. Ngumgani   (  ) 
 6. Gogo/mkhuku  (  ) 
 7. Nguloniketwe ngemtsetfo  (  ) 
 8. Kungetulu kwakunye   (  ) 
 
3.0. TINKHOMBA LETIHAMBELANA NEMCONDVO 
3.1. Nguyiphi indlela loyisebentisako ekwelapheni noma ngabe ngusiphi sifo? 
1. Yakamoya   (  ) 
2. Yesilungu  (  ) 
3. Yesintfu   (  )  
4. Ngibhica sintfu nesilungu (  ) 







3.2. Kusho kutsini kuwe kunatsa emaphilisi ngekwetsembeka? 
1. Kunatsa onkhe malanga    (  ) 
2. Kunatsa ute ulanyulelwe kufa     (  ) 
3. Kunatsa ngendlela lolulekwe ngayo  (  ) 
4. Kunatsa ute ululame      (  ) 
5. Ngetulu kwakunye        (  ) 
 
3.3. Ngekucabanga kwakho sibangwa yini sifo sesifuba sengati? 
1. Sisicalekiso    (  ) 
2. Singemaloyo   (  ) 
3. Siyindalo    (  ) 
4. Ngemagciwane   (  ) 
5. Ngetulu kwakunye   (  ) 
6. Angati   (  ) 
7. Kubate emasotja emtimbeni  (  ) 
8. Kuhambelana ngeligciwane le HIV  (  ) 
9. Kubhema     (  ) 
 
3.4. Ngekucabanga kwakho, sitsatselwana njani sifuba sengati? 
 1. Ngekusebentisa tintfo tekudla ndzawonye  (  ) 
 2. Ngekusebentisa kwekulala kwalomunye  (  ) 
 3. Ngehabula lugwayi   (  ) 
 4. Ngekukhwehlela   (  ) 
 5. Ngetulu kwakunye   (  ) 
 6. Angati    (  )  
 
4.0. TINTFO LETISIKHUTSATEKO EKUNATSENI KAHLE EMAPHILISI 
 
4.1. Ikhona yini imbadalo loyitfolako ekunatseni emaphilisi esifo sesifuba sengati? 
1. Chake (  ) 
2. Yebo   (  ) 
 
4.2. Uma ikhona, ngulenjani? Uma kute chubeka uye kumbuto 4.3 
1. Lucingo                   (  ) 
2. Kudla                  (  ) 
3. Yimali    (  ) 
4. Ngetulu kwakunye   (  ) 
 
4.3. Kukhona yini kusekeleka lokuftolako endzaweni lophila kiyo usanatsa imitsi yesifo sesifuba sengati? 
1. Kute         (  ) 
2. Kukhona        (  ) 
 
4.4. Uma kukhona, ngubani lokusekelako? Uma kute, chubeka uye kumbuto 4.5  
1. Ngumgcugcuteli wetemphilo  (  ) 
2. Livolontiya lemmango   (  ) 
3. Ngulosebenta emtfolamphilo   (  ) 
4. Ngumakhelwane    (  ) 
5. Ngulomunye wemndeni   (  ) 






7. Ngetulu kwakunye    (  ) 
 
4.5 Yini lokukukhutsata kutsi unatse emaphilisi? 
 1. Kufisa kubuyela emsebentini   (  ) 
 2. Kufisa kubona bantfwabami bacedza sikolwa (  ) 
 3. Kufisa kuphela kabanti   (  ) 
 4. Kusekeleka emndenini   (  ) 
 
4.6 Wakutfola yini kwelulekwa ngaphambi kwekucala kunatsa imitsi yesifuba sengati? 
1. Chake (  ) 
2. Yebo   (  ) 
 
4.7 Uma welulekwa, ngubani?  
1. Ngulomunye emndenini  (  ) 
2. Sigulane lesinelwati    (  ) 
3. Nguloniketa temphilo  (  ) 
   
4.8 Uyakutfola yini kufundziseka ngesifo sesifuba sengati emtfolampilo wakho? 
1. Angikutfoli    (  ) 
2. Ngiyakutfola  (  ) 
 
4.9 Uma ufundziseka, ngubani lokufundzisako? Uma ungakutfoli, chubeka uye kumbuto 5.1 
1. Ngulomunye emndenini  (  ) 
2. Sigulane lesinelwati    (  ) 
3. Nguloniketa temphilo  (  ) 
  
4.10 Uma ufundziseka, kukusita njani? 
1. Ngungeta ngitive ngincono             (  ) 
2. Kungenta ngibone tingoti tekunganatsi kahle emaphilisi          (  ) 
3. Kungenta ngikhone kufundzisa labanye           (  ) 
4. Kunginika lwati ngalesifo nekwelashwa kwaso                   (  ) 
5. Ngetulu kwakunye               (  ) 
 
5.0. TINTFO LOTIVA TITIVIMBO EKUNATSENI IMITSI 
 
5.1 Ukhashane kanganani umtfolamphilo wakho?  
1. Kungaba ngemabamnga lasihlanu emakhilomitha            (  ) 
2. Kungaba ngemabanga langu sitfupha kuya kulasiphohlongo emakhilomitha (  ) 
3. Kungaba ngemabanga layimfica kuya kulalishumi emakilomitha          (  ) 
4. Kungaba ngemabanga langetulu kwelishumi emakhilomitha           (  ) 
 
5.2 Uyakhona yini kuhlonipha lilanga lakho lekuyolandza imitsi yakho yesifo sesifuba sengati? Uma 
ukhona, chubeka uye kumbuto 5.4 
1. Angikhoni   (  ) 
2. Ngiyakhona    (  ) 
 
5.3 Uma ungakhoni, ngabe yini imbangela yaloko. Timphendvulo tingaba ngetulu kwayinye. 






2. Kubate kwekuhamba          (  ) 
3. Ngisuke ngigula       (  ) 
4. Ngiyakhohlwa       (  ) 
5. Ngetulu kwakunye                       (  ) 
 
5.4 Ngabe imitsi yakho yesifo sesifuba sengati ivamisile yini kuba khona emtfolamphilo wakho? Uma 
ikhona, chubeka uye kumbuto 5.6 
1. Anginasiciniseko  (  ) 
2. Ayibi khona     (  ) 
3. Ibakhona    (  ) 
 
5.5 Uma kute, uvamise kwenta njani? 
 1. Ngitsenga ekhemisi   (  ) 
 2. Ngicela kuletinye tigulane  (  ) 
 3. Ngiyema ate abekhona (  ) 
 
5.6 Uwatsatsa njani emaphilisi akho? 
1. Nome kanjani     (  ) 
2. Njengoba kubhaliwe ebhokisini lemaphilisi  (  ) 
3. Njengoba ngitjeliwe emtfolamphilo        (  )         
4. Ngetulu kwakunye     (  ) 
 
5.7 Ikhona yini imivuka levelako usanatsa imitsi yakho? Uma kute, chubeka uye kumbuto 5.10  
1. Kute   (  ) 
2. Ikhona      (  ) 
 
5.8 Uma ikhona, nguyiphi? 
 1. Kushisa     (  ) 
 2. Umsindvo emadlebeni   (  ) 
 3. Kufuna kuhlanta nekuhlanta   (  ) 
 4. Kubate inkhaphunkhaphu yekudla  (  ) 
 5. Kungalali kahle ebusuku   (  ) 
 6. Tifo tesikhumba    (  ) 
 7. Kuchamela futsi    (  ) 
 8. Kubulawa sisu    (  ) 
 9. Kudzinwa     (  ) 
 10. Umbala lohlukile wemcamo   (  ) 
 11. Kuba buhlungu kwetinyawo netandla(  ) 
 12. Ngetulu kwakunye    (  ) 
 
5.9 Uma ikhona, wenta njani? 
1. Ngichubeka nginatse emaphilisi (  ) 
2. Ngiyayekela kunatsa emaphilisi (  ) 
3. Ngiya emtfolampilo ngibike        (  ) 
4. Ngetulu kwakunye     (  ) 









5.10 Kukhona yini lokunye lokungenta unganatsi imitsi yakho kahle? Uma kute, chubeka uye kumbuto 
5.12 
1. Kute   (  ) 
2. Kukhona        (  ) 
 
5.11 Uma kukhona, kungaba yini?  
1. Kubate kudla  (  ) 
2. Kugulela futsi  (  ) 
3. Kuhlala ngedvwa  (  ) 
4. Kubate umsekeli  (  ) 
5. Ngetulu kwakunye  (  ) 
 
5.12. Kukhona yini buncono solo wacala kulashelwa sifo sesifuba sengati? Uma Bukhona, chubeka uye 
kumbuto 5.14 
1. Kute        (  ) 
2. Kukhona (  ) 
 
5.13 Uma kute, ucabanga kutsi kungabangwa yini?  
 1. Kuba naletinye tifo ngaphandle kwalesi  (  ) 
 2. Lamaphilisi enta simo siyembili   (  ) 
 3. Kubate umsekeli     (  ) 
 4. Kugulela futsi     (  ) 
 5. Kubate kudla     (  ) 
 6. Ngetulu kwakunye     (  ) 
 
5.14 Uke uwakhohlwe yini kuwanatsa emaphilisi? Uma ungawakhohlwa, chubeka uye kumbuto 5.17 
1. Chake   (  ) 
2. Yebo     (  ) 
 
5.15 Uma ukhohlwa, yini lobese uyakwenta? 
1.  Ngiwanatsa ngalokuphindziwe   (  ) 
2.  Ngiwanatsa uma sengikhumbula    (  ) 
3. Ngibikela bemtfolampilo    (  ) 
4. Ngimela sikhatsi lesinye sekuwanatsa  (  ) 
5. Ngetulu kwakunye     (  ) 
6. Ngiyawayekela kuwanatsa    (  ) 
 
5.16 Uma ungakholwa kumbuto 5.14, yini lekukhumbutako? 
 1. Ngiyeva nje emtimbeni (  ) 
 2. Ngumngani    (  ) 
 3. Ngulomunye wemndeni  (  ) 
 4. Ngicipha sikhatsi   (  ) 
 5. Ngetulu kwakunye   (  )  
 
5.17 Uma ukhohlwa kumbuto 5.14, yini umphumela wekukhohlwa kunatsa emaphilisi?  
1. Kutfola ligciwane leligwamile lesifo sesifuba sengati   (  ) 






3. Angeke ngilapheke kahle                                         (  ) 
4. Ngetulu kwakunye      (  ) 
5. Angati       (  ) 
 
5.18. Kukhona yini lesinye tifo lolashelwasona ngaphandle kwesifuba sengati? 
1. Chake    (  ) 
2. Yebo      (  ) 
 
5.19. Uma sikhona, ngusiphi? 
 1. Ngumdlavuza  (  ) 
 2. Sifo sesisu   (  ) 
 3. Sifo sashukela  (  ) 
 4. Sifo sehayihayi  (  ) 
 5. Ligciwane lembulalave (  ) 
 6. Ngetulu kwakunye     (  ) 
 
5.20. Utsatsa mangakhi emaphilisi ngelilanga? 
 1. Ngetulu kwalasihlanu (  ) 
 2. Lasihlanu   (  ) 
 3. Lamane   (  ) 
 4. Lamatsatfu   (  ) 
 5. Ngephansi kwalamatsatfu (  ) 
 
5.21. Uyakhona kuwanatsa Njengoba utjeliwe? Uma ukhona, chubeka uye kumbuto 5.23 
 1. Yebo  (  ) 
 2. Chake  (  ) 
 
5.22 Uma ungakhoni, ngutiphi tizatfu? 
 1. Sikhatsi lesidze sekunatsa emaphilisi  (  ) 
 2. Kudzinwa kunatsa emaphilisi   (  ) 
 3. Imivuka     (  ) 
 4. Ngetulu kwakunye    (  ) 
 
5.23. Budlelwano bakho netisebenti temtfolamphilo bunjani? 
1. Bubi    (  ) 
2. Buhle      (  ) 
3. Buhle kakhulu    (  ) 
 
5.24. Uma bungasiko lobuhle, ngabe bubangwa yini? 
 1. Baba matasatasa    (  ) 
 2. Kushoda kwetisebenti   (  ) 
 3. Kubate kukhulumiseka kahle   (  ) 
 4. Kungaphatseki kahle ngetento  (  ) 
  











DATA COLLECTION INSTRUMENT FOR TB EXPERTS  
This structure questionnaire is in accordance to the study’s purpose, objectives and hypothesis and HBM 
tenets. 
Instructions: Please respond to all questions. Put a tick in the box against the response you feel is 
appropriate for the question. 
Code no. ---------------------------------- 
1.0 DEMOGRAPHIC DATA  
1.1 Age:  
1. 20-29  (   )   
2. 30-39  (   )   
3. 40-49  (   )   
4. 50-59  (   ) 
 
1.2 Gender:  
1. Male  (   )   
2. Female  (   )    
3. Bisexual  (   ) 
 
1.3 Marital Status:  
1. Single  (   )   
2. Married (   )   
3. Divorced (   )   
4. Separated     (   ) 
4. Widowed  (   ) 
5. Cohabiting    (   ) 
 
1.4 Residential Level: 
1. Rural  (  ) 
2. Urban  (  ) 
3. Peri-urban  (  ) 
 
1.5 Educational Level:  
1. Certificate (  ) 
2. Diploma  (  ) 
3. Bachelor’s Degree  (  ) 
4. Master’s degree (  ) 
5. Doctorate degree  (  ) 
 
1.6 Employment Status:  
1. Nurse  (   )  






3. Expert  (   )  
4. Program Officer (   ) 
 
1.7 Religion: 
1. None   (  ) 
2. Traditional  (  ) 
3. Christianity  (  ) 
4. Satanism   (  ) 
 
2.0 EXPERT STRUCTURAL FACTORS 
 
2.1 How long have you been working in this TB facility?............years/months 
2.2 Are you using any TB guidelines in this facility? 
 1. No  (   ) 
 2. Yes  (   ) 
 
2.3 If yes, specify the type of guideline 
1. WHO    (   ) 
2. Health facility made   (   ) 
3. Swaziland Ministry of Health (   ) 
4. More than one    (   ) 
 
2.4 Are the medications listed in the guidelines available in your facility? 
1. No, they are not available  (   ) 
2. Some drugs are not available (   ) 
3. Yes, they are available   (   ) 
 
2.5 If they are not available, what could be the reason?   
      
1. I am not sure   (   ) 
2. Lack of transport money  (   ) 
3. Unsafe drug storage area  (   ) 
4. Inadequate drug quantities   (   ) 
5. Delayed ordering process  (   ) 
 
2.6 Which action do you take when there are no TB drugs in the facility? 
1. I give them another appointment date   (   ) 
2. I give them the available alternative drugs (   ) 
3. I send them back home     (   ) 
4. I report the issue to the TB clinic manager  (   ) 
 
2.7 Which procedure(s) do you follow when a TB client is initiated on treatment for the first time? You may 
tick more than one response.  
1. Admit client for closer monitoring and tests procedures (   ) 
2. Advise client on compliance o the therapy   (   ) 
3. Advise client on honouring treatment appointment dates  (   ) 
4. Refer client to an adherence officer   (   ) 






2.8 Is there any TB treatment adherence assessment you conduct on the clients who are on treatment?  
1. No (   ) 
2. Yes (   ) 
 
2.9 If yes, which one(s). If no, skip to question 2.10. 
1. DOT    (   ) 
2. Pill count   (   ) 
3. Client self-reporting (   ) 
4. Check monthly treatment record when re-supplying drugs (   ) 
5. Trace clients who miss appointments         (   ) 
6. More than one response                       (   ) 
 
2.10 According to you, how are your clients doing in terms of adherence to their treatment? 
1. Poor    (   ) 
2. Moderate  (   ) 
3. Good  (   ) 
4. Very good  (   ) 
 
2.11 If adherence is good or very good, what do you think is the cause? 
1. Incentives    (   ) 
2. Social support   (   ) 
3. Rapport with clients   (   ) 
 
2.12 If adherence is poor, what do you think is the cause? 
1. Lack of incentives   (   ) 
2. Lack of social support  (   ) 
3. Poor with clients   (   ) 
4. More than one response (   ) 
 
3.0 DETERMINANTS WHICH ENDHANCE ADHERENCE TO TB TREATMENT 
3.1 Do your clients receive incentives as they take the TB treatment? 
1. No  (   )   
2. Yes  (   )  
  
 3.2 If yes, what type of incentive do they receive? If no, skip to Question 3.3. 
     1. Phone (   ) 
     2. Money (   ) 
     3. Food ration (   ) 
     4. More than one response (   ) 
1. Cellphones   (   ) 
2. Money  (   )       
 3.3 Do you remind your clients about taking their medication?  
1. No      (   ) 
2. Yes      (   ) 
 
3.4 If yes, which method(s) do you use to remind them? If no, skip to question 4.1 
1. Send short message services (SMS)  (    ) 






3. DOT officer visitation     (    ) 
4. Contact family member    (    ) 
5. More than one method    (    ) 
 
4.0 BARRIERS TO ADHERENCE TO TB TREATMENT 
 
4.1 Do your clients keep their treatment refill appointment dates? 
1. No   (    ) 
2. Yes   (    ) 
4.2 If no, what do you think is the cause? If yes, skip to Question 4.3. 
1. Forgetfulness   (    ) 
2. Transport cost   (    ) 
3. Busy    (    ) 
4. Client’s decision   (    ) 
5. Illness   (    ) 
6. More than one response (    ) 
 
4.3 Do you clients report any side effects? 
 1. No    (   ) 
 2. Yes     (   ) 
 
4.4 If yes, which side effect (s) is commonly reported? If no, skip to question 4.6. 
1. Fever   (   ) 
2. Ringing ears   (   ) 
3. Nausea and vomiting  (   ) 
4. Poor appetite   (   ) 
5. Sleepless nights  (   ) 
6. Skin disorders  (   ) 
7. Polyuria   (   ) 
8. Abdominal discomfort (   ) 
9. Fatigue   (   ) 
10. Discoloured urine  (   ) 
11. Tingling, burning or numbness of hands and feet       (   ) 
12. More than one response     (   ) 
   
 4.5 If yes to 4.3, which steps do you take after the clients have reported the side effect?  
1. Switch to another regimen if side effects are severe   (   ) 
2. Give medication to treat side effects   (   ) 
3. Report to the TB clinic manager    (   ) 
4. Advise to stop taking the tablets     (   ) 
5. More than one        (   ) 
 
4.6 Do you teach your clients about the importance of adhering to TB treatment? 
1. No    (   ) 
2. Yes    (   ) 
 
4.7 If yes, how are the responses from the clients on adherence? If no, skip to question 4.8.? 






2. Promising   (   ) 
3. Very promising   (   ) 
 
4.8 Which problems are barriers to the clients adherence do you come across with?   
1. They just disappear   (   ) 
2. They take too much alcohol  (   ) 
3. They have other illnesses (   ) 
4. Lack of incentives   (   ) 
5. More than one response  (   ) 
 
4.9 State your opinion which you thin may hinder clients from adhering to their TB treatment, as shown in 
the able below. Please tick in the appropriate box:  
Key: 1. SA: Strongly agree; 2. A: Agree; 3. DU: Don’t understand; 4. D: Disagree; 5. SD: Strongly 
Disagree 
Content SA A DU D SD 
1. 2. 3. 4. 5. 
1. Client’s Gender       
2. Client’s educational level       
3. Transport Costs      
4. Distance to the health facility       
5. Treatment supporter       
6. Length of treatment       
7. Side effects       
8. Food availability at home      
9. Knowledge about TB       
10. Belief system      
 
5.0 Is there any additional hindrance to clients’ adherence to TB treatment? 
----------------------------------------------------------------------------------------------------------------------------- ---------------
-------------------------------------------------------------------------------------------------------------------- -------------- 










ANNEXURE I: SISWATI VERSION 
 
LITFULUSI LEKUGCOGCA LWATI KULABASEBENTA NGESIFO SESIFUBA SENGATI 
Imibuto kulolucwaningo yakhiwe ngendlela lehambelana nenhloso, nemigomo nangekucombelela 
imiphumela. Timphendvulo titomakwa ngulongenele lolucwaningo emabhokisini laniketiwe. 
Uyacelwa uphendvule yonkhe imibuto. Faka luphawu ngekumaka eceleni kwemphendvulo lova ungatsi 
ingiyo. 
Inombolo yalongenele --------------------------------------------------------------------------- 
1.0 LWATI NGENHLALO YAKHO 
1.1 Iminyaka yakho: 
1. 20-29 (  ) 
2. 30-39 (  )    
3. 40-49 (  )  
4. 50-59 (  ) 
                                                                                      
1.2 Bulili: 
1. Ngimdvuna   (  )  
2. Ngimsikati   (  )  
3. Ngiyimphacambili  (  ) 
 
1.3 Sigaba sekwendza: 
1. Angikendzi       (  ) 
2. Ngendzile       (  ) 
3. Ngahlukanisa ngekwemtsetfo    (  ) 
4. Angihlali ndzawonye nalengivana naye (  ) 
5. Ningumfelokati      (  ) 
6. Ngingumasihlalisane      (  ) 
 
1.4 Kuhlala kwakho: 
1. Emaphandleni    (  ) 
2. Edolobheni     (  ) 
3. Emacentselweni nelidolobha/eskomu  (  ) 
  
1.5 Sigaba semfundvo: 
1. Sitifiketi    (  ) 
2. Ngine Diploma   (  ) 
3. Ngine Degree   (  ) 
4. Ngine Master’s Degree  (  ) 
5. Ngine Doctorate Degree  (  ) 
 
1.6 Sigaba sekusebenta: 
1. Ngingunesi    (  ) 






3. Ngingu lobukela kunatsa kahle emaphilisi  (  )  
1.7 Inkholo: 
1. Kute   (  ) 
2. Sintfu           (  ) 
3. BuKrestu  (  ) 
4. Busatane  (  ) 
5. BuIslam  (  ) 
6. BuJuda  (  ) 
 
2.0 LWATI NGALOKUHAMBELANA NESIFUBA SENGATI 
 
2.1 Sonesikhatsi lesinganani usebenta kulotfolamphilo wesifo sesifuba sengati? ---------------- 
2.2 Ukhona yini umkhombandlela lowusebentisako wesifo sesifuba sengati kulomtfolamphilo? 
1. Kute   (  ) 
2. Ukhona       (  ) 
 
2.3 Uma ukhona, ngabe ngumuphi? 
1. Wakamhlabuhlangene wetemphilo     (  ) 
2. Wemtfolamphilo letakhele wona   (  ) 
3. Ngulewakhiwe litiko letemphilo eSwatini  (  ) 
4. Ngetulu kwakunye                           (  ) 
 
2.4 Ingabe lemitsi lekumkhombandlela iyatfolakala yini la emtfolamphilo? 
1. Ayitfolakali   (  ) 
2. Ayitfolakali yonke  (  ) 
3. Iyatfolakala   (  ) 
 
2.5 Uma ingatfolakali, ingabe kubangwa yini? 
1. Anginasiciniseko     (  ) 
2. Kubate kwekutfwala imitsi          (  ) 
3. Kungavikeleki kwendzawo lagugcinwa khona imitsi  (  ) 
4. Kute kahle linani      (  ) 
3. Imitsi ayifiki ngesikhatsi    (  ) 
 
2.6 Wentanjani uma kute imitsi yetigulane? 
1. Ngibanika lilanga lelinye lokubuya  (  ) 
2. Ngibanika umutsi lokhona kuphela  (  ) 
3. Ngivele ngibancandze baye ekhaya  (  ) 
4. Ngibikela baphatsi    (  ) 
 
2.7 Nchubo yini loyilandzelako uma sigulane siniketwa emaphilisi esifo sesifuba sengati kwekucala? 
Timphendvulo tingaba ngetulu kwayinye. 
1. Siyamlalisa atocwaningwa kabanti        (  ) 
2. Siyameluleka ngekunatsa ngekwetsembeka imitsi yakhe     (  ) 
2. Simtjela kutsi abuye ngesikhatsi latjelwe ngaso kutogcwalisa emaphilisi (  ) 
4. Simmikisa kulokhokhela ngekunatsa kahle emaphilisi      (  ) 







2.8 Ikhona yini indlela leniyisebentisako yekubuka kutsi sigulane ngabe sinatsa ngekwetsembeka 
emaphilisi aso? 
1. Kute      (  ) 
2. Ikhona  (  ) 
2.9 Uma ikhona, ndlela yini? Uma kute, phendvula umbuto 2.10 
 1. Kunatsa emaphilisi embikwe sisebenti semphilo  (  ) 
 2. Kubala emaphilisi      (  ) 
 3. Kuva ngesigulane      (  ) 
 4. Kuhlola kunatsa kwemaphilisi kwenyanga   (  ) 
 5. Kulandzelela labo labapholotile    (  ) 
 6. Ngetulu kwakunye       (  ) 
 
2.10 Ngekucabanga kwakho ngabe tigulane takho tichuba njani ngekwetsembeka kunatsa imitsi? 
1. Kubi    (  ) 
2. Kusemkhatsini  (  ) 
2. Kuhle       (  ) 
3. Kuhle kakhulu   (  ) 
 
2.11 Uma kukahle noma kukahle kakhulu, ngabe kubangwa yini kutsi betsembeke?  
 1. Imbadalo   (  ) 
 2. Kusekeleka   (  ) 
 3. Budlelwano lobuhle  (  ) 
 
2.12 Uma kukubi, yini imbangela yaloko?  
 1. Kubate imbadalo  (  ) 
 2. Kungasekeleki  (  ) 
 3. Budlelwane lobubi  (  ) 
 4. Ngetulu kwakunye  (  ) 
 
3.0 TINKHOMBA LETIKHUTSATA KUNATSA IMITSI NGEKWETSEMBEKA 
 
3.1 Ngabe tigulane takho tiyayitfola yini imbadalo (incentives) tisanatsa emaphilisi esifo sesifuba sengati? 
1. Kute    (  ) 
2. Ikhona (  ) 
 
3.2 Uma ikhona, ngulenjani? Uma kute, chubeka uye kumbuto 3.3 
1. Lucingo    (  ) 
2. Yimali    (  ) 
2. Kudla lokukaliwe   (  ) 
3. Ngetulu kwakunye  (  ) 
  
3.3 Niyatikhumbuta yini tigulane takho ngekunatsa emaphilisi? 
1. Chake    (  ) 
2. Yebo      (  ) 
 
3.4 Uma nitikhumbuta, tindlela tini lenitisebentisako kukhutsata tigulane kunatsa ngekwetsembeka 
emaphilisi? Uma kute, chubeka uye kumbuto 4.1 






2. Sishaya lucingo     (  ) 
3. Tisebenti temitsi tiyabavakashela emakhaya  (  ) 
4. Sitsintsa lomunye wemndeni    (  ) 
5. Ngetulu kwakunye     (  ) 
 
4.0 TINTFO LETITIVIMBEKO EKUNATSENI EMAPHILISI NGEKWETSEMBEKA 
4.1 Ingabe tigulane takho tiyatigcina yini tinsuku tekulandza imitsi yato? 
1. Chake   (  ) 
2. Yebo     (  ) 
 
4.2 Uma bangatigcini, ucabanga kutsi ngabe kubangwa yini? Uma batigcina, chubeka uye kumbuto 4.3.  
1. Kukhohlwa   (  ) 
2. Tindleko tekuhamba   (  ) 
3. Kuba matasatasa (  ) 
4. Kutincomela   (  ) 
5. Kugula   (  ) 
6. Ngetulu kwakunye  (  ) 
 
4.3 Ikhona yini imivuka labayibikako basanatsa emaphilisi? 
1. Kute   (  ) 
2. Ikhona  (  ) 
 
4.4 Uma ikhona, kuvamise kuba yini? Uma kute, chubeka uye kumbuto 4.6 
 1. Kushisa     (  ) 
 2. Umsindvo emadlebeni   (  ) 
 3. Kufuna kuhlanta nekuhlanta   (  ) 
 4. Kubate inkhaphunkhaphu yekudla  (  ) 
 5. Kungalali kahle ebusuku   (  ) 
 6. Tifo tesikhumba    (  ) 
 7. Kuchamela futsi    (  ) 
 8. Kubulawa sisu    (  ) 
 9. Kudzinwa     (  ) 
 10. Umbala lohlukile wemcamo   (  ) 
 11. Kuba buhlungu kwetinyawo netandla(  ) 
 12. Ngetulu kwakunye   
 
4.5 Ubese sewenta njani uma babika lemivuka?  
1. Ngiyabashintja kuleminye imitsi   (  ) 
2. Ngibanika umutsi wekwelapha imivuka  (  ) 
3. Ngibapota kumphatsi wemtfolamphilo  (  ) 
4. Ngibayala kutsi bawayekele emaphilisi  (  ) 
5. Ngetulu kwakunye     (  ) 
 
4.6 Uyatifundzisa yini tigulane ngebumcoka bekunatsa emaphilisi ngekwetsembeka? 
1. Chake  (  ) 
2. Yebo     (  ) 
 






1. Atitsembisi   (  )  
2. Tiyetsembisa  (  ) 
3. Tiyetsembisa kakhulu (  ) 
 
4.8 Tingcinamba tini lobhekene nato etigulaneni takho mayelana nekunatsa kahle emaphilisi esifo 
sesifuba sengati? 
1. Bayanyamalala   (  ) 
2. Banatsa tjwala kakhulu   (  ) 
3. Banaletinye tifo   (  ) 
4. Kute imbadalo   (  ) 
5. Ngetulu kwakunye   (  ) 
 
4.9 Chatsanisa imibono yakho kulokulandzelako ngetinkhomba letihlupha tigulane kutsi tinganatsi imitsi 
yato ngekwetsembeka: Ngicela ukhombise imphendvulo yakho ngekufaka luphawu (kumaka) 
kulamabhokisi laniketiwe: 
 
Lokufinyetiwe nenchazelo: 1. NK: Ngivuma kakhulu; 2. N: Ngiyavuma; 3. AK: Angicondzi kahle; 4. 
A: Angivumelani; 5. AK: Angivumelani kakhulu 
Luhlu NK N AK A AK 
1. 2. 3. 4. 5. 
1. Bulili besigulane      
2.  Sigaba sekufundza 
kwesigulane 
     
3. Tindleko tekuhamba      
4. Libanga lokuya lemtfolamphilo       
5. Kuba  nalokusekelako 
ekunatseni imitsi 
     
6. Bundze sekwelashwa      
7. Imivuka      
8. Kuba khona kudla ekhaya      
9. Lwati ngesifo sesifuba sengati      
10. Inkholelo      
 
5.0 Yini lokunye longakungeta lokungaba yingcinamba ekunatseni emaphilisi esifuba sengati 
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